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Chapter 1
1. HeMatoPoIesIs
Hematopoiesis is the formation and development of blood cells. This process takes place in 
humans prenatally in the embryonic yolk sac in the first 3 to 6 weeks after gestation (Dzierzak 
et al., 1998; Palis and Yoder, 2001). By the third month of development, the fetal liver is the 
predominant hematopoietic organ and after birth, the bone marrow becomes the major site 
of hematopoiesis. All blood cells develop from hematopoietic stem cells (HSCs). An HSC has 
the ability to undergo asymmetric cell division, producing one identical stem cell daughter 
cell (self renewal) and one progenitor cell that has the potential to give rise to progeny of 
all blood cell lineages (pluripotency). The direct descendants of the pluripotent progenitors 
are the lineage restricted or committed progenitor cells, which proliferate and differentiate 
into distinct mature blood cells, i.e., granulocytes (neutrophils, eosinophils and basophils), 
lymphocytes, erythrocytes, monocytes (macrophages), natural killer cells, mast cells, platelets 
and dendritic cells (Figure 1).
Hematopoiesis is tightly controlled by hematopoietic growth factors (HGFs), which func-
tion through the activation of specific hematopoietic receptors. Interaction between a growth 
factor and its receptor promotes signal transmission and activates interacellular signaling 
cascades leading to cell proliferation and survival, while certain HGFs in addition control Chapter 1 
 
 
 
Figure 1. Schematic representation of the hematopoietic system 
 
Figure 1. schematic representation of the hematopoietic system
Pluripotent hematopoietic stem cells give rise to myeloid or lymphoid progenitor cells which develop into distinct 
mature blood cells. This process is regulated by various cytokines of which the major factors directing the last step 
of maturation are depicted. CMP: common myeloid progenitor; CLP: common lymphoid progenitor; MEP: mega-
karyocyte erythroid progenitor; GMP: granulocyte macrophage progenitor.
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cell differentiation and function. HGFs are glycoproteins that can be produced by multiple 
cell types, for instance fibroblasts, lymphocytes, monocytes/macrophages, stromal and en-
dothelial cells. Where the different HGFs act in the process of blood cell development is 
shown in Figure 1. Major HGFs are erythropoietin (Epo) driving erythropoiesis, the colony-
stimulating factors (CSFs) involved in myeloid cell development, various interleukins (IL-1 
to IL-13), the megakaryocytic growth factor thrombopoietin (TPO), and stem-cell factor 
(SCF) and FLT3 ligand which are growth factors for pluripotent progenitor cells. The CSFs 
include granulocyte-CSF (G-CSF), granulocyte-macrophage CSF (GM-CSF), multipotential 
CSF (multi-CSF, also known as IL-3), and monocyte/macrophage CSF (M-CSF, also known 
as CSF-1).
Most of HGFs support the proliferation of early progenitors and have limited ability to 
induce differentiation. G-CSF, however, regulates both proliferation and differentiation of 
myeloid progenitors to neutrophils, which are crucial blood cells for host defense system 
against infections.
2. G-csF and Its recePtor
G-CSF is a member of the cytokine class I superfamily. The G-CSF gene (now referred to as 
CSF3) is located on human chromosome 17 at position q11-22 (Kanda et al., 1987). G-CSF is 
produced by a variety of cells, of which monocytes and macrophages are the most prominent 
examples (Demetri and Griffin, 1991). G-CSF plays crucial roles in myeloid progenitor cell 
proliferation, survival and maturation in steady state conditions as well as during stages of 
bacterial infections, when neutrophil levels need to be increased (“emergency” granulopoi-
esis). Increased production and release of G-CSF is observed following stimulation with 
bacterial lipopolyssacharide (Kolb-Maurer et al., 2004; Lieschke et al., 1994) and some 
cytokines such as TNF (Koeffler et al., 1987), IL-1 (Fibbe et al., 1988; Zsebo et al., 1988) and 
IL-3 (Oster et al., 1989). G-CSF-deficient mice (csf3-/-) are viable, fertile, and superficially 
healthy, but have a chronic neutropenia and are unable to control bacterial infection such 
as Listeria monocytogenes, supporting the essential role of G-CSF in “emergency” situations 
(Lieschke et al., 1994).
Recombinant G-CSF treatment has been used clinically to reduce the duration of neutrope-
nia and infection risk following chemotherapy. More importantly, G-CSF treatment restores 
neutrophil production in patients with severe forms of chronic or congenital neutropenia, 
thereby reducing the risk of severe recurrent infections and related mortality (Dale et al., 
1993; Welte and Boxer, 1997). Finally, because G-CSF administration to stem cell donors 
results in mobilization of the HSCs into the peripheral blood, it is now routinely used in 
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hematopoietic stem cell harvest protocols. Since its introduction about 17 years ago, G-CSF 
has become one of the most successful recombinant proteins in clinical use.
The biological activities of G-CSF are mediated via the G-CSF receptor (G-CSFR), a member 
of the hematopoietin receptor superfamily. G-CSF binds to its receptor with high affinity (Kd: 
100-500pM). Human G-CSFR (CD114, also known as CSF3R) is encoded by a single gene 
(CSF3R) located on the short arm of chromosome 1. Murine and human G-CSFR proteins 
are single transmembrane polypeptides of 812 and 813 amino acids (130kDa), respectively, 
with an overall homology of 72.5% at the nucleotide level and 62.5% at the amino acid level 
(Fukunaga et al., 1990). The extracellular portion of the receptor has 603 amino acids and is 
composed of an immunoglobulin-like (Ig-like) domain, a cytokine receptor homology (CRH) 
domain with four conserved cysteine residues and a WSXWS motif that is essential for ligand 
binding, and three fibronectin type III (FN III) modules (Anaguchi et al., 1995; Fukunaga 
et al., 1991). The cytoplasmic domain of G-CSFR contains regions with limited structural 
similarity with other hematopoietic receptors termed box1, box2 and box3. The membrane 
proximal region that contains box1 and box2 is involved in transduction of proliferation 
signals. The membrane distal domain that contains box3 is essential for ligand-induced dif-
ferentiation signals of myeloid progenitor cell lines and is implicated in the transduction of 
phagocytic signals in mature neutrophils (Dong et al., 1993; Fukunaga et al., 1993; Santini et 
al., 2003).
In the hematopoietic system, G-CSFR is primarily expressed in neutrophil progenitors and 
mature neutrophils. The average receptor numbers per cell increase with maturation of the 
myeloid cells, with the highest numbers being expressed on peripheral neutrophils. However, 
G-CSFR can also be found on monocytes, myeloid and lymphoid leukemia cells, normal B 
and T lymphocytes and various non-hematopoietic cells and tissues, including endothelial 
cells, placenta and fetal organ tissues (Boneberg et al., 2000; Budel et al., 1989; Corcione et al., 
1996; Hanazono et al., 1990; Morikawa et al., 2002; Shimoda et al., 1993). Interestingly, recent 
studies have indicated that G-CSFR is upregulated on cardiomyocytes and neuronal cells after 
ischemic heart failure and stroke, respectively, and that G-CSF treatment in these conditions 
may be of clinical benefit (Harada et al., 2005; Li et al., 2006; Takano et al., 2003; Takano et 
al., 2006). G-CSFR deficient mice (csf3r-/-) show severe reduction in neutrophil levels which 
is approximately 15% of wild type (WT) littermates. Furthermore, myeloid progenitor cells 
are significantly decreased in the bone marrow of these mice (Liu et al., 1996).
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3. G-csF sIGnalInG
Similar to other members of the hematopoietin receptor superfamily, G-CSFR lacks intrinsic 
kinase activity and recruits members of the Janus tyrosine kinase (JAK) family to phosphory-
late tyrosine (Y) residues residing in its cytoplasmic domain. Human G-CSFR contains four 
conserved tyrosines located at positions 704, 729, 744, and 764.
Activation of the G-CSFR results in the activation of three members of the JAK family, 
JAK1, JAK2 and Tyk2 and of members of the Src kinase family (Nicholson et al., 1995; 
Nicholson et al., 1994; Shimoda et al., 1997; Shimoda et al., 1994; Ward et al., 1998). JAKs 
have seven defined regions of homology (JH1-JH7), among which JH1 and JH2 comprise the 
kinase and pseudokinase domains, respectively (Wilks et al., 1991; Ziemiecki et al., 1994). 
The N-terminal FERM domain (JH4-JH7) is necessary for binding to box1 and box2 regions 
of cytokine receptors (He et al., 2003; Hilkens et al., 2001; Zhou et al., 2001). Although the 
exact nature of JAK association with receptor remains to be resolved (Murray, 2007), it has 
been shown that tryptophan 650 (W650) located in the G-CSFR membrane-proximal region 
is necessary for JAK2 activation and proliferation signals (Barge et al., 1996).
Upon activation by G-CSF, G-CSFR is phosphorylated at four conserved tyrosines that serve 
as docking sites for SH2 domain-containing signaling proteins such as signal transducer and 
activator of transcription 3 (STAT3) and a variety of other down stream signaling proteins 
(Figure 2). Mutation of these tyrosines to phenylalanine revealed that they are differentially 
involved in growth regulatory functions. For instance, while tyrosine 764 (Y764) played an 
important role in promoting colony growth, Y729 showed inhibitory effects (Hermans et al., 
2003).
Among different members of the STAT protein family, STAT1, STAT3 and STAT5 are acti-
vated by the G-CSFR. Binding of STATs to an activated receptor complex brings them in prox-
imity of the JAKs, leading to their tyrosine phosphorylation, homo- or hetero-dimerization 
and translocation to the nucleus for binding to target gene promoters. Whereas activation of 
STAT1 and STAT5 requires the membrane-proximal region of G-CSFR, STAT3 activation 
depends on its recruitment to Y704 and Y744 of receptor (Chakraborty et al., 1999; Ward et 
al., 1999c). However, it was shown that tyrosine null G-CSFR can still activate STAT3 at high 
concentrations of G-CSF, suggesting that STAT3 activation by G-CSF in steady state versus 
emergency granulopoiesis is differentially regulated. (Akbarzadeh et al., 2002; Nicholson et 
al., 1996; Ward et al., 1999a)
Introduction of dominant negative forms of STAT3 interferes with growth arrest and neu-
trophil differentiation of 32D cells (de Koning et al., 2000; Shimozaki et al., 1997). Expression 
of G-CSFR mutant Y704F in mouse models revealed that STAT3 contributes in transduction 
of both proliferation and differentiation signals (McLemore et al., 2001). However, mice 
lacking STAT3 in their hematopoietic progenitors showed neutrophilia (Lee et al., 2002), 
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indicating that, in vivo, STAT3 is required for maintaining an appropriately balanced neu-
trophil production but is not essential for differentiation. The negative role of STAT3 on the 
 
Figure 2. signaling pathways coupled to G-csFr
Upon G-CSF stimulation tyrosines located at cytoplasmic domain of G-CSFR become phosphorylated By JAKs and 
serve as docking sites for various signaling molecules. Activation of different signaling pathways leads to positive or 
negative regulation of G-CSFR. See main text for functional implications.
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proliferation of myeloid progenitor cells has been attributed to two mechanisms: upregula-
tion of cyclin-dependent kinase inhibitor p27Kip1 (de Koning et al., 2000) and induction of the 
suppressor of cytokine signaling (SOCS) protein, SOCS3 (Lee et al., 2002; van de Geijn et al., 
2004a; van de Geijn et al., 2004b).
Unlike STAT3, activation of STAT5 occurs independently of phosphorylated tyrosines of 
G-CSFR via binding to activated JAK kinases (Fujitani et al., 1997). However maximal activa-
tion needs an additional domain encompassing Y704. STAT5 promotes proliferation and 
survival in response to G-CSF (Dong et al., 1998). In agreement with this, bone marrow cells 
from mice lacking both STAT5A and STAT5B, the two isoforms of STAT5 showed reduced 
response to G-CSF (Teglund et al., 1998).
Similar to most other hematopoietin receptors, the G-CSFR activates p21Ras/Raf/MEK/
MAPK and phosphatidylinositol 3-kinase (PI3-kinase) /protein kinase B (PKB) signaling 
pathways. These pathways transmit signals that contribute to proliferation and survival (de 
Koning et al., 1998; Dong and Larner, 2000; Hunter and Avalos, 1998). Tyrosine 764 of G-
CSFR plays a prominent role in the activation of p21Ras and MAPK pathway owing to the 
fact that this tyrosine forms a unique docking site for the adaptor protein Shc (Akbarzadeh et 
al., 2002; de Koning et al., 1998; Hermans et al., 2003; Ward et al., 1999b) (Figure 2).
4. sIGnalInG deFects caused by c-terMInal truncatIons oF tHe 
G-csFr Found In severe conGenItal neutroPenIa PatIents
A number of independent mutations in the gene encoding the G-CSFR have been described 
in myeloid diseases, including severe congenital neutropenia (SCN). The most frequent mu-
tations in SCN result in the introduction of stop codons in the G-CSFR C-terminal region, 
the region implicated in induction of maturation and growth arrest. Expression of these 
truncated forms of G-CSFR in SCN patients is associated with an increased risk of developing 
acute myeloid leukemia (AML) (Dong et al., 1995; Dong et al., 1997; Freedman and Alter, 
2002). Introduction of an equivalent mutation (Δ715 G-CSFR) in mice results in hyperprolif-
erative phenotype in response to G-CSF (Hermans 1998, McLemore 1998). Several signaling 
abnormalities have been linked to Δ715 G-CSFR. In cells expressing this mutant, activation 
of PI3K/PKB pathway is increased and STAT5 activity is significantly prolonged compared to 
WT G-CSFR. Moreover, endocytosis and signal attenuation are disturbed in cells expressing 
Δ715 G-CSFR, due to loss of internalization motifs present in the C-terminal region and 
the lack of recruitment sites for negative regulators of signaling such as SHIP1, SHP-1 and 
SOCS3(see below). Recently, is was shown that the Δ715 G-CSFR confers a strong prolifera-
tive advantage to pluripotent hematopoietic stem cells in vivo and that STAT5 is essential for 
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the clonal dominance of mutant stem cells over their normal counterparts.. Strikingly, this 
effect depended strongly on exogenous G-CSF (Liu et al., 2008).
5. neGatIve control oF G-csF sIGnalInG
Activation of growth factor-induced signaling cascades requires specific mechanisms to 
antagonize them, to ensure that signals do not exceed a critical threshold. These mechanisms 
of negative signaling have been shown to be crucial for normal development (Dikic and 
Giordano, 2003; Greenhalgh and Hilton, 2001). Negative regulation of G-CSF signaling is 
governed by multiple mechanisms involving protein tyrosine and inositol lipid phosphatases, 
suppressor of cytokine signaling (SOCS) proteins, endocytosis and lysosomal degradation of 
signaling complexes. The action of these mechanisms and their contribution to the down-
regulation of G-CSF signaling will be briefly introduced below.
5.1. Protein tyrosine phosphatases sHP-1 and sHP-2
The Src homology 2 (SH2) domain-containing protein tyrosine phosphatase SHP-1 contains 
two SH2 domains and is predominantly expressed in hematopoietic cells. Mice with a loss-
of-function mutation in the shp1 gene (“moth-eaten”) suffer from myeloid and lymphoid 
abnormalities, supporting its role in regulation of proliferation and differentiation of he-
matopoietic cells. SHP-1 has been shown to dephosphorylate both the activated cytokine 
receptors and the JAKs bound to these receptors (Valentino and Pierre, 2006) and negative 
regulation of signaling by SHP-1 has been demonstrated for several receptors, including 
the EpoR (Klingmuller et al., 1995) and G-CSFR (Ward et al., 2000). SHP-1 protein levels 
are up-regulated during G-CSF-mediated granulocytic differentiation of myeloid 32D cells. 
Enforced expression of SHP-1 in these cells resulted in inhibition of proliferation and ac-
celeration of differentiation, while introduction of a phosphatase-dead mutant resulted in 
a delay of differentiation. In contrast to other cytokine receptors such as EpoR, recruitment 
of SHP-1 to the G-CSFR does not depend on phosphorylated tyrosines within the receptor 
C-terminus (Dong et al., 2001; Tapley et al., 1997; Ward et al., 2000).
Another member of SH2 domain-containing protein tyrosine phosphatase family, SHP-2, 
is also recruited to G-CSFR. Tyrosine 729 as well as the distal C-terminal region of receptor 
serves as binding motifs for this association (van de Geijn et al., 2004a). SHP-2 has been sug-
gested to play a negative role in G-CSF signaling by dephosphorylation of STAT5 molecules 
(Yu et al., 2000). However SHP-2 also plays a positive role in signaling by promoting p21Ras 
activation (Shi et al., 2000).
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5.2. sH2 domain-containing inositol phosphatase sHIP1
For several cytokine receptors including G-CSFR, SHIP1 has been suggested to negatively 
regulate proliferative signaling (Chacko et al., 1996; Damen et al., 1996; Ono et al., 1996). 
SHIP1 is an 5′-phosphatidylinositol (PtdIns) phosphatase that dephosphorylates PtdIns(3,4,5)
P3, the active PI-3kinase metabolite and results in production of PtdIns(4,5)P2 lipids in the 
cell. PIP3 then initiates a cascade of downstream signaling pathways by interacting with 
pleckstrin homology (PH) domain-containing proteins, such as protein kinase B. Therefore, 
SHIP1 and PI-3kinase control PtdIns(3,4,5)P3 levels in the cells.
The distal C-terminal region of the G-CSFR mediates phosphorylation of SHIP1 and the 
formation of Shc/SHIP complexes (Hunter and Avalos, 1998). Mutation of tyrosine 764 to 
phenylalanine of the G-CSFR (Y764 G-CSFR) showed requirement of this tyrosine for in 
vivo phosphorylation of SHIP and SHIP/Shc complex formation (Dong et al., 1998; Hunter 
et al., 2004).
Although expression of SHIP1 is restricted to cells of hematopoietic origin, it appears that 
its function in myeloid linage differs from its role in lymphoid cells (Gloire et al., 2007). 
Whereas SHIP1 -/- mice are lymphopenic, they show an increased number of neutrophils 
a
 
A 
 
B 
 
 
b
Figure 3. schematic structure and e3 ubiquitin ligase activity of socs3
(A) Domain structure of SOCS3, a member of SOCS protein family. KIR: kinase inhibitory region. (B) Interaction 
of SH2 domain of SOCS proteins with phosphorylated tyrosine of target protein recruits members of ECS complex. 
This complex then functions as an E3 ubiquitin ligase in a concerted action with E1 and E2 enzymes to ubiquitinate 
the target protein; Ub: ubiquitin molecule.
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and monocytes/macrophages in the bone marrow (Helgason et al., 1998; Liu et al., 1999; 
Nakamura et al., 2004). Furthermore, these mice show deficiency in controlling aggregation 
of platelets and in hemostasis (Giuriato et al., 2003; Severin et al., 2007).
5.3. The family of socs (suppressor of cytokine signaling) box-containing proteins
The SOCS protein family comprises of eight members, termed cytokine inducible SH2-
containing protein (CIS) and SOCS 1 to 7 (Hilton et al., 1998; Starr et al., 1997; Yoshimura et 
al., 2005). All SOCS proteins contain a central SH2 domain which binds to a phosphorylated 
tyrosine-containing motif of target protein and a C-terminal conserved SOCS box domain 
consisting of approximately 40 amino acids (Figure 3A). SOCS1 and SOCS3 have an extra 
domain in common, the kinase inhibitory region (KIR), which downregulates JAK activity 
(Fujimoto and Naka, 2003; Kile et al., 2002). SOCS proteins are characterized by a variable 
N-terminal domain, an SH2 phosphotyrosine-interacting domain and the C-terminal SOCS 
box motif. Subsequent screening of DNA and protein databases revealed that at least 40 ad-
ditional proteins contain a SOCS box. Instead of an SH2 domain, most of these proteins 
posses an alternative protein interaction domain such as WD40 repeats (Wsb proteins), 
ankyrin-repeats (ASB proteins) or a SPRY domain (SSB proteins) (Hilton et al., 1998; Kile 
et al., 2002). There are several different proteins with divergent SOCS boxes such as MUF1, 
elongin A and the von Hippel-Lindau (VHL) tumor suppressor protein (Aso et al., 1995; 
Kamura et al., 2001; Kibel et al., 1995).
The N-terminal domain of the SOCS box motif is constitutively bound to the Elongin B/C 
complex (Kamura et al., 1998), whereas the C-terminal region recruits members of the Cullin 
family (Cullin2 or Cullin5) and RING finger proteins Rbx1 or Rbx2 (Kamizono et al., 2001; 
Kamura et al., 2004; Maine et al., 2007; Ungureanu et al., 2002). The ECS (Elongin-Cullin-
SOCS box) complex functions as an E3 ubiquitin ligase and in a concerted action with E1 
(ubiquitin activating) and E2 (ubiquitin conjugating) enzymes, add ubiquitin molecules to 
target proteins. The ubiquitinated target is subsequently degraded in lysosomes or protea-
somes (Figure 3B).
Among the various SOCS deficient mouse strains that have been generated, SOCS1 and 
SOCS3 deficient mice showed the most striking phenotypes. SOCS1 deficient mice are healthy 
at birth but die before weaning due to fatty degeneration of the liver, monocytic infiltration 
of organs and significant loss of lymphocytes (Naka et al., 1998; Starr et al., 1998). These mice 
exhibit excessive responses induced especially by interferon gamma (Alexander et al., 1999). 
SOCS3 deficient mice are embryonic lethal due to deregulated leukemia inhibitory factor 
(LIF) and cardiotrophin-1 signaling (Robb et al., 2005; Roberts et al., 2001; Takahashi et al., 
2003). However there is a discrepancy between this study and an earlier study done by Marine 
et al. who suggested that deletion of socs3 results in lethality due to massive erythrocytosis 
(Marine et al., 1999).
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5.3.1. socs proteins and their role in G-csF signaling
Expression of SOCS mRNAs induced in response to cytokine stimulation is under transcrip-
tional control of STATs. Both SOCS1 and SOCS3 are able to play a role in attenuation of 
G-CSF signaling, however SOCS3 is the most prominent physiological inhibitor. Expression 
of SOCS3 is robustly up-regulated in myeloid cells by G-CSF, while expression of SOCS1 
is induced at much lower levels (Hortner et al., 2002; Starr et al., 1997; van de Geijn et al., 
2004b). SOCS3 expression is severely reduced in STAT3 deficient mice treated with G-CSF, 
supporting the notion that SOCS3 is the major STAT3 target gene for negative regulation of 
G-CSF signaling (Lee et al., 2002).
Several mechanisms have been postulated to explain the inhibitory effects of SOCS proteins 
on cytokine signaling. The first mechanism is binding of SOCS SH2 domain to phospho-
rylated tyrosine of a cytokine receptor, and therefore competes with STAT recruitment or 
other positively acting signaling molecules for receptor tyrosine docking (Ram and Waxman, 
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Figure 4. a schematic representation of receptor endocytosis
EGFR is representative of a receptor which is ubiquitinated and routs to lysosomes, whereas TFR is not ubiquitinated 
and recycles to plasma membrane. See main text for a detailed explanation. PM: plasma membrane; CCV: clathrin-
coated vesicle; EE: early endosome; MVB: multivesicular body; RE: recycling endosome; EGFR: epidermal growth 
factor receptor; TFR: transferrin receptor. 
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2000; Yoshimura et al., 1995). The second mechanism is inhibition of JAK kinase activity via 
KIR; the mechanism only used by SOCS1 and SOCS3 proteins (Giordanetto and Kroemer, 
2003; Nicholson et al., 1999; Yasukawa et al., 2000). Whereas the SH2 domain of SOCS1 
has high affinity for JAK proteins, the SH2 domain of SOCS3 has a lower affinity for JAKs 
but a high affinity for phosphorylated tyrosines in receptor (Y729 in the case of G-CSFR) 
(Nicholson et al., 2000). The third, already discussed mechanism of inhibition of signaling 
by SOCS proteins involves the SOCS box, required for the formation of an ECS complex that 
drives degradation of target proteins. The SOCS box of SOCS1 and SOCS3 is important for 
G-CSF-induced inhibition of STAT5 activation and to a lesser extent for inhibition of STAT3 
activation (van de Geijn et al., 2004b), highlighting a dominant inhibitory mechanism by tar-
geting for ubiquitination rather than abrogation of JAK activity. Interestingly, it was shown 
recently that mice expressing a truncated SOCS3 protein lacking the C-terminal SOCS box 
had normal steady state hematopoiesis; however these mice are hypersensitive to G-CSF 
treatment leading to significantly elevated neutrophil levels when compared with wild type 
littermates. These findings underscore the role of the SOCS3 SOCS box for G-CSF-induced 
emergency granulopoiesis (Boyle et al., 2007).
5.4. endocytosis and intracellular trafficking to degradative compartments
Intracellular routing of activated receptors plays a major role in signal attenuation. In the 
past decade major progress has been made in understanding the molecular mechanisms of 
endocytotic membrane trafficking and the influence of endocytosis on receptor signaling 
and vise versa (von Zastrow and Sorkin, 2007). Receptor endocytosis classically involves 
internalization from the plasma membrane, trafficking to early endosomes, late endosomes, 
multivesicular bodies (MVBs) and finally to lysosomes (Figure 4).
5.4.1. endocytosis
Receptor endocytosis may take place by two distinct routes. Clathrin-mediated internaliza-
tion involving formation of vesicles coated with clathrin is currently the best characterized 
mechanism and has been shown for several receptors such as G-CSFR, growth hormone 
receptor (GHR) and interleukin-2 receptor (IL-2R). The basic components for this type of 
internalization include the hetero-tetrameric adaptor complex (AP2) (Kirchhausen et al., 
1997), endophilin (Guichet et al., 2002; Schmidt et al., 1999), dynamin (Marks et al., 2001; 
McNiven, 1998; Wang et al., 1995) and EPS15 (Fallon et al., 2006; Torrisi et al., 1999) which 
in turn can bind other proteins such as Epsin and Numb (Horvath et al., 2007; Iannolo et al., 
1997; Santolini et al., 2000).
The second internalization route involves caveolae. These flask-like structures are enriched 
in cholesterol and glycosphingolipid and bud from the plasma membrane. Interestingly, in 
case of the transforming growth factor (TGF)-β receptor both clathrin- and caveolae-depen-
dent receptor endocytosis was demonstrated and it was suggested that caveolae-mediated 
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internalization is required for receptor turnover,while clathrin-mediated endocytosis pro-
motes TGF-β receptor signaling (Di Guglielmo et al., 2003).
Three basic classes of internalization codes have been described for receptors: tyrosine-based 
codes including NPXY (X representing any amino acid) and YXXφ (where φ is a hydrophobic 
amino acid) (Guarnieri et al., 1993; Heilker et al., 1999), dileucine motifs and lysine residues. 
Beside these internalization-sorting signals, conjugated ubiquitin and ubiquitination can also 
function as a signal for internalization as was shown for EGF receptor and IL-2R alpha chain 
(Haglund et al., 2003a; Hicke, 2001; Nakatsu et al., 2000; Shih et al., 2000).
Receptor internalization can either occur in response to ligand stimulation or constitutively. 
Whereas the internalization kinetics of ligand-stimulated receptor is rapid (within minutes), 
constitutive internalization occurs at a slow rate (within hours). Both ligand-induced and 
constitutive internalization of the G-CSFR depend on an amino acid stretch in the COOH 
terminus (a.a. 749-769), that contains a dileucine motif. The presence of a phosphorylated 
Ser749 at position -4 of the dileucine motif and a tryptophane residue critical for binding and 
activation of JAKs (Trp650) are essential for ligand-activated but not constitutive internaliza-
tion of the G-CSFR (Aarts et al., 2004).
5.4.2. Post endocytotic trafficking into early endosomes
Following internalization, clathrin coated vesicles embracing receptors disassociate from the 
plasma membrane and fuse with early endosomes. One essential protein that has been impli-
cated in fusion of endocytotic vesicles with early endosomes is the small GTPase Rab5 (Zerial 
and McBride, 2001) which in turn recruits early endosomal antigen-1 (EEA-1) (Christofo-
ridis et al., 1999; Mills et al., 1998; Simonsen et al., 1998). EEA-1 localizes to the cytoplasmic 
face of the early endosome membrane by its cysteine-rich motif, termed the FYVE domain, 
which interacts with phosphatidylinositol-3-phosphate (Patki et al., 1997; Weissman, 2001). 
Notably, Rab5 and EEA1 proteins are frequently used as markers for early endosomes in 
confocal microscopy studies, including those reported in this thesis.
Early endosomes are considered as sorting endosomes, where decisions for destination of the 
receptor are being made. Ubiquitination of cytoplasmic lysines of receptors serves as a sorting 
signal at this stage for targeting them to late endosomes/ lysosomes or proteasomes, there-
fore ubiquitination of lysine residues plays a pivotal role in receptor turnover. Conversely, 
recycling back to the plasma membrane is correlated with the absence of receptor ubiquitina-
tion and loss of ubiquitination enhances receptor recycling (Levkowitz et al., 1998). Several 
members of the cytokine receptor family, like growth hormone receptor (GHR) (van Kerkhof 
and Strous, 2001), leptin receptor (LR) (Uotani et al., 1999) and gp130 (Blanchard et al., 2000; 
Dittrich et al., 1996) follow the endosomal/lysosomal pathway for degradation after ubiquit-
ination. On the other hand, the thrombopoietin receptor (TpoR) does not route to lysosomes 
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and is recycled to the plasma membrane after endocytosis (Dahlen et al., 2003). For the EpoR, 
it has been shown that most of its intracellular domain is degraded after ubiquitination by 
the proteasomal pathway before receptor internalization, whereas the remaining part of the 
EpoR is internalized and routed to lysosomes for degradation (Walrafen et al., 2005).
The cytoplasmic domain of the human G-CSFR contains five conserved lysines, located at 
positions 681, 682 and 762. These lysines are candidates of ubiquitination and may play a 
potential role in intracellular trafficking of the G-CSFR.
How activated G-csFr complexes are degraded following endocytosis and which 
motifs in the cytoplasmic domain of the receptor are involved in this process has not 
been investigated. In chapter 2 we studied intracellular routing of the activated G-
csFr and its effect on G-csF-induced signaling following receptor internalization. 
to examine the differential role of cytoplasmic lysines of the G-csFr in sorting to 
degradation compartments, we made use of single lysine and lysine add back mutants 
of G-csFr. 
5.4.3. different forms of ubiquitination and their role in receptor routing and degradation
Ubiquitin (Ub) is an 8.6 kDa polypeptide that is highly conserved among different species 
and which forms a covalent attachment to a lysine residue of the substrate by its C-terminal 
glycine. Conjugation of a single ubiquitin to one lysine (K) of a target substrate is referred 
to as monoubiquitination. Multiubiquitination is the result of attachment of single ubiq-
uitin molecules to multiple lysine residues of the substrate. Many studies have shown that 
endocytosis and MVB sorting of plasma membrane receptors involves either mono-or 
muli ubiquitination. Ubiquitin contains seven lysines residues, which in turn can bind to 
ubiquitin, giving rise to polyubiquitination (Pickart, 2001). Although it was initially thought 
that polyubiquitination exclusively targets proteins for degradation in proteasomes, more 
recent studies indicate that this holds true only for polyubiquitin chains formed via K48 
of ubiquitin. In contrast, polyubiquitin chains made through K29 or K63 appear to be in-
volved in lysosomal targeting (Chastagner et al., 2006; Haglund et al., 2003b; Pickart, 2001; 
Weissman, 2001). However there appear to be some exceptions to this rule. For instance, 
the transcriptional regulator of myogenesis Pax3 is monoubiquitinated but its degradation 
occurs in proteasomes (Boutet et al., 2007; Boutet and Rando, 2008).
5.4.4 Function of e3 ligases
Ubiquitination is a sequential action of three enzymes, Ub-activating (E1), Ub-conjugating 
(E2) and Ub-ligating (E3) enzymes (Hershko and Ciechanover, 1998). E1 mediates ATP-
dependent activation of the glycine of ubiquitin for conjugation and transferring to E2 
24
Chapter 1
enzyme. Although some E2s can ubiquitinate substrates directly, in most cases E3 ubiquitin 
ligases are required to interact with E2 and transfer ubiquitin to the target substrate.
There are three major types of E3 ligases: HECT (Homologous to E6-AP Carboxyl Terminus) 
domain, RING (Really Interesting New Gene)-finger domain and a modified RING motif 
U-box (UFD2-homology domain) (Ardley and Robinson, 2005). While HECT-type E3 li-
gases such as Nedd4 have a direct role in ubiquitination, RING-type and U-box E3 ligases 
promote ubiquitination by positioning the activated E2 in close proximity to the substrate. 
RING-finger E3 ligase family is divided in two classes; they can be single proteins (e.g. c-Cbl) 
or protein complexes. The latter include the SCF (Skp1/ Cullin/ F box) and ECS (Elongin 
BC/ Cullin/ SOCS box) complexes (Petroski and Deshaies, 2005; Raiborg et al., 2002; Zheng 
et al., 2002).
The socs box of socs proteins is involved in the formation of the ecs complex 
that functions as an e3 ligase. Previous studies had demonstrated that socs3 is a 
negative regulator of G-csF signalling and that the socs box is critical for this in-
hibitory effect. because there are five conserved lysines in the cytoplasmic domain of 
the G-csFr, we asked whether socs3 could mediate ubiquitination of the G-csFr 
and whether this ubiquitination results in sorting of the receptor to a particular 
compartment and in attenuation of signalling. These questions have been addressed 
in chapter 2, a.o. by employing ubiquitination assays and microscopic imaging in 
presence or absence of socs3 sirna.
Despite intensive investigations on the role and mechanisms of ubiquitin conjugation within 
the last decade, the specificity and the selection process of the lysine residues targeted for 
ubiquitination is still poorly understood. Studies in chimeric models, including fusion of 
ubiquitin to the C-terminal region of receptors, indicate that ubiquitination and especially 
monoubiquitination is sufficient to promote endocytosis and MVB sorting. This model sug-
gests that the position of ubiquitin conjugation is not a significant indicator in endocytosis. 
However, it has become clear that specific lysine residues are ubiquitinated in some proteins 
and that the precise ubiquitination site(s) can be functionally important (Mukhopadhyay 
and Riezman, 2007). For example, exclusive mutation of lysine residues present in the kinase 
domain of the EGFR is sufficient to attenuate lysosomal degradation of the receptor (Huang 
et al. 2006).
Furthermore, it is still unclear what determines the specificity of an E3 ligase for a given 
substrate. One explanation is the presence of unique determinants in the target substrate, 
for instance specific motifs in the cytoplasmic domain of a receptor that lead to preferential 
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lysine selection by an E3 ligase. Such a mechanism has been shown for β-transduction repeat-
containing protein (β-Trcp), a member of RING-finger type of E3 ligase family, which can 
form an SCF complex via its F box. β-Trcp is involved in endocytosis and degradation of 
several receptors like EpoR (Meyer et al., 2007), interferon alpha receptor1 (IFNAR1) (Ku-
mar et al., 2007) and prolactin receptor (Li et al., 2004). Recognition of a unique motif in the 
substrate by β-Trcp results in selection of lysine residues located 9-13 amino acids upstream 
of this destruction motif to be the target of ubiquitination. However, existence of a distinct 
motif is not always required for binding of an E3 ligase. For example, Cbl another member 
of RING-finger type of E3 ligase family has been shown to be involved in downregulation 
of receptors including hepatocyte growth factor receptor (HGFR or Met), EGFR and stem 
cell factor receptor (SCFR or c-Kit). Direct binding of Cbl to phosphorylated tyrosine of 
activated receptor is sufficient for its function (Carter et al., 2004; Masson et al., 2006; Thien 
and Langdon, 2005)
In chapter 2 of this thesis, it is demonstrated that recruitment of socs3 to the phos-
phorylated tyrosine of the G-csFr results in ubiquitination and lysosomal sorting 
of the activated receptor complexes. This process is strictly controlled by ubiquitina-
tion of the juxtamembrane lysine of the G-csFr on position 632. Why this lysine is 
exclusively involved in G-csFr trafficking is unknown. We explored the following 
possibilities: (I) K632 is part of a specific motif needed to  recruit the ubiquitin ma-
chinery, (II) Positioning of K632  in proximity of the plasma membrane is essential 
for interaction with  the molecular determinants directing lysosomal sorting. These 
questions have been addressed in chapter 3. 
5.4.5. Intracellular trafficking into late endosomes
Fusion of early endosomes results in the formation of late endosomes, which tend to be in 
close proximity of the nucleus. This localization is distinct from early endosomes, which 
are usually found in the cell periphery (Marmor and Yarden, 2004). Two members of Rab 
GTPase family, Rab7 and Rab9 have been implicated in trafficking through late endosomes 
(Gonzalez-Gaitan and Stenmark, 2003). Late endosomes may contain internal vesicles pro-
duced by invagination of the limiting membrane and budding into the lumen, and are then 
referred to as multivesicular bodies (MVBs).
Conjugation of ubiquitin to a particular target not only serves as a signal for prevention 
of recycling to plasma membrane but also plays an important role in efficient transport into 
the MVB pathway (Gruenberg and Stenmark, 2004; Katzmann et al., 2001; Reggiori and 
Pelham, 2002; Shaw et al., 2003). The main machinery that recognizes ubiquitinated cargo 
is formed by the ESCRT (the endosomal sorting complexes required for transport) proteins 
(Katzmann et al., 2003). There are three complexes of ESCRT proteins: ESCRT-I, ESCRT-II 
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and ESCRT-III, which are sequentially recruited to the endosomal membrane (Saksena et al., 
2007; Slagsvold et al., 2006; Teo et al., 2006).
Interactions of proteins of the sorting machinery with ubiquitinated cargo involves one 
or more ubiquitin binding domains (UBDs) in these proteins (Haglund and Dikic, 2005; 
Haglund and Stenmark, 2006). Several UBDs have been identified, among which are UIM 
(Ub-interacting motif), VHS (vps27, Hrs, STAM) and GAT (GGA and TOM1) domains. 
Although different UBDs have different structural folds, they all contact the hydrophobic 
Ile44 of Ub with slight variation in the interaction (Hicke et al., 2005; Hurley et al., 2006). 
A comprehensive and continuosly updated overview of these motifs can be found on www.
pawsonlab.mshri.on.ca.
One of the well-established UBDs is UIM, present in HRS (hepatocyte growth factor regu-
lated tyrosine kinase substrate) and STAM (signal transducing adaptor molecule). The HRS/
STAM complex is also being referred to ESCRT-0 because of its involvement in recognition 
of ubiquitinated cargo by their UIM prior to the ESCRT-I complex (Bache et al., 2003; Bilo-
deau et al., 2002; Shih et al., 2002; Slagsvold et al., 2006). HRS binds to phosphatidylinositol 
3-phosphate (PIP3) domains of early endosomes via interaction of its FYVE domain (Stahelin 
et al., 2002). Additionally, it recruits a member of ESCRT-I complex, Tsg101 (tumor suppres-
sor gene 101) (Bache et al., 2003; Bilodeau et al., 2002; Katzmann et al., 2003). Consequently 
cargo transports to ESCRT-I complex and MVB sorting continues by recruitment and func-
tion of downstream complexes, ESCRT-II and ESCRT-III. The next step is activation of 
deubiquitinating enzyme to remove ubiquitin tags from ubiquitinated cargo (Amerik et al., 
2000). Finally ESCRT complexes dissociate from the endosomal membrane to function for 
sorting of other ubiquitinated cargos (Babst et al., 1997; Babst et al., 1998). Following sort-
ing of the cargo to MVBs, these vesicles fuse with lysosomes and deliver their contents into 
the lumen of the lysosome. Lysosomes are characterized by expression of glycoproteins like 
lysosomal associated membrane (Lamp) and presence of lysosomal enzymes. Acidic pH (4.8) 
and digestive enzymes within lysosomes are the major factors responsible for degradation of 
the delivered cargo.
6. ForWard routInG and steady state dIstrIbutIon oF PlasMa 
MeMbrane recePtors
Within the endoplasmic reticulum, newly synthesized proteins that are properly folded pack-
age as vesicles carrying cargo and pass through a series of membrane-enclosed organelles to 
reach the trans-Golgi network (TGN) (Figure 4). This pathway is taken by plasma membrane-
localized receptors, including cytokine receptors, which during their migration undergo 
post-translational modifications (e.g. glycosylation) to attain their mature status. Mature 
receptors then move from the TGN to the plasma membrane, their functional destination 
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(Duvernay et al., 2005; Mellman and Warren, 2000). Misfolded or unassembled proteins are 
disposed by a quality control system, endoplasmic reticulum-associated degradation (ERAD) 
(Meusser et al., 2005).
The density of receptors on the plasma membrane has an impact on signaling output. 
Therefore, regulation of steady state distribution of receptors on the cell surface plays an 
important role in signaling events. Cell surface localization and constitutive trafficking of 
several receptors have been shown to be controlled by JAK proteins; however the underlying 
mechanisms are heterogeneous for different receptors. Whereas members of Janus kinases 
enhance stability of mature forms of GH receptor and Tpo receptor and preclude their lyso-
somal and proteasomal degradation, respectively (He et al., 2005; Royer et al., 2005), in the 
case of IFNAR1 binding of TYK2 is found to attenuate receptor degradation by blocking a 
di-leucine internalization motif (Ragimbeau et al., 2003; Royer et al., 2005). Taken together 
these studies indicate that enhanced surface expression of cytokine receptors mediated by 
JAKs is receptor-specific and results from different mechanisms including increased receptor 
stability or biogenesis, altered forward routing, decreased endocytosis or combination of 
these processes.
The Janus kinases JaK1, JaK2 and tyK2 are activated by G-csFr. In chapter 4 
we studied the mechanisms regulating steady state distribution of the G-csFr and 
examined if JaK proteins play a role in this regulation. Furthermore, we studied if 
JaKs interfere with receptor endocytosis and lysosomal routing linked to dileucine-
based motif and differential cytoplasmic lysines, respectively. as model systems, we 
used ba/F3 cells overexpressing JaK1, JaK2 or tyK2 and human fibrosarcoma cells 
selectively deficient for these JaK kinases.
Besides the role of ubiquitin in receptor endocytosis and sorting to multivesicular bodies, 
ubiquitin can direct proteins to endosomes from the TGN (Figure 4). It has been shown that 
the Golgi-localized gamma-ear-containing Arf-binding (GGA) proteins, which are mainly 
associated with the TGN, can bind ubiquitin via their GAT domain. These proteins facilitate 
sorting at TGN and degradation of ubiquitinated target is hastened by sorting to endosomes. 
Accordingly, the appearance of ubiquitinated molecule on the cell surface gets prevented. 
Thus GGAs may function as ubiquitin sorting receptors in a manner similar to ESCRT-0 
complex at TGN as suggested for EGF receptor and a member of human GGA family, GGA3 
(Puertollano and Bonifacino, 2004; Scott et al., 2004).
Low levels of the G-CSFR on the cell surface compared to a large intracellular pool indicate 
that there is a tightly controlled balance between sorting to the plasma membrane and deg-
radation of the newly synthesized receptors. Indeed, it has been shown that WT G-CSFR is 
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predominantly associated with Golgi apparatus and cytoplasmic structures of cell positive for 
lysosomal marker (Aarts et al., 2004). Therefore, ubiquitination of lysine residues of receptor 
plays an imperative role in maintaining the balance in constitutive distribution of G-CSFR.
Although ligand-induced trafficking and signal downregulation has been largely investigated, 
very little is known about mechanisms controlling constitutive expression of cytokine recep-
tors and their intracellular routing in ligand-independent pathways.
Preliminary studies in our laboratory using yeast-two hybrid assays suggested that 
Wsb2 (Wd40 repeat and socs-box containing protein 2) may bind to the cooH 
terminus of the G-csFr. Given that Wsb2 can form an ecs complex through its socs 
box, this protein was a potential candidate e3 ligase in ubiquitination of cytoplasmic 
lysines of the G-csFr. studies presented in chapter 5 were performed to establish 
the interaction of Wsb2 with the G-csFr using the mammalian protein-protein in-
teraction trap (MaPPIt) system. regulation of forward routing of G-csFr by Wsb2 
and its involvement in appropriate balance between proliferation and differentiation 
signals were then investigated in further detail. 
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abstract
The hematopoietic system provides an attractive model for studying growth factor-controlled 
expansion and differentiation of cells in relation to receptor routing and its consequences 
for signal transduction. Suppressor of cytokine signaling (SOCS) proteins regulate recep-
tor signaling partly via their ubiquitin ligase (E3)-recruiting SOCS box domain. Whether 
SOCS proteins affect signaling through modulating intracellular trafficking of receptors is 
unknown. Here we show that a juxtamembrane lysine residue (K632) of the granulocyte 
colony-stimulating factor receptor (G-CSFR) plays a key role in receptor routing and dem-
onstrate that the effects of SOCS3 on G-CSF signaling to a major extent depend on this lysine. 
Mutation of K632 causes accumulation of G-CSFR in early endosomes and leads to sustained 
activation of signal transducer and activator of transcription 5 and ERK, but not protein 
kinase B. Myeloid progenitors expressing G-CSFR mutants lacking K632 show a perturbed 
proliferation/differentiation balance in response to G-CSF. This is the first demonstration of 
SOCS-mediated ubiquitination and routing of a cytokine receptor and its impact on main-
taining an appropriate signaling output.
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IntroductIon
In the past 5 years, a major role has been demonstrated for protein ubiquitination in the 
control of endocytosis and intracellular routing of receptor tyrosine kinases, particularly of 
the epidermal growth factor (EGF) receptor (reviewed in (Haglund et al., 2003; Marmor and 
Yarden, 2004; Miaczynska et al., 2004; Polo and Di Fiore, 2006). For instance, upon ubiquit-
ination by the E3 ligase Cbl, EGF receptor associates with multiple proteins containing an 
ubiquitin interaction motif (UIM), which guides EGF receptors into the different compart-
ments of the endocytotic pathway. One such UIM-containing protein is hepatocyte growth 
factor receptor substrate (Hrs), implicated in the sorting of ubiquitinated cargo from early en-
dosomes towards late endosomes, the lumen of multivesicular bodies and finally to lysosomes 
(Haglund et al., 2003). Receptor endocytosis is no longer considered as a mechanism solely 
involved in termination of signaling. Rather, it became clear that signaling processes proceed 
in endosomes and that temporal and spatial dissociation as well as integration of signals may 
occur during endocytosis (Miaczynska et al., 2004; Polo and Di Fiore, 2006). This form of cell 
signaling orchestration is believed to contribute significantly to cellular processes such as cell 
fate determination, migration and differentiation (Polo and Di Fiore, 2006). However, owing 
to a paucity of appropriate model systems, insights into the impact of receptor routing on 
fine-tuning of cellular responses in response to growth factors are still scarce.
Granulocyte colony-stimulating factor (G-CSF) is the main cytokine involved in the pro-
duction of neutrophilic granulocytes (Avalos et al., 1990). Activation of the G-CSF receptor 
(G-CSFR), a member of the class I cytokine receptor superfamily, supports the prolifera-
tion, survival and differentiation of neutrophilic progenitor cells (van de Geijn et al., 2003). 
Similar to most cytokine receptors, G-CSFR activates multiple signaling pathways fuelled by 
activation of JAK kinases. For instance, JAK-phosphorylated tyrosine-based motifs become 
docking sites for SH2-containing signaling molecules, such as signal transducer and activator 
of transcription (STAT) 3 (Shao et al., 2006; Ward et al., 1999a), components of the p21Ras/
Raf/MAPK pathway (de Koning et al., 1998; Rausch and Marshall, 1997) and suppressor 
of cytokine signaling 3 (SOCS3) (Hermans et al., 2003; Hortner et al., 2002). In addition, 
the membrane-proximal cytoplasmic region of the G-CSFR is involved in the activation 
of protein kinase B (PKB), a serine/threonine kinase implicated in cell survival, and in the 
activation of STAT5 (Dong and Larner, 2000).
G-CSF stimulates proliferation and survival of myeloid progenitor cells, followed by a cell 
cycle arrest and differentiation towards neutrophils. Probably, this complex response requires 
attenuation of each of the signaling functions of G-CSFR during receptor endocytosis and 
intracellular routing. In support of this notion, perturbed signaling by G-CSFR truncation 
mutants, found in patients with acute myeloid leukemia preceded by severe chronic neutro-
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penia, is to a large extent due to their inability to undergo endocytosis (Hunter and Avalos, 
1999; Ward et al., 1999c).
Routing of class I cytokine receptors has been studied only to a limited extent and ap-
pears markedly heterogeneous. Most members studied thus far, for example, the growth 
hormone receptor (GHR) (van Kerkhof and Strous, 2001), leptin receptor (LR) (Uotani et al., 
1999), prolactin receptor (PRLR) (Kelly et al., 1991), interleukin (IL)-9 receptor (Yen et al., 
2000), gp130 (Blanchard et al., 2000; Dittrich et al., 1996), and the IL-2 receptor beta chain 
(Yen et al., 2000) follow the endosomal/lysosomal pathway. Endocytosis of LR depends on 
ubiquitination of two lysine residues in its cytoplasmic tail (Belouzard and Rouille, 2006). 
The ubiquitin-conjugating system is also required for endocytosis of GHR, but this does not 
depend on the cytoplasmic lysines of GHR (Alves dos Santos et al., 2001; Govers et al., 1999). 
In contrast, the Ub-conjugating system is not essential for internalization of PRLR (Lu et 
al., 2005). The thrombopoietin receptor (TPOR) forms a noteworthy exception, as it does 
not route to late endosomes and lysosomes but is rapidly recycled to the plasma membrane 
(Dahlen et al., 2003; Royer et al., 2005). This diversity in control of endocytosis and lysosomal 
routing emphasizes the importance of intracellular trafficking for the specific regulatory 
functions of the different receptors of this superfamily.
Human G-CSFR contains five cytoplasmic lysines (K632, K672, K681, K682 and K762) 
that are candidates for Ubiquitination and all are conserved between humans and mice. We 
recently reported that cytoplasmic lysines in the G-CSFR play a key role in its steady-state 
membrane expression and protein stability and provided evidence that WD40 and SOCS 
box-containing protein (Wsb) negatively controls forward routing of G-CSFR depending on 
these lysines (Erkeland et al., 2006). However, whether ubiquitination of one or more of these 
lysine residues is crucial for ligand-induced G-CSFR endocytosis, trafficking to early and late 
endosomes, which Ub-ligases might be involved and how this influences G-CSF-induced 
proliferation and differentiation signaling remained unknown.
Studies in conditional knockout mice have established that SOCS3 is a major negative regula-
tor of G-CSF-induced neutrophil production in vivo (Croker et al., 2004; Kimura et al., 2004). 
SOCS proteins can inhibit cytokine signaling via multiple mechanisms: i.e., by competition 
for SH2-containing signaling substrates in receptor binding, by inhibition of JAK kinase 
activity through their kinase inhibitory region, or by recruitment of elongins B and C to the 
SOCS box to form an E3 Ub-ligase complex for degradation of signaling substrates (Kile et 
al., 2002). In an earlier report, we have shown that the SOCS box has a major role in SOCS3-
mediated inhibition of G-CSF signaling (van de Geijn et al., 2004b), but how this is achieved 
remained unclear.
In this study, we show that a G-CSFR mutant lacking all five conserved cytoplasmic 
lysine residues (K5R) internalizes normally but fails to route to lysosomes. K5R is retained 
in early endosome antigen 1 (EEA1) and Hrs-positive endocytotic vesicles, where it con-
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tinues to activate STAT5, but not PKB. Subsequent mutational analysis demonstrated that 
membrane-proximal lysine K632 is most crucial for lysosomal routing of the G-CSFR and 
for attenuation of G-CSF-induced STAT activity, cell proliferation and for the induction of 
terminal neutrophilic differentiation of myeloid 32D cells. We then show that ubiquitination 
of G-CSFR-K632 and lysosomal routing of the G-CSFR both depend on the integrity of the 
SOCS3 recruitment site (Y729) of G-CSFR. Finally, we demonstrate that inhibition of STAT5 
activation by SOCS3 fully depends on the cytoplasmic lysines of G-CSF-R, in particular K632. 
These results reveal a major role of SOCS3 in G-CSFR routing from early (Hrs-positive) to 
late (Rab7-positive) endosomes and lysosomes and highlight the importance of receptor 
routing for an appropriate balance of proliferation and differentiation of myeloid progenitors 
in response to G-CSF.
MaterIal and MetHods
antibodies
Mouse-anti-human CD114 (G-CSF receptor) and MoAb anti-EEA-1 were purchased from Becton-
Dickinson/PharMingen (San Diego, CA). Rat anti-Lamp-1 (clone 1D4B) was obtained from Research 
Diagnostics (Flanders, NJ). Mouse anti-HA MoAb, goat anti EEA-1, rabbit anti- Rab7 and rabbit 
anti-STAT5a and anti-STAT5b were purchased from Santa Cruz, Biotechnology, Inc (Santa Cruz, 
CA). MoAb anti-pSTAT5 (STAT5A-pY694, STAT5B-pY699) was from Upstate Biotechnology, Inc 
(Charlottesville, VA) and anti-pSTAT3 (pY705) from Cell Signaling Technology, Inc (Danvers, MA). 
Texas Red-conjugated streptavidin (Caltag Laboratories (Burlingame, CA) was used for detection of 
biotinylated G-CSF (bio-G). MoAbs against pPKB, pERK and total ERK were from Santa Cruz. FLAG 
M2 MoAb was purchased from Sigma, St Louis, MO. Rabbit anti-Hrs was a gift from Dr. H. Stenmark 
(Department of Biochemistry, Institute for Cancer Research, The Norwegian Radium Hospital and 
The University of Oslo, Oslo, Norway). Dye-coupled immunoglobulin (Ig) antibodies used in CLSM 
were purchased from Molecular Probes (Invitrogen, Breda, The Netherlands): donkey anti-mouse 
Alexa Fluor 488 (for G-CSFR), goat anti-rabbit Alexa Fluor 546 (for Rab7 and Hrs), rabbit anti-goat 
Alexa Fluor-546 (for EEA1), and goat anti-rat Alexa Fluor488 (Lamp-1). Goat anti-mouse Ig coupled to 
phycoerythrin (GAM-PE) used in flow cytometry was from Dako (Dako BV, Heverlee, Belgium).
expression constructs
The pBabe expression constructs of wt G-CSFR, d749-769 and Y729F have been described previously 
(Aarts et al., 2004; Ward et al., 1999b). The K632R, K672R, K681R, K682R, K762R and K5R G-CSFR 
constructs were made in pLNCX containing wt G-CSFR using the Stratagene QuickChange site directed 
mutagenesis kit (Stratagene, La Jolla, CA). The single lysine add-back mutants were made in a similar 
way using K5R as template. C-terminal double HA-tagged versions of wt and mutant G-CSFR were 
created by PCR using a 5’ oligonucleotide spanning a region in the cDNA corresponding to amino 
acids 590-595 (GRFR7) and a 3’ oligonucleotide containing a segment spanning the amino acids imme-
diately upstream of the stop codon of the G-CSFR, a double HA-tag, and a restriction site. All mutant 
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constructs were verified by sequencing. Expression vectors for SOCS1, SOCS2, SOCS3 and SOCS3Δbox 
and reporter constructs have been described previously (van de Geijn et al., 2004b). FLAG-tagged Ub in 
pCDNA3 was a gift from Dr. B. van der Reijden (Nijmegen, The Netherlands).
cell culture, transfection, retroviral transduction and introduction of sirna
Ba/F3 cells and 32D.cl8.6 cells, a sub-line of the IL-3-dependent murine myeloid 32Dcl3 cell line 
that lacks endogenous G-CSFR (de Koning et al., 1998), were maintained in RPMI-1640 medium 
supplemented with 10% fetal calf serum (FCS), 100 IU/ml penicillin, 100 µg/ml streptomycin and 
murine IL-3 (10 ng/ml) at 37°C and 5% CO2. To obtain Ba/F3 cells expressing wt or mutant G-CSFR, 
cells were electroporated as described (de Koning et al., 1996). Subsequently, cells were diluted and 
expanded in 96 wells plates in IL-3-containing medium supplemented with puromycin (1µg/ml) to 
obtain individual clones. 32D.cl8.6 clones expressing different G-CSFR constructs were obtained by 
retroviral transduction as described (Aarts et al., 2004). HeLa and Phoenix E cells were cultured in 
Dulbecco Modified Eagle’s medium (DMEM, glucose 4.5g/l) supplemented with 10% FCS and 100 IU/
ml penicillin, 100 µg/ml streptomycin in a humidified atmosphere at 37°C and 7% CO2. HeLa cells were 
plated on glass coverslips and transfected with G-CSFR constructs using lipofectamin (Invitrogen). 
Phoenix E cells were transfected using the calcium phosphate precipitation method. To reduce SOCS3 
expression, HeLa cells (2 x 105) were transfected using an siRNA transfection kit (Mirus Bio Corpora-
tion, Madison WI, USA) according to the manufacturer’s instructions. The siRNA’s used were SOCS3 
human ON-TARGET plus siRNA SMARTpool (Dunn et al., 2005), siCONTROL non-targeting siRNA 
#1 and siGLO cyclophylin B siRNA, all obtained from Dharmacon, Chicago IL, USA.
Immunoprecipitation and Western blotting
Phoenix E cells (G. Nolan, Stanford, CA) were transfected with HA-tagged wt or mutant-G-CSFR and 
FLAG-tagged Ub using the calcium-phosphate precipitation method. After 48 hrs, cells were stimulated 
with G-CSF (100 ng/ml) for 30 min or left untreated, washed with cold PBS and resuspended in lysis 
buffer containing 20 mM Tris HCl pH8.0, 13 7mM NaCl, 10 mM EDTA, 100 mM NaF, 1% NP40, 10% 
glycerol, 2 mM Na3VO4 and 1 mM Pefablock SC, 50 µg/ml aprotinin, 50 µg/ml leupeptin, 50 µg/ml baci-
tracin, and 50 µg/ml iodoacetamide. Immunoprecipitation was performed using anti HA-antibodies 
and protein G-Sepharose beads. Alternatively, G-CSFR pull down was performed with biotinylated G-
CSF (bio-G), prepared using a biotin labeling kit according to the manufacturer’s instructions (Roche 
Molecular Biochemicals, Mannheim, Germany). Cells were incubated with bio-G (10 μg/ml) for 15 min 
at 16°C and for another 30 min at 37°C. Subsequently, cells were washed with cold PBS, resuspended in 
lysis buffer and incubated with streptavidin-conjugated magnetic beads (Dynabeads, In vitrogen) for 1 
h at 4°C. Beads were washed and resuspended in 1x Laemlli buffer (pH 11) and supernatants subjected 
to Western blotting as described (Ward et al., 1999b).
Immunocytochemistry and confocal microscopy
To visualize postendocytic receptor trafficking in situ, cells were incubated with G-CSFR antibodies (2.5 
µg/ml) and G-CSF (100 ng/ml) for 20 min at 16°C, washed (PBS) and transferred to 37°C. Subsequently, 
cells were permeabilized by treatment for 5 min with 0.05% saponin, fixed with 3% paraformaldehyde 
and stained for fluorescence microscopy (Raiborg et al., 2002). To visualize receptor internalization in 
32D cells, cells were incubated with bio-G for 1 h at 4°C, washed (PBS) and transferred to 37°C to induce 
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internalization. After washing (PBS), cells were spun onto glass slides, fixed (4% paraformaldehyde and 
0.05% gluteraldehyde) and stained for CLSM (Aarts et al., 2004). Cover slips were examined in the 
multitrack detection mode of a Zeiss LSM 510 instrument equipped with argon/HeNe lasers and a x 63 
Planapochromat oil immersion objective.
cell proliferation assay and cytology
To determine the proliferation and differentiation characteristics of the 32D.cl8.6 cells transduced with 
various G-CSFR constructs in response to G-CSF, cells were washed three times in Hanks Balanced 
Salt Solution (HBSS) and seeded at a density of 2 x 105 cells/ml in RPMI 1640 medium, supplemented 
with 10% FCS and 100 ng/ml human G-CSF. Viable cells were counted daily using a CASY1 electronic 
cell counter (Schärfe-System, Reutlingen, Germany) and readjusted to 2 x 105 cells/ml. To analyze 
granulocytic differentiation, cells were spun onto glass slides and examined by light microscopy after 
May-Grünwald-Giemsa staining.
bone marrow cells
Hematopoietic progenitor cells were collected from the femurs and tibiae of 8 to 12 week-old Csf3r-/- 
mice as described (Hermans et al., 2003). Cells were washed twice in HBSS/5% FCS/0.5% bovine serum 
albumin (BSA) and prestimulated for 2 days at a final concentration of 5×105 cells/ml in Cell Gro (SCGM 
BE SP047; Boehringer Ingelheim Bioproducts Partnership, Heidelberg, Germany), supplemented with 
a cytokine cocktail composed of murine IL-3 (10 ng/ml), human Flt3-ligand, human thrombopoietin, 
murine stem cell factor (100 ng/ml) and granulocyte macrophage-colony-stimulating factor (2 U/ml). 
Retroviral infection was performed with viral supernatant of Phoenix E cells as described (Erkeland et 
al., 2003).
colony assay
Bone marrow cells were plated in triplicate at a density of 5×104 cells in 1 ml of methylcellulose contain-
ing medium supplemented with 30% fetal bovine serum (FBS), 1% BSA, 0.1 mM 2-mercaptoethanol, 
2 mM L-glutamine, and G-CSF (20 U/ml) as described (Hermans et al., 2003). Colonies consisting of 
more than 50 cells were counted on day 7 of culture.
Flow cytometric analysis of G-csFr
G-CSFR-expressing 32D.cl8.6 transfectants (0.5x106 cells) were incubated at 4°C for 1 hr with G-CSFR 
antibody in PSA, consisting of PBS supplemented with 1% FCS, and 0.02% NaN3 to block endocytosis. 
After washing, cells were incubated with GAM-PE for 1 hour at 4°C, washed and analyzed on a FACS 
Calibur flow cytometer (Becton Dickinson). For internalization experiments, 32D cells (0.5x106 cells 
per time point) were incubated with anti-G-CSFR antibodies in the presence or absence of 100 ng/ml 
G-CSF for 1 hr at 4°C and subsequently incubated for 0, 15, 30 or 60 min. at 37°C. Subsequently, cells 
were washed in PSA, and incubated for 1 hr at 4°C with GAM-PE. To measure G-CSFR rerouting, 
cells incubated with G-CSF for 60 min were washed with PSA, incubated without G-CSF at 37°C for 
indicated times in the presence of cycloheximide (10 μg/ml) incubated with GAM-PE for 1 h at 4°C and 
analyzed after a final wash in PSA analyzed. Peak channel values of FITC fluorescence histograms were 
taken as a measure of average G-CSFR densities.
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electrophoretic mobility shift assay (eMsa)
32D cells were washed in HBSS and deprived of serum and factors for 4 h at 37°C in RPMI at a density 
of 1x106 cells/ml. Subsequently, cells were stimulated with G-CSF (100 ng/ml) for 10 min, washed twice 
with HBSS and incubated for 30, 60 or 120 min in RPMI in the absence of G-CSF. Preparation of 
nuclear extracts and STAT5 EMSA were carried out as described (de Koning et al., 2000).
luciferase assay
Luciferase assays to assess the effects of increasing levels of SOCS proteins on STAT5 activity induced 
by wt and mutant G-CSFR were performed as described (van de Geijn et al., 2004a; van de Geijn et 
al., 2004b). In brief, HEK293 cells were transfected with the indicated G-CSFR constructs, increasing 
amounts of SOCS constructs and a STAT5-responsive luciferase construct. After 2 days, cells were 
stimulated with G-CSF for 6 hrs and assayed for luciferase activity. G-CSF-induced luciferase reporter 
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Figure 1. Cytoplasmic lysines of G-CSFR are not involved in ligand-induced receptor internalization 
 
Figure 1. cytoplasmic lysines of G-csFr are not involved in ligand-induced receptor internalization
(A) Flow cytometric analysis of internalization kinetics of G-CSFR in 32D clones expressing wt G-CSFR (open bars) 
or mutant K5R (filled bars). G-CSFR cell surface expression was assessed at various time points after addition of 
G-CSF. Data represent the mean percentages of fluorescence compared to the fluorescence at t=0 min from three 
different clones. (B) G-CSFR wt and K5R are not rapidly recycled to the plasma membrane. G-CSF was added at t= 
-60 min and washed out at t= 0. Cells were then resuspended in the presence of cycloheximide and analyzed for cell 
surface expression of G-CSFR as outlined under in A. The mean fluorescence at t=-60 min was set at 100%. This result 
is representative of three experiments with three independent 32D clones.
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activity without transfected SOCS constructs was set at 100%. All experiments were performed in 
triplicate and data presented are representative of three independent experiments.
results
cytoplasmic lysines are not essential for ligand-induced endocytosis of G-csFr
Previously, we reported that internalization of the G-CSFR is guided by two adjacent inter-
nalization motifs, one of them containing a serine-type dileucine motif (Aarts et al., 2004; 
Ward et al., 1999c). To determine a possible role of cytoplasmic lysine residues in endocytosis 
and routing, we first compared internalization kinetics of wild type (wt) G-CSFR and mutant 
K5R, in which cytoplasmic lysines had been replaced by arginines, in 32D cells. As shown in 
Figure 1A, the rates of G-CSF-induced internalization of wt and K5R G-CSFR were similar. In 
 
Figure 2. Role of G-CSFR lysines in lysosomal routing 
Figure 2. role of G-csFr lysines in lysosomal routing
 HeLa cells ectopically expressing wt or K5R G-CSFR were incubated with G-CSFR antibodies and G-CSF for 20 min 
at 16°C, washed and transferred to 37°C for 15 or 120 min as indicated. Subsequently, cells were fixed and stained for 
internalized G-CSFR (green, left panels) and organelle markers EEA1, Rab7 or Hrs (red, middle panels) and analyzed 
by CLSM. Merged pictures are shown in the right panels, indicating co-localization in yellow. Insets show enlarge-
ments of the boxed areas. (A) Presence of wt G-CSFR in EEA1-positive early endosomes at 15 min and in Rab7- posi-
tive late endosomes/lysosomes at 120 min after internalization. (B) K5R is present in EEA1-positive endosomes at 
15 min, but is not detectable at Rab7-positive endosomes/lysosomes at 120 min after internalization. (C) Presence of 
K5R (arrows) but not wt G-CSFR in EEA1-positive endosomes at 120 min after internalization. (D) Presence of K5R 
but not wt G-CSFR in Hrs-positive endosomes 120 min after internalization. Scale bar, 10μm
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addition, the amount of cell surface receptors did not substantially increase within 2 hrs after 
G-CSF withdrawal (Figure 1B). Moreover, no co-localization was found between internalized 
anti-G-CSFR antibodies and a marker for recycling endosomes (TRITC-conjugated transfer-
rin) from 30 min post-internalization onwards (data not shown). These results establish that 
cytoplasmic lysines does not contribute significantly to ligand-induced G-CSFR endocytosis 
and that internalized wt or K5R G-CSFR do not massively recycle to the plasma membrane.
lysosomal routing of G-csFr depends on cytoplasmic lysines
To examine the post-endocytic fate of the internalized G-CSFR, nonactivating antibodies 
directed against an extracellular epitope of G-CSFR were used to track receptor localization 
by confocal laser scanning microscopy (CLSM) (Aarts et al., 2004). HeLa cells transfected 
with wt G-CSFR were allowed to bind G-CSFR antibodies and G-CSF for 20 min at 16°C, 
washed and then transferred to 37°C to permit internalization. Fifteen minutes after transfer, 
the internalized G-CSFR resided predominantly in EEA1-positive early endosomes (Figure 
2A, upper panel). From 30 min onward, the G-CSFR accumulated in Rab7 positive late endo-
some/lysosomes, which was complete after 2 h (Figure 2A, lower panel). These results show 
that the G-CSFR follows the endosomal-lysosomal degradation route.
We then asked whether replacement of the cytoplasmic lysines affected intracellular traf-
ficking of the G-CSFR. Similar to the wt G-CSFR, mutant K5R accumulated in EEA1 positive 
early endosomes 15 min after induction of internalization (Figure 2B, upper panel). However, 
contrary to the wt G-CSFR, no transfer of K5R to Rab7 positive late endosomes had occurred 
after 2 h (Figure 2B, lower panel). Instead, a fraction of K5R was retained in EEA1- positive 
supplementary Figure 1. retention of K5r G-csFr in early endosomes 4hrs after internalization
Hela cells were transfected with wt or K5R G-CSFR and stained for localization in EEA1 positive endosomes as 
detailed under Figure 2.
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early endosomes (Figure 2C; lower panel, arrows), which was not the case for wt G-CSFR 
(Figure 2C, upper panel). Even 4 hr after internalization, mutant K5R was still found in early 
endosomes, indicating a block or severe delay in lysosomal routing (supplementary Figure 
1). A large fraction of K5R co-localized with Hrs (Figure 2D, lower panel), a marker for 
prelysosomal endosomes. In contrast, wt G-CSFR co-localized with Hrs at 30 min (Supple-
mentary Figure 2), but not at 2 h post-internalization (Figure 2D, upper panel). Together, 
these data show that internalized G-CSFR route to an Hrs-positive endosomal compartment 
via a lysine independent mechanism. Subsequently, one or more lysines in the cytoplasmic 
tail are required for routing to lysosomes. Co-localization of the wt G-CSFR or mutant K5R 
with caveolin 1 was not observed (data not shown), indicating that G-CSFR internalization 
via the raft/caveolar endocytotic pathway does not occur under these conditions.
 
 
Figure 3. Intracellular localization of K5R G-CSFR in myeloid 32D cells 
 
 
 
 
Supplementary Figure 2. Co-localization of wt G-CSFR with Hrs, 30min after internalization 
 
 
 
 
supplementary Figure 2. co-localization of wt G-csFr with Hrs, 30min after internalization
Hela cells were transfected with wt G-CSFR and stained for localization in HRS positive endosomes as detailed under 
Figure 2.  
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Figure 3. Intracellular localization of K5r G-csFr in myeloid 32d cells
32D clones expressing wt or K5R G-CSFR were allowed to bind biotinylated G-CSF (bio-G) for 60 min at 4°C, 
washed and transferred to 37°C for an additional 60 min. Subsequently, cells were spun on glass slides, fixed, immu-
nostained for bio-G and Lamp-1 and analyzed by CLSM. Scale bar: 10 μm
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As cell context may potentially influence routing mechanisms, we validated the results ob-
tained in HeLa cells in myeloid 32D cells. Because Rab7 immunoreactivity is low in these cells, 
antibodies against lysosome-associated membrane protein-1 (Lamp-1) were used instead to 
mark the lysosomal compartment (Granger et al., 1990). Kinetics of lysosomal routing of 
G-CSFR in 32D cells were similar to those in HeLa cells: 1 hr after receptor activation, most 
wt G-CSFR accumulated in lysosomes (Figure 3, upper panel), whereas K5R did not (Figure 
3, lower panel).
differential involvement of internalization motifs and cytoplasmic lysines in attenuation 
of G-csF signaling
To compare the effects of receptor internalization domain and lysosomal routing on G-CSF 
signaling, we studied the kinetics of signaling off-switch from wt G-CSFR, mutant K5R and 
a mutant lacking the internalization domain (d749-769). 32D and Ba/F3 clones with compa-
rable expression levels of wt, d749-769 or K5R G-CSFR were used (Figure 4A and data not 
shown). First, we assessed the kinetics of downregulation of G-CSF-induced STAT5 activity 
in 32D cells by electrophoretic mobility shift assay (EMSA) following G-CSF washout after 
10 min of stimulation (Figure 4B). Compared with wt G-CSFR, both d749-769 and K5R 
G-CSFR showed a significant delay in the attenuation of STAT5 activity (Figure 4B). Western 
blot analysis with phosphospecific antibodies against signaling substrates showed that phos-
phorylation of STAT3, STAT5 and ERK induced by mutants K5R and d749-769 is prolonged 
compared with wt G-CSFR after G-CSF washout (Figure 4C). In contrast, PKB activitation 
was prolonged after activation of d749-769, but normally attenuated after activation of mu-
tant K5R (Figure 4C). These results indicate that PKB activation is abrogated immediately 
upon receptor internalization, whereas activation of STAT3, STAT5 and Erk continues upon 
routing of the G-CSFR to early endosomes. The latter experiments were performed in Ba/
F3 cells instead of 32D cells, because 32D cells were less optimal for Western blot analysis, 
probably due to higher levels of protease activity. A quantification of these data is presented 
in supplementary Table 1.
Subsequently, we assessed the consequences of removal of the internalization domain and 
substitution of the lysine residues for G-CSF-induced proliferation and differentiation. As 
demonstrated previously, 32D cells expressing wt G-CSFR proliferated 6 to 8 days and dif-
ferentiated into neutrophilic granulocytes from day 6 onwards (Figure 4D and E) (Ward et 
al., 1999a). In contrast, 32D cells expressing d749-769 or K5R continued with proliferation in 
response to G-CSF at the expense of terminal granulocytic differentiation (Figure 4D and E). 
Colony assays with G-CSFR-deficient (Csf3r-/-) bone marrow cells, retrovirally transduced 
with wt, d749-769 or K5R G-CSFR and cultured in G-CSF-supplemented semi-solid medium 
were then performed. Both the numbers and size of G-CSF-induced colonies formed by d749-
769 or K5R G-CSFR-expressing bone marrow cells exceeded those of wt G-CSFR transduced 
cells (Figure 4F), indicating that both defective internalization and lysosomal routing result 
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Figure 4. Role of internalization motif and cytoplasmic lysines in G-CSF signal attenuation and myeloid 
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Figure 4. role of internalization motif and cytoplasmic lysines in G-csF signal attenuation and myeloid dif-
ferentiation
 (A) Flow cytometric analysis of membrane expression of wt, d749-769 or K5R G-CSFR in 32D cells. Bold histo-
grams: cells stained with anti-G-CSFR and GAM-PE; shaded histograms: cells stained with GAM-PE only. (B) 32D 
cells expressing wt or mutant G-CSFR were deprived of IL-3 and serum for 4 hrs, incubated with G-CSF for 10 min at 
37°C, washed and kept at 37°C in medium without factors. Nuclear extracts were assayed at the indicated time points 
by EMSA for activated STAT5 using β-casein oligonucleotides (C) Ba/F3 cells expressing wt or mutant G-CSFR were 
treated as described under B and lysates immunoblotted and stained with anti-pSTAT5, anti-pSTAT3, anti-pPKB, 
anti-pERK and restained with anti-ERK to verify equal loading. Results are representative of three independent 
experiments in different Ba/F3 clones. (D) Proliferation of 32D.cl8.6 cells expressing wt or mutant G-CSFR during 
9 days of culture in the presence of G-CSF. Numbers of viable cells were determined at the indicated times. Data 
represent mean values +/- SEM of 3 clones per construct. (E) Differential counts of cells taken from cultures shown 
in panel D. On day 8, three clones per construct were analyzed and scored for percentages of blast cells (black bars), 
band forms (gray bars) or mature neutrophils (white bars). (F) G-CSF-induced colony formation by Csfr3-/- primary 
bone marrow cells after retroviral transduction of wt or mutant G-CSFR constructs. Upper panel: mean colony 
numbers per 25.000 infected bone marrow cells from triplicate colony assays. Lower panel: photomicrograph of rep-
resentative colonies showing differences in colony size. Data are representative of two independent experiments. No 
G-CSF-induced colonies were observed with Csfr3-/- bone marrow cells transduced with empty vector.
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in a hyperproliferative response of primary hematopoietic progenitors to G-CSF. Notably, 
the internalization defect had a more pronounced impact on proliferation signaling than the 
lysosomal routing defect, which might relate to the fact that G-CSF-induced PKB activation 
by the internalization defective mutant is sustained, whereas it is downregulated with normal 
kinetics after activation of mutant K5R (Figure 4C and supplementary Table 1) (Dong and 
Larner, 2000).
supplementary table 1. Quantification of Figure 4c*
phosphostat5
G-csF stimulation after G-csF washout
WT 3% 100% 1% 1%
D749-69 9.6% 100% 86% 32.6%
K5R 7.5% 100% 91% 67%
phosphostat3
G-csF stimulation after G-csF washout
G-csFr type 0 min 10 min 60 min 120 min
WT 7.3% 100% 11.5% 1%
D749-69 4% 100% 95.5% 35.4%
K5R 1% 100% 87% 60%
phosphoPKb
G-csF stimulation after G-csF washout
G-csFr type 0 min 10 min 60 min 120 min
Wt 7.3% 100% 11.5% 1%
D749-69 33,2% 100% 92% 50%
K5R 10% 100% 26% 15%
phosphoerK
G-csF stimulation after G-csF washout
G-csFr type 0 min 10 min 60 min 120 min
WT 43.6% 100% 86% 3.5%
D749-69 15% 100% 99% 49.5%
K5R 6% 100% 98% 55%
Data were quantified using ImageQuant 5.2 software (GE Healthcare Bio-Sciences Corp, Piscataway, NJ, USA). Data 
are expressed as signal intensities relative to signals at 10 min after G-CSF stimulation, which were set at 100%.
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G-csFr-K632 is the most critical lysine for lysosomal routing and attenuation of G-csF 
signaling
To determine which of the five cytoplasmic lysines of G-CSFR are involved in lysosomal 
routing and termination of signaling, we constructed single lysine substitution mutants. 
Mutant K632R failed to accumulate in Rab7-positive lysosomes 2 hr after internalization, 
whereas a significant proportion of mutants K672R, K681R, K682R and K762R co-localized 
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Figure 5. Intracellular localization of G-csFr mutants
(A) HeLa cells were transfected with G-CSFR mutants K632R, K672R and Y729F and examined for localization in 
Rab7-positive endosomes or lysosomes after 120 min as detailed under Figure 2. (B) HeLa cells were co-transfected 
with wt G-CSFR and 30 nM SOCS3 siRNA (upper panel) or 30 nM control siRNA (lower panel) and analyzed as 
outlined above.
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with Rab7 at this time point (Figure 5A and supplementary Figure 3). EMSA’s on stable 32D 
clones expressing either one of these mutants showed that only mutation of G-CSFR-K632 
resulted in prolonged STAT activation following ligand washout (Figure 6A upper panel). To 
further substantiate this result, we made G-CSFR constructs with single lysine residues added 
back into K5R (mKA to mKE). Only the add-back of K632 (mKA) restored the attenuation of 
STAT activation at a rate comparable to wt G-CSFR, whereas adding back each of the other 
lysines had little or no effect (Figure 6A, lower panel). In G-CSF-containing medium, 32D/
K632R cells showed sustained and enhanced proliferation in response to G-CSF, whereas 
clones expressing the other lysine substitution mutants were arrested in proliferation and 
differentiated comparably to 32D/wt cells (Figure 6B). Together, these results establish that 
G-CSFR-K632 plays a key role in lysosomal receptor degradation, termination of G-CSF-
induced STAT activation and inhibition of proliferation signaling.
 
 
Supplementary Figure 3. Intracellular localization of G-CSFR mutants 
 
 
supplementary Figure 3. Intracellular localization of G-csFr mutants
HeLa cells were transfected with G-CSFR mutants K6812R, K682R and K762R and examined for localization in Rab7 
positive endoso es or lysosomes as detailed under Figure 2.
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G-csFr is ubiquitinated on K632
To investigate whether G-CSFR lysines are acceptors for ubiquitination, we transfected cells 
with haemagglutinin (HA)-tagged G-CSFR constructs and FLAG-tagged Ub and subjected 
these to HA immunoprecipitation and FLAG Western blot analysis. G-CSFR immunopre-
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Figure 6. Involvement of G-csFr K632 in attenuation of G-csF-induced stat5 activation and cell prolifera-
tion
(A) STAT5 EMSA on 32D cells expressing wt G-CSFR or s ngle K to R substitution mutants (upper panel) or single 
add-back mutants (lower panel). Cells were deprived of IL-3 and serum, incubated for 10 min at 37°C with 100 ng/
ml G-CSF, washed to remove G-CSF and subjected to EMSA. FACS histograms indicate expression levels of differ-
ent mutants, see Figure 4B for explanation. (B) Proliferation of 32D cells expressing wt or single K to R substitution 
mutants cultured in the presence of G-CSF. Numbers of viable cells were determined at the indicated time points. 
Data represent mean values +/- s.e.m of three independent clones.
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cipitates showed FLAG-immunoreactive bands with estimated molecular sizes between 140 
and 170 kDa (Figure 7A). In contrast, no significant FLAG-immunoreactivity was detected 
in immunoprecipitates from cells transfected with K5R, indicating that ubiquitination is 
receptor lysine specific. Mutant K5R was significantly more abundant than G-CSFR wt in 
cell lysates, as was expected based on its reduced lysosomal routing. However, because only 
a minor fraction (approximately 5%) of the total G-CSFR protein is present on the plasma 
membrane (Aarts et al., 2004; Harada et al., 2005), these results may reflect predominantly 
intracellular G-CSFR. To examine specifically ubiquitination of G-CSFR expressed on the 
cell membrane, cells were incubated with biotinylated G-CSF (bio-G) and ligand-bound G-
CSFR was precipitated using streptavidin-coated magnetic beads. FLAG-immunoreactivity 
was observed with wt G-CSFR (figure 7B) but not with K5R. In addition, substantial FLAG 
immunoreactivity of mKA was seen, indicating that G-CSFR-K632 is subject to ubiquitina-
tion. Notably, substitution mutant K632R is still robustly ubiquitinated, indicating that other 
lysines in G-CSFR also serve as substrates for E3 ligases (supplementary Figure 4). Additional 
experiments with single add-back mutants indicated that K672, K681, K682 and to a lesser 
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Figure 7. ubiquitination of G-csFr
 (A) Phoenix E cells cotransfected with HA-tagged wt or K5R G-CSFR and FLAG-tagged Ub were incubated with (+) 
or without (-) G-CSF for 30 min, and HA-immunoprecipitates analyzed by Western blotting using anti FLAG (upper 
panel) or anti HA-antibodies (lower panel). (B) A similar set up as in (A), but instead of HA immunoprecipitation, 
cells were incubated with bio-G for 20 min at 16°C and for 30 min at 37°C and subsequently G-CSFR was pulled 
down with streptavidin-coated magnetic beads
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extent K762 are ubiquitinated (data not shown). Having established that these lysines are not 
critical for lysosomal routing in the endocytotic pathway, they may possibly be involved in 
other functions, such as forward routing and protein stability, as recently proposed (Erkeland 
et al., 2006). The E3 ligase involved in ubiquitination of these lysines is not SOCS3, as is 
evident from the observation that G-CSFR mutant Y729F (lacking the SOCS3 docking site) 
is ubiquitinated (supplementary Figure 4).
Involvement of socs3 in ubiquitination and lysosomal routing of G-csFr
Previously, it was shown that the inhibitory action of suppressor of cytokine signaling 3 
(SOCS3) in G-CSF-induced STAT5 activation to a major extent depends on the SOCS-box 
(van de Geijn et al., 2004b). This raises the question whether SOCS3 may be directly involved 
in ubiquitination of G-CSFR, specifically on K632. We addressed this possibility using a 
G-CSFR mutant that lacks the SOCS3 recruitment site Y729 (Hortner et al., 2002; van de 
Geijn et al., 2004a). Substitution of Y729 by phenylalanine resulted in a significantly reduced 
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supplementary Figure 4. ubiquitination of G-csFr mutants
Phoenix E cells were cotransfected with FLAG-tagged Ub and different mutants of G-CSFR. G-CSFR pull down was 
performed with bio-G and SA-conjugated magnetic beads.
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supplementary Figure 5. lysosomal degradation of G-csFr depending on receptor lysines
Phoenix E cells were transfected with wt or K5R G-CSFR and cultured for 120 min and 240 min in the presence of 
cycloheximide (5 μg/ml) to block de novo protein synthesis and for wt receptor also with NH4Cl to inhibit lysosomal 
acidification. Western blot stained for G-CSFR shows that mutant K5R is not degraded and that NH4Cl inhibits 
degradation of wt G-CSFR.
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ubiquitination of G-CSFR-K632 (compare mKA to mKA/Y729F, Figure 7B). This led us to 
examine the possible involvement of SOCS3 in lysosomal routing of G-CSFR. Two hours 
after internalization, no substantial co-localization of G-CSFR mutant Y729F with Rab7 
was seen (Figure 5A), indicating that loss of SOCS3 recruitment to Y729 prevents lysosomal 
routing of G-CSFR. To further substantiate the role of SOCS3 in the lysosomal routing of 
G-CSFR, we inhibited its expression using siRNA in wt G-CSFR-expressing cells. In these 
experiments, the efficacy of transfection as detected by siGlo Cyclophilin B siRNA exceeded 
90% (data not shown). As expected, SOCS3-siRNA but not control siRNA significantly re-
duced co-localization of G-CSFR with Rab7 2 h after G-CSF-induced internalization (Figure 
5B). Protein stability assays in which lysosomal activity is inhibited by NH4CL-mediated 
de-acidification confirmed that lysosomes play a major role in G-CSFR degradation (supple-
mentary Figure 5).
G-csFr-K632 is the most critical lysine for the inhibitory effects of socs3 on G-csF-
induced stat5 activation
SOCS3 causes a dose-dependent reduction of G-CSF-induced STAT5 activity from the wt 
G-CSFR in luciferase reporter assays (van de Geijn et al., 2004b). Using this assay, we asked 
whether SOCS3-mediated inhibition of G-CSF signaling directly depends on the cytoplasmic 
lysines of the G-CSFR. As demonstrated previously, inhibition of STAT5 activation was lost 
completely after mutation of Y729 of the G-CSFR (mutant Y729F) (Figure 8A). Strikingly, 
mutant K5R was also hardly inhibited by SOCS3, indicating that lysines of the G-CSFR are 
crucial for SOCS3-controlled attenuation of STAT5 activation (Figure 8A). In contrast, add-
ing back K632 (mKA) fully restored sensitivity to SOCS3 (Figure 8A). These inhibitory effects 
of SOCS3 on wt and mKA G-CSFR were lost upon removal of the SOCS box, consistent with 
the role of the SOCS box domain in recruiting ubiquitin ligase activity (Figure 8B). Indi-
vidual add- backs of the lysines K672 (mKB), K681 (mKC) or K682 (mKD), restored SOCS3 
responses only at the highest concentrations, whereas adding back K762 (mKE) had even less 
effect (Figure 8C). These results identify the juxtamembrane lysine K632 as the most critical 
target within the G-CSFR for SOCS3-mediated termination of STAT5 activation. In contrast 
 
 
Supplementary Figure 6. Expression of SOCS proteins in luciferase experiments 
 
 
 
 
Figure 9. Model of SOCS3-controlled termination of G-CSF signaling 
supplementary Figure 6. expression of socs proteins in luciferase experiments
Western blot analysis with Myc antibodies showing expression levels of Myc-Tagged SOCS1, SOCS2 and SOCS3 in 
luciferase experiments shown in Figure 8. Experimental details can be found in (van de Geijn et al., 2004)
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to SOCS3, the inhibitory effect of SOCS1 on STAT5 activation was not abrogated by muta-
tion of Y729 of G-CSFR, supporting the notion that recruitment to G-CSFR Y729 is required 
for SOCS3, but not SOCS1 to inhibit STAT5 activation (Figure 8D). This result complies 
with a study showing that phosphorylated Y729-containing peptides have high affinity for 
the SH2 domain of SOCS3, but not SOCS1 (Hortner et al., 2002), but is in apparent conflict 
with a study showing some Y729 dependent inhibitory effects of SOCS1 on STAT5 activation 
(Zhuang et al., 2005). However, also in this latter study, the authors failed to demonstrate a 
physical interaction between G-CSFR-Y729 and SOCS1. Notably, the inhibitory effects of 
SOCS1 were not affected by mutation of K632 or other lysines in the G-CSFR cytoplasmic 
domain (Figure 8D), further arguing against a direct effect of SOCS1 on G-CSFR routing. 
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Figure 8. role of lysines of G-csFr in socs3-mediated inhibition of stat5 activation
HEK293 cells were transfected with the indicated G-CSFR constructs, increasing amounts of SOCS3 (panel A and 
C), SOCS3 and SOCS3dBox (panel B), SOCS 2 (panel D) and SOCS1 (panel E) and a STAT5-responsive luciferase 
construct. SOCS protein levels were determined by Western blotting, of which a representative analysis is shown in 
supplementary Figure 6. For each G-CSFR construct, G-CSF-induced luciferase reporter activity in the absence of 
SOCS was set at 100%. Data are representative of 3 independent experiments each performed in triplicate.
64
Chapter 2
Two recent studies have shown that SOCS2 interacts with and degrades SOCS3, thereby play-
ing a unique role in cytokine signaling (Piessevaux et al., 2006; Tannahill et al., 2005). We 
therefore investigated the effects of SOCS2 on STAT5 activation by wt G-CSFR and mutants, 
but found that SOCS2 had no effect on G-CSF-induced STAT5 activation (Figure 8E) and did 
not neutralize the inhibitory effects of ectopically expressed SOCS3 (data not shown).
dIscussIon
role of receptor lysine K632 in G-csFr routing and control of G-csF signaling
In this study, we have shown that G-CSFR routing from early endosomes to lysosomes depends 
on the integrity of a single lysine, G-CSFR-K632, in the juxtamembrane cytoplasmic region 
and that maintaining an appropriate balance of G-CSF-induced signals largely depends on 
this mechanism. In contrast, G-CSFR internalization was not affected by substitution of any 
of the five conserved cytoplasmic lysines for arginines. This result differs from a recent study 
on the related LR, which showed that two lysines in the cytoplasmic domain are critical for 
internalization (Belouzard and Rouille, 2006). The reason for this discrepancy might relate to 
the fact that the LR lacks tyrosine or dileucine-based endocytosis motifs found in other class 
I cytokine receptor chains such as G-CSFR and gp130, and instead carries a Ub-based novel 
internalization motif (Belouzard and Rouille, 2006). However, it remains possible that the 
Ub-conjugation system controls G-CSFR endocytosis via an indirect mechanism, as has been 
demonstrated for GHR (Govers et al., 1999).
An important question is which effector protein(s) linked to K632 is responsible for 
lysosomal routing of G-CSFR. We considered the UIM-containing protein Hrs as the most 
plausible candidate, as it has been shown to form a multivalent complex, including other 
UIM-containing proteins such as STAM1/STAM2 and Eps15 that guides endocytosed mem-
brane proteins to lysosomes (Bache et al., 2003). However, we were unable to demonstrate 
association of Hrs to G-CSFR in immunoprecipitation assays. Furthermore, siRNA-mediated 
knockdown of Hrs did not alter off-rate kinetics of STAT5 activation as seen with G-CSFR 
mutants lacking K632 (data not shown). It thus remains to be determined which proteins or 
protein complexes are crucial for ligand-induced lysosomal routing of G-CSFR and attenua-
tion of STAT5 activation.
consequences of G-csFr routing for G-csF signaling
Another major objective was to determine how intracellular trafficking impacts on G-CSF 
signaling. From the off-rate experiments with G-CSFR mutant K5R, which internalizes nor-
mally but fails to route to late endosomes and lysosomes, it can be deduced that activation 
of STAT5 and ERK continues in early endosomes. In contrast, PKB activation by K5R was 
terminated following G-CSF washout with kinetics similar to wt G-CSFR, whereas it was 
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sustained with internalization defective G-CSFR mutant d749-769 (Figure 4C). These find-
ings suggest that distinct mechanisms of signal attenuation are involved in the termination 
of PKB versus STAT5 and ERK activation, depending on the intracellular localization of 
G-CSFR. Although this needs further study, several potential mechanisms can be envisaged. 
For instance, as demonstrated for the insulin receptor and the tyrosine phosphatase PTP1B 
(Romsicki et al., 2004), an endosome-associated phosphatase activity might be involved that 
affects PKB but not STAT5 and ERK. Alternatively, divergence in intracellular routing of 
signaling intermediates, for example, through caveolin-mediated internalization, may cause 
dissociation of the PI-3K/PKB pathway from the G-CSFR complex in early clathrin-coated 
endosome, as was recently shown for the abrogation of PI-3K/PKB signaling after internal-
ization of integrin receptors (del Pozo et al., 2005).
socs3 as a key regulator of G-csFr routing and stat5 activation
Together with previous reports, our present data support a model in which SOCS3, recruited 
to the phosphorylated Y729 of G-CSFR following receptor activation, inhibits G-CSF signal-
ing by two mechanisms (Figure 9). The first mechanism engages the kinase inhibitory region 
(KIR) of SOCS3 to inhibit JAK kinase activity and has been documented for a number of 
receptors (Kile and Alexander, 2001). The second, new mechanism supported by our data 
involves ubiquitination of the G-CSFR protein on a membrane proximal lysine, which 
triggers routing of the G-CSFR from an Hrs positive compartment to lysosomes. Although 
functionally distinct, these mechanisms do not necessarily have to act independently. For 
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Figure 9. Model of SOCS3-controlled termination of G-CSF signaling 
Figure 9. Model of socs3-controlled termination of G-csF signaling
Following activation by G-CSF, G-CSFR recruits SOCS3 via phosphorylated tyrosine residue Y729. SOCS3 inhibits 
JAK activity via its kinase inhibitory region to inactivation of G-CSFR. This may also be achieved in part by direct 
recruitment of SOCS3 to JAK itself (Kile and Alexander, 2001). A second and novel mechanism involves recruitment 
of E3 ligase activity, leading to ubiquitination of K632 of G-CSFR. This triggers G-CSFR transition from Hrs-positive 
endosomes to lysosomes, attenuating activation of STAT5.
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instance, the unidentified protein(s) recruited to Ub-K632 and involved in lysosomal routing 
may be negatively controlled by JAK activity, which would imply that the KIR of SOCS3 
indirectly also controls lysosomal routing of G-CSFR. Conversely, the SOCS box of SOCS3 
may also be involved in degradation of JAK proteins (Kile and Alexander, 2001), which in 
turn could have an effect on routing of G-CSFR.
The K632 of G-CSFR resides at position –5 relative to the box 1 domain (PGIPSP). Intrigu-
ingly, this lysine is conserved among several other class I cytokine receptors, for example, 
leptin receptor, gp130, IL-4R and IL-7R. This might be suggestive of a general role of this 
conserved juxtamembrane lysine and merits investigations aimed at determining whether 
control of receptor routing by members of the SOCS protein family may be a more common 
theme in cytokine receptor signaling.
67
Chapter 2
reFerences
Aarts, L.H., Roovers, O., Ward, A.C. and Touw, I.P. (2004) Receptor activation and 2 distinct COOH-
terminal motifs control G-CSF receptor distribution and internalization kinetics. Blood, 103, 571-
579.
Alves dos Santos, C.M., ten Broeke, T. and Strous, G.J. (2001) Growth hormone receptor ubiquitina-
tion, endocytosis, and degradation are independent of signal transduction via Janus kinase 2. J Biol 
Chem, 276, 32635-32641.
Avalos, B.R., Gasson, J.C., Hedvat, C., Quan, S.G., Baldwin, G.C., Weisbart, R.H., Williams, R.E., Golde, 
D.W. and DiPersio, J.F. (1990) Human granulocyte colony-stimulating factor: biologic activities 
and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood, 75, 
851-857.
Bache, K.G., Raiborg, C., Mehlum, A. and Stenmark, H. (2003) STAM and Hrs are subunits of a multi-
valent ubiquitin-binding complex on early endosomes. J Biol Chem, 278, 12513-12521.
Belouzard, S. and Rouille, Y. (2006) Ubiquitylation of leptin receptor OB-Ra regulates its clathrin-
mediated endocytosis. Embo J, 25, 932-942.
Blanchard, F., Duplomb, L., Wang, Y., Robledo, O., Kinzie, E., Pitard, V., Godard, A., Jacques, Y. and 
Baumann, H. (2000) Stimulation of leukemia inhibitory factor receptor degradation by extracellular 
signal-regulated kinase. J Biol Chem, 275, 28793-28801.
Croker, B.A., Metcalf, D., Robb, L., Wei, W., Mifsud, S., DiRago, L., Cluse, L.A., Sutherland, K.D., 
Hartley, L., Williams, E., Zhang, J.G., Hilton, D.J., Nicola, N.A., Alexander, W.S. and Roberts, A.W. 
(2004) SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granu-
lopoiesis. Immunity, 20, 153-165.
Dahlen, D.D., Broudy, V.C. and Drachman, J.G. (2003) Internalization of the thrombopoietin receptor 
is regulated by 2 cytoplasmic motifs. Blood, 102, 102-108.
de Koning, J.P., Schelen, A.M., Dong, F., van Buitenen, C., Burgering, B.M., Bos, J.L., Lowenberg, B. and 
Touw, I.P. (1996) Specific involvement of tyrosine 764 of human granulocyte colony-stimulating 
factor receptor in signal transduction mediated by p145/Shc/GRB2 or p90/GRB2 complexes. Blood, 
87, 132-140.
de Koning, J.P., Soede-Bobok, A.A., Schelen, A.M., Smith, L., van Leeuwen, D., Santini, V., Burgering, 
B.M., Bos, J.L., Lowenberg, B. and Touw, I.P. (1998) Proliferation signaling and activation of Shc, 
p21Ras, and Myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor. Blood, 
91, 1924-1933.
de Koning, J.P., Soede-Bobok, A.A., Ward, A.C., Schelen, A.M., Antonissen, C., van Leeuwen, D., Lo-
wenberg, B. and Touw, I.P. (2000) STAT3-mediated differentiation and survival and of myeloid cells 
in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor 
p27(Kip1). Oncogene, 19, 3290-3298.
del Pozo, M.A., Balasubramanian, N., Alderson, N.B., Kiosses, W.B., Grande-Garcia, A., Anderson, 
R.G. and Schwartz, M.A. (2005) Phospho-caveolin-1 mediates integrin-regulated membrane do-
main internalization. Nat Cell Biol, 7, 901-908.
68
Chapter 2
Dittrich, E., Haft, C.R., Muys, L., Heinrich, P.C. and Graeve, L. (1996) A di-leucine motif and an 
upstream serine in the interleukin-6 (IL-6) signal transducer gp130 mediate ligand-induced endo-
cytosis and down-regulation of the IL-6 receptor. J Biol Chem, 271, 5487-5494.
Dong, F. and Larner, A.C. (2000) Activation of Akt kinase by granulocyte colony-stimulating factor 
(G-CSF): evidence for the role of a tyrosine kinase activity distinct from the Janus kinases. Blood, 
95, 1656-1662.
Dunn, S.L., Bjornholm, M., Bates, S.H., Chen, Z., Seifert, M. and Myers, M.G., Jr. (2005) Feedback 
inhibition of leptin receptor/Jak2 signaling via Tyr1138 of the leptin receptor and suppressor of 
cytokine signaling 3. Mol Endocrinol, 19, 925-938.
Erkeland, S.J., Aarts, L.H., Irandoust, M., Roovers, O., Klomp, A., Valkhof, M., Gits, J., Eyckerman, S., 
Tavernier, J. and Touw, I.P. (2006) Novel role of WD40 and SOCS box protein-2 in steady-state 
distribution of granulocyte colony-stimulating factor receptor and G-CSF-controlled proliferation 
and differentiation signaling. Oncogene.
Erkeland, S.J., Valkhof, M., Heijmans-Antonissen, C., Delwel, R., Valk, P.J., Hermans, M.H. and Touw, 
I.P. (2003) The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid trans-
forming gene interfering with neutrophilic differentiation. Blood, 101, 1111-1117.
Govers, R., ten Broeke, T., van Kerkhof, P., Schwartz, A.L. and Strous, G.J. (1999) Identification of 
a novel ubiquitin conjugation motif, required for ligand-induced internalization of the growth 
hormone receptor. Embo J, 18, 28-36.
Granger, B.L., Green, S.A., Gabel, C.A., Howe, C.L., Mellman, I. and Helenius, A. (1990) Characteriza-
tion and cloning of lgp110, a lysosomal membrane glycoprotein from mouse and rat cells. J Biol 
Chem, 265, 12036-12043.
Haglund, K., Di Fiore, P.P. and Dikic, I. (2003) Distinct monoubiquitin signals in receptor endocytosis. 
Trends Biochem Sci, 28, 598-603.
Harada, M., Qin, Y., Takano, H., Minamino, T., Zou, Y., Toko, H., Ohtsuka, M., Matsuura, K., Sano, 
M., Nishi, J., Iwanaga, K., Akazawa, H., Kunieda, T., Zhu, W., Hasegawa, H., Kunisada, K., Nagai, T., 
Nakaya, H., Yamauchi-Takihara, K. and Komuro, I. (2005) G-CSF prevents cardiac remodeling after 
myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med, 11, 305-311.
Hermans, M.H., van de Geijn, G.J., Antonissen, C., Gits, J., van Leeuwen, D., Ward, A.C. and Touw, 
I.P. (2003) Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor 
receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood, 101, 2584-2590.
Hortner, M., Nielsch, U., Mayr, L.M., Johnston, J.A., Heinrich, P.C. and Haan, S. (2002) Suppressor of 
cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and 
modulates its signal transduction. J Immunol, 169, 1219-1227.
Hunter, M.G. and Avalos, B.R. (1999) Deletion of a critical internalization domain in the G-CSFR in 
acute myelogenous leukemia preceded by severe congenital neutropenia. Blood, 93, 440-446.
Kelly, P.A., Djiane, J., Postel-Vinay, M.C. and Edery, M. (1991) The prolactin/growth hormone receptor 
family. Endocr Rev, 12, 235-251.
Kile, B.T. and Alexander, W.S. (2001) The suppressors of cytokine signalling (SOCS). Cell Mol Life Sci, 
58, 1627-1635.
69
Chapter 2
Kile, B.T., Schulman, B.A., Alexander, W.S., Nicola, N.A., Martin, H.M. and Hilton, D.J. (2002) The 
SOCS box: a tale of destruction and degradation. Trends Biochem Sci, 27, 235-241.
Kimura, A., Kinjyo, I., Matsumura, Y., Mori, H., Mashima, R., Harada, M., Chien, K.R., Yasukawa, 
H. and Yoshimura, A. (2004) SOCS3 is a physiological negative regulator for granulopoiesis and 
granulocyte colony-stimulating factor receptor signaling. J Biol Chem, 279, 6905-6910.
Lu, J.C., Piazza, T.M. and Schuler, L.A. (2005) Proteasomes mediate prolactin-induced receptor down-
regulation and fragment generation in breast cancer cells. J Biol Chem, 280, 33909-33916.
Marmor, M.D. and Yarden, Y. (2004) Role of protein ubiquitylation in regulating endocytosis of recep-
tor tyrosine kinases. Oncogene, 23, 2057-2070.
Miaczynska, M., Pelkmans, L. and Zerial, M. (2004) Not just a sink: endosomes in control of signal 
transduction. Curr Opin Cell Biol, 16, 400-406.
Piessevaux, J., Lavens, D., Montoye, T., Wauman, J., Catteeuw, D., Vandekerckhove, J., Belsham, D., 
Peelman, F. and Tavernier, J. (2006) Functional cross-modulation between SOCS proteins can 
stimulate cytokine signaling. J Biol Chem, 281, 32953-32966.
Polo, S. and Di Fiore, P.P. (2006) Endocytosis conducts the cell signaling orchestra. Cell, 124, 897-900.
Raiborg, C., Bache, K.G., Gillooly, D.J., Madshus, I.H., Stang, E. and Stenmark, H. (2002) Hrs sorts 
ubiquitinated proteins into clathrin-coated microdomains of early endosomes. Nat Cell Biol, 4, 
394-398.
Rausch, O. and Marshall, C.J. (1997) Tyrosine 763 of the murine granulocyte colony-stimulating factor 
receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase 
pathway. Mol Cell Biol, 17, 1170-1179.
Romsicki, Y., Reece, M., Gauthier, J.Y., Asante-Appiah, E. and Kennedy, B.P. (2004) Protein tyrosine 
phosphatase-1B dephosphorylation of the insulin receptor occurs in a perinuclear endosome com-
partment in human embryonic kidney 293 cells. J Biol Chem, 279, 12868-12875.
Royer, Y., Staerk, J., Costuleanu, M., Courtoy, P.J. and Constantinescu, S.N. (2005) Janus kinases affect 
thrombopoietin receptor cell surface localization and stability. J Biol Chem, 280, 27251-27261.
Shao, H., Xu, X., Jing, N. and Tweardy, D.J. (2006) Unique structural determinants for Stat3 recruitment 
and activation by the granulocyte colony-stimulating factor receptor at phosphotyrosine ligands 704 
and 744. J Immunol, 176, 2933-2941.
Tannahill, G.M., Elliott, J., Barry, A.C., Hibbert, L., Cacalano, N.A. and Johnston, J.A. (2005) SOCS2 
can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation. Mol Cell 
Biol, 25, 9115-9126.
Uotani, S., Bjorbaek, C., Tornoe, J. and Flier, J.S. (1999) Functional properties of leptin receptor 
isoforms: internalization and degradation of leptin and ligand-induced receptor downregulation. 
Diabetes, 48, 279-286.
van de Geijn, G.J., Aarts, L.H., Erkeland, S.J., Prasher, J.M. and Touw, I.P. (2003) Granulocyte colony-
stimulating factor and its receptor in normal hematopoietic cell development and myeloid disease. 
Rev Physiol Biochem Pharmacol, 149, 53-71.
70
Chapter 2
van de Geijn, G.J., Gits, J., Aarts, L.H., Heijmans-Antonissen, C. and Touw, I.P. (2004a) G-CSF receptor 
truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppres-
sion of STAT3 intact. Blood, 104, 667-674.
van de Geijn, G.J., Gits, J. and Touw, I.P. (2004b) Distinct activities of suppressor of cytokine signaling 
(SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling. J Leukoc Biol, 
76, 237-244.
van Kerkhof, P. and Strous, G.J. (2001) The ubiquitin-proteasome pathway regulates lysosomal degra-
dation of the growth hormone receptor and its ligand. Biochem Soc Trans, 29, 488-493.
Ward, A.C., Hermans, M.H., Smith, L., van Aesch, Y.M., Schelen, A.M., Antonissen, C. and Touw, 
I.P. (1999a) Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human 
granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on 
G-CSF concentration. Blood, 93, 113-124.
Ward, A.C., Smith, L., de Koning, J.P., van Aesch, Y. and Touw, I.P. (1999b) Multiple signals mediate 
proliferation, differentiation, and survival from the granulocyte colony-stimulating factor receptor 
in myeloid 32D cells. J Biol Chem, 274, 14956-14962.
Ward, A.C., van Aesch, Y.M., Schelen, A.M. and Touw, I.P. (1999c) Defective internalization and 
sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe 
congenital neutropenia/acute myeloid leukemia. Blood, 93, 447-458.
Yen, C.H., Yang, Y.C., Ruscetti, S.K., Kirken, R.A., Dai, R.M. and Li, C.C. (2000) Involvement of the 
ubiquitin-proteasome pathway in the degradation of nontyrosine kinase-type cytokine receptors of 
IL-9, IL-2, and erythropoietin. J Immunol, 165, 6372-6380.
Zhuang, D., Qiu, Y., Haque, S.J. and Dong, F. (2005) Tyrosine 729 of the G-CSF receptor controls the 
duration of receptor signaling: involvement of SOCS3 and SOCS1. J Leukoc Biol, 78, 1008-1015.

CHAPTER3
Site-specific ubiquitination  
determines lysosomal sorting  
and signal attenuation of the G-CSF receptor
Albert Wölfler, Mahban Irandoust, Annemarie Meenhuis, Judith Gits, 
Onno Roovers, and Ivo P. Touw 
(Manuscript submitted)
74
Chapter 3
abstract
Ubiquitination of cytokine receptors controls intracellular receptor routing and signal du-
ration but the underlying molecular determinants are unclear. The suppressor of cytokine 
signaling protein SOCS3 drives lysosomal degradation of the granulocyte colony-stimulating 
factor receptor (G-CSFR), depending on SOCS3-mediated ubiquitination of a specific lysine 
located in a conserved juxtamembrane motif. Here, we show that despite ubiquitination of 
other lysines positioning of a lysine within the membrane-proximal region is indispensable 
for this process. Neither reallocation of the motif nor fusion of ubiquitin to the C-terminus 
of the G-CSFR could drive lysosomal routing. However, within this region, the lysine could 
be shifted 12 amino acids towards the C-terminus without losing its function, arguing against 
the existence of a linear sorting motif and demonstrating that positioning of the lysine rela-
tive to the SOCS3 docking site is flexible. G-CSFR ubiquitination peaked after endocytosis, 
was inhibited by methyl-β-cyclodextrin and severely reduced in internalization defective 
G-CSFR mutants, indicating that ubiquitination mainly occurs at endosomes. Apart from 
elucidating structural and spatio-temporal aspects of SOCS3-mediated ubiquitination, these 
findings have implications for the abnormal signaling function of G-CSFR mutants found in 
severe congenital neutropenia, a hematopoietic disorder with a high leukemia risk.
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IntroductIon
Granulocyte colony-stimulating factor (G-CSF) is the major cytokine involved in the pro-
duction of neutrophilic granulocytes (Akbarzadeh and Layton, 2001; Avalos et al., 1990). 
G-CSF induces the proliferation and survival of myeloid progenitor cells, followed by a cell 
cycle arrest and neutrophilic differentiation (Touw and van de Geijn, 2007). This response 
depends on the balanced activation and subsequent attenuation of signaling pathways linked 
to the G-CSF receptor (G-CSFR), a member of the class I cytokine receptor superfamily 
(Touw and van de Geijn, 2007). Signal attenuation of G-CSFR is severely compromised by 
mutations causing truncations in the cytoplasmic domain of the G-CSFR, which are found 
in patients with a severe form of neutropenia and a predisposition to acute myeloid leukemia 
(Germeshausen et al., 2007). Two major mechanisms implicated in the perturbed signaling 
functions of these truncated G-CSFR mutants are the loss of a dileucine-based internalization 
motif(Hunter and Avalos, 1999; Ward et al., 1999) and the deletion of Y729, the tyrosine 
residue involved in the recruitment of the suppressor of cytokine signaling protein SOCS3 
(Hermans et al., 2003; Hortner et al., 2002). 
Covalent attachment of ubiquitin (Ub) to cytoplasmic lysine residues of activated mem-
brane receptors is one of the major mechanisms involved in downregulation of signaling 
(Mukhopadhyay and Riezman, 2007). The process of ubiquitination requires Ub-activating 
(E1), -conjugating (E2) and -ligase (E3) activities. Substrate specificity is mediated by the E3 
ligase, by recognizing and interacting with the target protein. The role of ubiquitination in 
internalization and intracellular degradation of membrane receptors has been best studied 
for receptor tyrosine kinases, such as the epidermal growth factor receptor (EGFR) (Marmor 
and Yarden, 2004). Upon ligand binding, the E3 ligase Cbl is recruited to the tyrosine-
phosphorylated receptor and induces ubiquitination of lysine residues located within the 
kinase domain (Huang et al., 2006). While ubiquitination of the EGFR itself is dispensable for 
receptor endocytosis, it is crucial for lysosomal routing and degradation of the EGFR (Huang 
et al., 2007; Marmor and Yarden, 2004). However, recent studies on other receptor systems, 
for instance the leptin receptor OB-Ra and the interferon α receptor type 1 (IFNAR1), have 
revealed that ubiquitination may also play a major role in receptor internalization (Belouzard 
and Rouille, 2006; Kumar et al., 2007), indicating that depending on the receptor type and cell 
context, E3 ligases control multiple steps in receptor trafficking and lysosomal degradation.
We recently reported that lysosomal routing and degradation of the granulocyte colony-
stimulating factor receptor (G-CSFR) depends on recruitment of suppressor of cytokine-
signaling 3 (SOCS3) to the activated receptor (Irandoust et al., 2007). Besides inhibiting 
signaling by interfering with JAK kinase activity through its kinase inhibitory region (KIR) 
(Yoshimura et al., 2007), SOCS3 forms a cullin-based E3 ligase complex by recruitment of 
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Elongin C and B as well as Cullin 2 via its SOCS box (a so called ECS E3 ligase) (Kamura et 
al., 2004). SOCS3-directed lysosomal routing and signaling downregulation of the G-CSFR 
was dependent on ubiquitination of lysine residues of the G-CSFR as well as on the presence 
of the SOCS box in SOCS3 (Irandoust et al., 2007). Importantly, in vivo evidence for a specific 
role of the SOCS box in G-CSFR negative signaling recently emerged from studies in knock-
in mice expressing a truncated SOCS3 protein lacking the C-terminal SOCS box (Boyle et 
al., 2007).
A key finding of our previous study was that SOCS3-induced downregulation of STAT5 
activity and lysosomal routing of the G-CSFR to a major extent depended on a juxtamem-
brane lysine residue at position 632 (K632), even though there are in total five conserved 
lysines present in the cytoplasmic domain of the G-CSFR (Irandoust et al., 2007). This result 
differed from studies showing that endocytosis and lysosomal routing could be triggered by 
a linear fusion of Ub to the cytoplasmic tail of a membrane receptor (Haglund et al., 2003; 
Hicke and Dunn, 2003; Raiborg et al., 2003; Sigismund et al., 2004). On the other hand, 
more recent studies have suggested that specific positioning of lysines within target proteins 
may be important for certain ubiquitination-dependent mechanisms because some E3 ligases 
preferentially select lysines next to their recruitment site within the target protein (Hunter, 
2007). For example, this applies to the F-box protein β-Transducin repeat-containing 
protein (β-Trcp) (Laney and Hochstrasser, 1999), which together with the linker Skp1 and 
Cul1 forms a multiprotein SCF (Skp1-Cul1-F-box) E3 ligase complex. β-Trcp ubiquitinates 
lysine residues at position 9-13 upstream of its binding motif (Fuchs et al., 2004). Targets of 
β-Trcp include some cytokine receptors, like interferon α receptor 1 (IFNAR1) (Kumar et al., 
2004; Kumar et al., 2003), prolactin receptor (Li et al., 2004) and the erythropoietin receptor 
(EPOR) (Meyer et al., 2007), but not the G-CSFR. Although ECS and SCF belong to the same 
cullin-RING ubiquitin ligase superfamily and share considerable structure similarity, noth-
ing is known about preferential lysine selection by ECS E3 ligases, such as SOCS3. In addition 
to being important for accessibility to E3 complexes, positioning of a lysine residue within 
a target protein may also be critical for binding with a downstream interacting protein, as 
has recently been implicated to be of major importance to regulate IFNAR1 internalization 
(Kumar et al., 2007).
In the present study, we investigated how positioning of the critical lysine residue determines 
the dynamics of ubiquitination, lysosomal routing and signal attenuation of the G-CSFR. We 
show that lysosomal sorting activity of a ubiquitinated lysine is confined to the membrane-
proximal region despite ubiquitination of other lysines. However, within this domain and 
relative to the SOCS3 binding site (Y729), positioning of the crucial lysine is to some extent 
flexible. We further show that G-CSFR ubiquitination predominantly takes place after recep-
tor internalization. Finally, we demonstrate that a G-CSFR deletion mutant (d715) found in 
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patients with neutropenia is severely hampered in ubiquitination, which corroborates the 
importance of ubiquitination for proper G-CSFR function and provides a mechanism for the 
dysfunction of this receptor mutant associated with leukemic progression of this disease.
MaterIal and MetHods
expression constructs
The constructs of human G-CSFR wt, K5R, K632R, mKA, mKB, mKC, mKD, mKE, d715 and d749-769 
in pBabe and pLNCX2 vector have been described previously (Aarts et al., 2004; Irandoust et al., 2007). 
Domain-fusion G-CSFR constructs were generated by PCR using GRFR7 as a forward primer (Aarts 
et al., 2004) and a reverse primer spanning the last 21 nucleotides of the G-CSFR sequence excluding 
the stop codon, the 36 nucleotides corresponding to 12 amino acids of the juxtamembrane domain and 
box-1 region (R631 to P642), a stop codon and a BglII restriction site. G-CSFR wt, K5R and K632R 
were used as templates. PCR fragments were then digested with HpaI and BglII (Aarts et al., 2004) and 
ligated in pBabe or pLNCX2 containing wt G-CSFR, which had also been digested with HpaI and BglII. 
Other single amino acid changes and multiple amino acids insertions were created using oligonucle-
otides containing the desired mutations and Stratagene QuikChange Site-Directed Mutagenesis Kit 
(Stratagene, La Jolla, CA). The authenticity of all constructs was verified by restriction enzyme analysis 
and DNA sequencing.
To create the K5R G-CSFR-Ub fusion construct, a first PCR was performed using GRFR7 as a forward 
primer (Aarts et al., 2004) and a 3’ chimeric oligonucleotide (G-CSFR/Ub), spanning a 3’ segment of 
the G-CSFR and a 5’ segment of Ub, as the reverse primer to amplify a C-terminal lysine-less G-CSFR 
fragment using K5R as template. Secondly, to amplify the Ub cDNA, a 5’ chimeric oligonucleotide 
(Ub/G-CSFR), spanning the 5’ segment of Ub and the 3’ segment of the G-CSFR, and a 3’ oligonucle-
otide spanning the 3’ segment of Ub plus containing a BglII restriction site (Ub/BglII) was used with 
Flag-tagged ubiquitin in pCDNA3 (see below) as a template. Finally, the products of theses two PCR 
were isolated, mixed 1:1, and used as templates for a PCR using GRFR7 and Ub/BglII as primers. The 
resulting fragment was digested with HpaI and BglII and ligated in pBABE or pLNCX2 containing 
wt G-CSFR, from which the wt HpaI/BglII fragment has been removed. The G-CSFR-d715-Ub fusion 
construct was made in a similar way using GRFR7 and Ub/BglII together with the appropriate chimeric 
primers spanning the 5’ segment of Ub and the 3’ segment of d715.
Flag-tagged Ub in pCDNA3 was a gift from Dr. B. van der Reijden (Nijmegen, The Netherlands). 
SOCS3 expression constructs and reporter constructs for luciferase assays have been reported previ-
ously (van de Geijn et al., 2004).
antibodies
Flag M2 monoclonal antibody (mAb) was purchased from Sigma (St Louis, MO). mAb anti-human 
CD114 (G-CSFR) and anti-CD114 coupled to phycoerythrin (PE) were from Becton-Dickinson/
PharMingen (San Diego, CA). Mouse anti-ubiquitin (P4D1), rabbit anti-Rab7, mAb anti-HA and rabbit 
polyclonal anti-STAT5 were obtained from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). Secondary 
goat anti-rabbit Alexa Fluor 546 and goat anti-mouse Alexa Fluor 488 were purchased from Molecular 
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Probes (Invitrogen, Breda, The Netherlands). For western blot analysis secondary goat anti-mouse and 
goat anti-rabbit either coupled to IRDyeTM680 or IR-DyeTM800CW were obtained from LI-COR 
Biosciences (Nebraska, USA). mAb anti-pSTAT5 (STAT5A-pY694, STAT5B-pY699) was from Upstate 
Biotechnology Inc. (Charlottesville, VA).
cell culture, transfection and retroviral transduction
Phoenix E, HEK293 and HeLa cells were maintained in Dulbecco modified Eagle medium (DMEM, 
glucose 4.5 g/l) supplemented with 10% FCS, 100 IU/ml penicillin and 100 µg/ml streptomycin in 
humidified atmosphere at 37°C and 5% CO2. HeLa cells were plated on glass coverslips and transiently 
transfected using lipofectamine (Invitrogen). Transfection of Phoenix E cells and HEK cells was done 
by the calcium phosphate precipitation method.
Murine myeloid 32D.cl8.6 and Ba/F3 cells, which both lack endogenous G-CSFR expression (de 
Koning et al., 1998), were cultured in RPMI-1640 medium supplemented with 10% FCS, 100 IU/ml 
penicillin, 100 µg/ml streptomycin and 10 ng/ml murine IL-3 at 37°C and 5% CO2. 32D.cl8.6 clones 
and Ba/F3 cells expressing different G-CSFR constructs were obtained by retroviral transduction as 
described (Aarts et al., 2004). Levels of G-CSFR expression were assessed by FACS analysis and clones 
with comparable G-CSFR expression were used in further experiments.
bio-G-csF pull downs
G-CSFR pull-down was performed with biotinylated G-CSF (bio-G) as described previously (Irandoust 
et al., 2007). Briefly, after transfection with G-CSFR constructs and Flag-tagged Ub, Phoenix E cells 
were incubated with bio-G (10 µg/ml; biotin labeling kit, Roche Molecular Biochemicals, Mannhein, 
Germany) for 15 min at RT and subsequently at 37°C for 30 min. Subsequently, cells were harvested, 
washed twice with ice-cold PBS and lysed in lysis buffer (20 mM Tris HCl pH 8.0, 137 mM NaCl, 10 
mM EDTA, 100 mM NaF, 1% NP40, 10% glycerol, 2 mM Na3VO4 and 1 mM Pefablock SC, 50 µg/ml 
aprotinin, 50 µg/ml leupeptin, 50 µg/ml bacitracin, and 50 µg/ml iodoacetamide as protease inhibitors). 
After incubating the lysates with streptavidin-coated magnetic beads (Dynabeads, Invitrogen) for 1hr 
at 4°C, beads were washed, resuspended in Laemlli buffer (pH 11) and boiled for 5 min. Subsequent 
SDS-polyacrylamide gel electrophoresis and Western blotting was performed as described (Ward et al., 
1999). Detection of proteins was done using fluorescently labeled secondary antibodies and the Odys-
sey Infrared Imaging System (LI-COR Biosciences, Nebraska, USA). Quantification of ubiquitination 
levels in Ba/F3 cells was done using the Odyssey Infrared Imaging System software according to the 
manufacturer’s instructions.
For bio-G pull-down experiments with Ba/F3 cells stably expressing indicated G-CSFR mutants, cells 
(1 x 107) were washed in HBSS and resuspended in RPMI containing 250 nM bafilomycin (Calbiochem, 
Invitrogen). In experiments determining the role of endocytosis in G-CSFR ubiquitination, methyl-
β-cyclodextrin (5 mM, Sigma-Aldrich, Zwijndrecht. The Netherlands) was added concomitantly with 
bafilomycin. After preincubation for 30 min at 37°C, bio-G was added for 1 hr. Subsequent procedures 
were done as described for Phoenix E cells.
cell proliferation assay and G-csF-induced stat5 phosphorylation
To investigate the proliferation characteristics of 32D8.6cl clones transduced with various G-CSF 
constructs, cells were washed twice in Hank’s balanced salt solution (HBSS) and seeded at a density of 1 
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x 105 cells/ml in RPMI-1640 medium supplemented with 10% FCS and 10 ng/ml human G-CSF. Viable 
cells were counted and readjusted to 1 x 105 cells/ml every second day.
To determine STAT5 phosphorylation off-rate kinetics after G-CSFR stimulation, Ba/F3 cells stably 
expressing the indicated G-CSFR mutants were washed twice in HBSS and serum and cytokine starved 
for 4 hours in RPMI-1640. After stimulation for 10 min with G-CSF (100 ng/ml), cells were washed 
twice with HBSS to remove G-CSF and monitored for residual STAT5 phosphorylation 60 and 120 min 
after stimulation. Cell lysates (2 x 106 cells) were prepared at the indicated time points and subjected to 
western blot analysis as described above.
luciferase assay
STAT5 luciferase assays were performed as described (Hermans et al., 2003). Briefly, HEK293 cells were 
transfected by calcium phosphate precipitation with the indicated G-CSFR constructs, with or without 
a SOCS3 construct (G-CSFR DNA to SOCS3 DNA ratio 16:1) and a STAT5-responsive luciferase 
construct. After overnight starvation in DMEM + 1% BSA, cells were stimulated with 250 ng/ml G-CSF 
on the second day after transfection for 6 hrs and assayed for luciferase activity. All experiments were 
done in triplicate.
Immunocytochemistry and confocal microscopy
Visualization of lysosomal routing of membrane G-CSFR after receptor activation was done using 
confocal laser scanning microscopy (CLSM) as described (Irandoust et al., 2007). In brief, Hela cells 
transiently expressing indicated G-CSFR constructs were incubated with G-CSFR antibody and G-CSF 
for 15min at RT, washed twice and incubated at 37°C for 1 hr. Subsequently, cells were permeabilized 
with saponin, fixed with 3% paraformaldehyde and stained for internalized receptors (DaM-488) and 
Rab7 (GaR-546) as marker of lysosomes (Raiborg et al., 2002).
statistics
Statistical significance was determined by a one-way ANOVA analysis followed by a two-sided Dunnett 
post-hoc test, unless otherwise stated. p-values <0.05 were considered significant.
results
ubiquitination of cytoplasmic lysine residues after G-csFr activation
Although the cytoplasmic domain of the G-CSFR contains five highly conserved lysines, 
SOCS3-induced downregulation of G-CSFR signaling via lysosomal routing and degradation 
criticallly depended on the presence of the juxtamembrane K632 (Irandoust et al., 2007). To 
test whether this relates to differential ubiquitination, we expressed the GCSFR mutant K5R, 
lacking all cytoplasmic lysine residues, or single lysine add-back mutants (mutants mKA to 
mKE) together with Flag-tagged Ub in phoenix E cells. After activation with biotinylated 
G-CSF (bio-G), ligand-bound receptors were pulled down using streptavidin-coated beads. 
Flag-immunoreactivity was observed with constructs mKA, mKB, mKC, and mKD and to 
a lesser extent with mKE, indicating robust ubiquitination of lysine residues K632, K672, 
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Figure 1. Ubiquitination of cytoplasmic lysine residues after G-CSFR activation i  . ubiquitination of cytoplasmic lysine residues after G-csFr activation
(A) Phoenix E cells co-transfected with the indicated G-CSFR constructs and Flag-Ub were incubated with bioti-
nylated G-CSF (bio-G) for 15 min at 16°C and for 30min at 37°C. Ligand-bound receptors were precipitated using 
streptavidin-coated beads and analyzed by Western blotting using anti-Flag (upper panel) or anti-G-CSFR antibodies 
(lower panel). (B) Ba/F3 cells stably expressing the indicated G-CSFR mutants were preincubated with bafilomycin 
(250nM) for 30 min to inhibit acidification of late endosomes and then stimulated with biotinylated G-CSF for 60 
min at 37°C. Ligand-bound receptors were precipitated using streptavidin-coated beads and analyzed by Western 
blotting using anti-Ub (upper panel) or anti-G-CSFR antibodies (lower panel). (C) The mean amounts of Ub in the 
G-CSFR immunoprecipitates were normalized to total receptor levels from four experiments performed as in B and 
expressed as a percentage (± SD) of the ubiquitination of WT G-CSFR. Receptor levels were lower for WT and mKA 
because the lysine on position 632 also regulates steady-state membrane expression of the G-CSFR (Meenhuis et al., 
Manuscript accepted)
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K681, and K682 after receptor activation (see Figure 1A). To rule out that overexpression 
of Ub caused physiologically irrelevant ubiquitination on these lysines (Ea et al., 2006), we 
generated Ba/F3 cells stably expressing wt G-CSFR and lysine add-back mutants at levels 
comparable to primary bone marrow cells, without introducing ectopic Flag-Ub. Ubiquitina-
tion of G-CSFR could barely be detected with the Ub antibody P4D1, due to rapid lysosomal 
degradation (data not shown). Upon inhibition of lysosomal degradation using the specific 
inhibitor bafilomycin (Tanaka et al., 2007) we could readily detect a Ub smear with mutants 
mKA, mKB, mKC and mKD but not with mKE (Figure 1B). We thus confirmed that ubiquit-
ination of K632, K672, K681 and K682 also occurred at physiological Ub levels. The amount 
of ubiquitination gradually declined from the membrane-proximal K632 to the more distal 
K682 (Figure 1C). Notably, substitution mutant K632R, which fails to route to lysosomes 
(Irandoust et al., 2007) is as robustly ubiquitinated as mKA, indicating that the overall level 
of ubiquitination is not the determinant for lysosomal targeting (Figure 1B and 1c, compare 
lanes 4 and 9).
K632 is not part of a motif that retains its function upon relocation
Because the unique involvement of K632 in lysosomal routing of G-CSFR could not be as-
signed to differences in ubiquitination levels, we wondered whether K632 is part of a motif, 
e.g., specifically recognized by proteins involved in lysosomal routing. To this end, we gener-
ated mutant K5R-D, in which amino acid stretch R631 to P642, was fused to the C-terminus 
  a
 
 
  b
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of mutant K5R (see also scheme in Figure 4A). We first tested whether the relocated K632 in 
K5R-D is still ubiquitinated. Indeed, ubiquitination of K5R-D was clearly observed in Flag-
Ub overexpressing Phoenix E cells (Figure 2A).
We then studied the functionality of the relocated motif using a STAT5 reporter assay (Iran-
doust et al., 2007). Whereas SOCS3 strongly inhibited STAT5 activation by wt and mKA 
G-CSFR, these inhibitory effects were not seen with mutant K5R-D (Figure 2B). In addition, 
stable expression of mutants K5R-D in 32D cells conferred a hyperproliferative response to 
G-CSF similar to K5R, indicating that, also in a myeloid cellular context, the lysine present 
in the domain fused to the C-terminus could not substitute for a properly positioned K632 to 
attenuate G-CSF signaling (Figure 2C).
Fusion of ub to the G-csFr c-terminus does not restore lysosomal sorting and signal 
downregulation
Fusion of Ub to either the C-terminus of a degradation-defective EGFR (Mosesson et al., 
2003) or to an EGFR mutant lacking the whole cytoplasmic domain (Haglund et al., 2003) is 
sufficient to restore ligand-dependent internalization and lysosomal sorting of these receptor 
chimeras. Because ubiquitination of the K5R-D mutant varied with experimental conditions, 
we tested whether fusion of Ub directly to the C-terminus restored lysosomal sorting of K5R. 
However, contrary to wt G-CSFR and the Ub-tagged EGFR, K5R-Ub did not route to rab7 
  c
 Figure 2. ubiquitination and function of the K5r-d fusion G-csFr mutant
(A) Phoenix E cells were co-transfected with the indicated constructs and incubated with bio-G as described in 
Figure 1a. Ligand-bound receptors were precipitated and analyzed by Western blotting using anti-Flag (upper panel) 
or anti-G-CSFR antibodies (lower panel). (B) HEK293 cells were transfected with the indicated G-CSFR constructs, a 
STAT5-responsive luciferase construct and with or without SOCS3. SOCS3-dependent inhibition of STAT5 luciferase 
activity observed by WT-G-CSFR was set at 100%. The mean (± SE) of three independent experiments done in trip-
licate is shown. (C) Proliferation of 32D cells expressing the indicated G-CSFR constructs in response to G-CSF (10 
ng/ml). Mean cell numbers (± SE) from three to four independent cell clones per construct are shown. ** p<0.01, *** 
p<0.001, relative to wt G-CSFR.
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positive lysosomes, but accumulated in Hrs-positive early endosomes (Figure 3A), as was 
seen with K5R (Irandoust et al., 2007). Accordingly, prolonged STAT5 phosphorylation in 
both K5R as well as K5R-Ub expressing Ba/F3 cells was observed after removal of G-CSF 
(Figure 3B). These results indicate that fusion of Ub to the C-terminus of K5R is not sufficient 
to restore lysosomal sorting and signal downregulation in a lysine-deficient G-CSFR, cor-
roborating our finding that site-specific ubiquitination of K632 is a prerequisite for lysosomal 
degradation of the G-CSFR.
Mutational analysis within the juxtamembrane domain and the box1 region reveals 
some flexibility in positioning of K632
The lysine within the juxtamembrane motif is highly conserved in the G-CSFR of differ-
ent species as well as in related cytokine receptor chains such as gp130 and leptin receptor 
(Figure 4A). To further delineate how imperative the exact positioning of K632 is for its 
function, we inserted five alanines immediately upstream or downstream of K632 using mu-
tagenesis PCR (mutants 5A-mKA and mKA-5A, respectively; see scheme Figure 4B). In these 
and the following mutants the remaining four lysines were replaced by arginines, to assure 
that the observed effects could be uniquely assigned to repositioning of the juxtamembrane 
lysine (Figure 4B). Insertion of 5 alanines either N- or C-terminal of K632 did not affect 
a A 
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SOCS3-dependent inhibition of STAT5 luciferase activity in HEK cells stimulated with G-
CSF (see Supplementary Figure 1A). In addition, 32D cells expressing these mutants showed 
proliferation characteristics comparable to cells expressing mKA (see Supplementary Figure 
1B). These results show that neither a stringent proximity of a lysine to the cell membrane, 
nor a strict positioning relative to the SOCS3 binding site are required for downregulation of 
G-CSFR signaling.
To more precisely define the region within which the lysine retained its function, we ‘walked’ 
lysines through the juxtamembrane domain and the adjacent box 1-region of mutant K5R 
by changing single amino acids at the indicated positions into lysines (Figure 4B). Whereas a 
lysine residue on position 631, 633, 634, 638 and 644 was ubiquitinated comparably to K632 
(Figure 4C), the mutants 628K and 630K were hardly ubiquitinated after G-CSF stimulation, 
suggesting that lysines at these positions are not accessible for SOCS3. Indeed, a lysine at 
position 628 or 630 failed to support SOCS3-mediated inhibition of G-CSF-induced STAT5 
activation (Figure 5A), affected lysosomal routing (see Supplementary Figure 2), and led to 
prolonged STAT5 activity upon G-CSF removal (Figure 5B). In addition, 32D cell clones 
expressing 628K or 630K exhibited hyperproliferation in response to G-CSF comparable to 
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Figure 3. Fusion of ubiquitin to the c-terminus does not restore lysosomal sorting and downregulation stat5 
activation
(A) HeLa cells ectopically expressing WT, K5R or K5R-monUb G-CSFR were incubated with anti-G-CSFR antibod-
ies and G-CSF for 20 min at 16°C, washed and transferred to 37°C for 60 min. Subsequently, cells were fixed and 
stained for internalized G-CSFR (green, left panels) and the late endosomal/lysosomal marker rab7 (red, middle 
panels) and analyzed by CLSM. Merged pictures are shown in the right panels indicating colocalization in yellow. 
Insets show enlargements of boxed areas. (B) Ba/F3 cells expressing WT or mutant G-CSFR were deprived of IL-3 
and serum for 4h, incubated with G-CSF for 10 min at 37°C, washed and kept at 37°C in medium without factors for 
the indicated time periods. Cell lysates were then immunoblotted and stained with anti-pSTAT5 and anti-STAT5. 
Results of one out of four experiments are shown.
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Figure 4. ubiquitination of juxtamembrane alanine-insertion and ‘walking’ lysine G-csFr mutants 
(A) Schematic representation showing conservation of juxtamembrane motif in G-CSFR (CSF3R) and related cytokine 
receptors gp130 and leptin receptor. TM: transmembrane domain (B) Schematic representation of G-CSFR mutants 
used in this study. (C) Phoenix E cells cotransfected with the indicated G-CSFR constructs and Flag-Ub were incu-
bated with bio-G as described in Figure 1a. Ligand-bound receptors were precipitated using streptavidin-coated beads 
and analyzed by Western blotting using anti-Flag (upper panel) or anti-G-CSFR antibodies (lower panel).
86
Chapter 3
clones expressing K5R (Figure 5C). In contrast, lysines on position 631, 633, 634, 638 and 644 
were ubiquitinated (Figure 4B) and these G-CSFR mutants showed normal lysosomal routing 
(see Supplementary Figure 2), SOCS3 dependent downregulation of G-CSF-induced STAT5 
luciferase activity and attenuation of STAT5 phosphorylation (Figure 5A and 5B). G-CSF-
induced growth characteristics of 32D cells expressing G-CSFR mutants with a lysine at posi-
tion 631, 633 and 634 were indistinguishable from mKA, but cells expressing mutants 638K 
and 644K displayed an intermediate phenotype in terms of cell proliferation (Figure 5C). This 
suggests a gradual decline of functionality of lysines moved towards box-1. Finally, moving 
the lysine downstream to position 672 resulted in a complete loss of functionality (Figure 5A 
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supplementary figure 1. Insertion o  5 alanines either up- or downstream of K632 does not affect K632-me iated 
G-csFr signal downregulation
(A) STAT5-responsive luciferase assays with or without SOCS3 were done as described in Figure 2c. The mean (± SE) 
of three independent experiments done in triplicate is show . (B) Proliferation in 32D cells expressing the indicated 
G-CSFR constructs. Numbers (± SE) of cells of three to four independent cell clones per constructs after 10 days of 
G-CSF treatment are given.
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and 5B). Taken together, these results indicate that, within the membrane-proximal region, 
repositioning of the lysine towards the TM region is not tolerated, whereas there is some 
flexibility towards the C-terminus. However, moving the lysine upstream of position 631 
results in an abrupt loss of ubiquitination and function, while positioning towards box-1 and 
further downstream leads to a decreased functional activity eventually resulting in a complete 
loss of function within the box-2 region.
G-csFr ubiquitination increases during endocytosis
Because ubiquitination of receptor lysines is not the prime determinant for G-CSFR inter-
nalization (Irandoust et al., 2007), we sought to determine when and in which intracellular 
compartment(s) ubiquitination of activated G-CSFR takes place. In Ba/F3 cells ubiquitina-
tion of the wt G-CSFR steadily increased over time and was maximal 30 min after receptor 
activation (Figure 6A). Because G-CSFR endocytosis is completed within minutes (Aarts et 
al., 2004), these data imply that G-CSFR ubiquitination mainly occurs at early endosomes. 
This is further substantiated by our finding that ubiquitination of wt G-CSFR was signifi-
cantly inhibited by methyl-ß-cyclodextrin (mßCD), a drug which impairs clathrin-mediated 
endocytosis of the G-CSFR (Figure 6A). In addition, an internalization defective G-CSFR 
mutant (d749-769), which lacks the critical dileucine-based endocytosis motif (Aarts et al., 
2004), showed a markedly delayed and reduced ubiquitination compared to wt G-CSFR, 
despite much higher membrane expression levels (Supplementary Figure 3). These results 
suggest that ubiquitination of G-CSFR increases progressively during endocytosis, possibly 
due to a more efficient recruitment of the ubiquitination machinery to early endosomes than 
to the plasma membrane.
Fusion of ubiquitin to G-csFr-d715 restores internalization but not lysosomal sorting
Somatically acquired nonsense mutations in the CSF3R gene are found in patients with se-
vere congenital neutropenia (SCN) who develop acute myeloid leukemia (AML)(Dong et al., 
1995; Germeshausen et al., 2007; Link et al., 2007). The truncated G-CSFR forms caused by 
these mutations, e.g. G-CSFR-d715, lack both the internalization motif and the binding site 
for SOCS3 (Y729). As a consequence, activated G-CSFR-d715 is hardly ubiquitinated (Figure 
6B) and is not routing to late endosomes/lysosomes (Figure 6C), thus resulting in prolonged 
STAT5 phosphorylation after G-CSF washout (Figure 6D). However, while internalization of 
G-CSFR-d715 is clearly inhibited compared to wt G-CSFR (compare Figure 7A, middle and 
left panel), some endocytotic vesicles containing internalized G-CSFR-d715 can be detected 
30 min. after G-CSF stimulation (Figure 7A, middle panel). 
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Figure 5. Position of a lysine within the juxtamembrane and box-1 region determines its role in G-CSFR 
signal downregulation 
 
Figure 5. Position of a lysine within the juxtamembrane and box-1 region determines its role in G-csFr signal 
downregulation
(A) STAT5-responsive luciferase assays with or without SOCS3 were done as described in Figure 2C. Mean values ± SE 
of at least three independent experiments (the total number of experiments for each construct is shown in parenthesis) 
each done in triplicate are shown. ** p<0.01, *** p<0.001 (B) STAT5 phosphory-lation patterns in Ba/F3 cells expressing 
indicated mutant G-CSFR as described in detail in Figure 3B. (C) G-CSF-induced proliferation in 32D cells expressing 
the indicated G-CSFR constructs as described in detail in Figure 2C. * p<0.05, ** p<0.01
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Supplementary figure 2. Lysosomal routing of selected ‘walking’ lysine G-CSFR mutants  
 
supplementary figure 2. lysosomal routing of selected ‘walking’ lysine G-csFr mutants 
HeLa cells ectopically expressing indicated G-CSFR mutants were processed as described (Figure 3a) and analyzed 
by CLSM after staining for internalized G-CSFR (green, left panels) and the late endosomal/lysosomal marker rab7 
(red, middle panels). Merged pictures are shown in the right panels indicating colocalization in yellow. Insets show 
enlargements of boxed areas
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Figure 6. G-csFr ubiquitination is inhibited by methyl-β-cyclodextrin (mßcd) and a disease-associated 
G-csFr mutant (d715) lacks ubiquitination completely
(A) and (B) Ba/F3 cells stably expressing the indicated G-CSFR mutants were preincubated with bafilomycin ± 
mßCD and stimulated with bio-G either for the indicated time periods (A) or 60 min (B) as described in Figure 
1b. Ligand-bound receptors were precipitated using streptavidin-coated beads and analyzed by Western blotting 
using anti-ubiquitin (upper panel) or anti-G-CSFR antibodies (lower panel). (C) HeLa cells ectopically expressing 
G-CSFR_d715 mutants were processed as described (Figure 3a) and analyzed by CLSM after staining for internalized 
G-CSFR (green, left panels) and the late endosomal-lysosomal marker rab7 (red, middle panels). Merged pictures 
are shown in the right panels indicating colocalization in yellow. (D) STAT5 phosphorylation patterns in Ba/F3 cells 
expres-sing WT or G-CSFR-d715 as described in detail in Figure 3B.
a
 
 b
 supplementary Figure 3. a G-csFr mutant lacking the di-leucine-based internalization motif (d749-69) is 
hampered and delayed in ubiquitination
 Ba/F3 cells stably expressing the indicated G-CSFR mutants were preincubated with bafilomycin and stimulated 
with bio-G either for the indicated time periods as described in Figure 1b. (A) Ligand-bound receptors were pre-
cipitated using streptavidin-coated beads and analyzed by Western blotting using anti-Ub (upper panel) or anti-G-
CSFR antibodies (lower panel). (B) Quantification of data as shown in A. The mean amounts of Ub in the G-CSFR 
immunoprecipitates were normalized to total receptor levels from three experiments and expressed as a percentage 
(± SD) of the ubiquitination of WT G-CSFR. 
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In view of the reported effects of Ub on internalization of the OB-Ra and IFNAR1 recep-
tors (Belouzard and Rouille, 2006; Kumar et al., 2007), we wondered whether fusion of Ub 
to the C-terminus of G-CSFR-d715 could restore endocytosis and then promote lysosomal 
routing, given that K632 is preserved in this mutant. Indeed, we observed that attachment 
of a Ub moiety resulted in the rapid formation of intracellular vesicles after ligand binding, 
comparable to wt G-CSFR (Figure 7A, right panel). However, in contrast to wt G-CSFR, 
but similar to K5R-Ub (Figure 3A), d715-Ub failed to enter rab7 positive late endosomes/
lysosomes (Figure 7B). These results establish that fusion of Ub to the C-terminus of d715 can 
overcome its internalization defect as was recently also reported for a leptin receptor isoform 
lacking endocytotic motifs (Belouzard and Rouille, 2006), but cannot restore lysosomal sort-
ing. This emphasizes the marked distinction between Ub-mediated endocytosis, for which 
positioning of the Ub appears quite irrelevant for its function, and lysosomal targeting, for 
which site-specific ubiquitination in the juxtamembrane region is crucial. The data also indi-
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Figure 7. Fusion of ubiquitin to the c-terminus of G-csFr_d715 restores internalization but not lysosomal 
sorting
(A) HeLa cells ectopically expressing wt, d715 or d715-Ub G-CSFR were labeled with anti-GCSFR antibody prior to 
incubation with G-CSF for 30min. After washing cells were permeabilized, stained with a secondary goat anti-mouse 
Alexa Fluor 488 and analyzed by CLSM. (B) HeLa cells ectopically expressing G-CSFR_d715-Ub were processed as 
described (Figure 3a) and analyzed by CLSM after staining for internalized G-CSFR (green, left panels) and the late 
endosomal/lysosomal marker rab7 (red, middle panels). Merged pictures are shown in the right panels indicating 
colocalization in yellow.
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cate that even when G-CSFR-d715 is artificially forced to route to early endosomes, this does 
not suffice to trigger lysosomal routing, implicating that the loss of SOCS3 activity recruited 
via Y729 of G-CSFR is not being compensated for by other E3 complexes once the receptor 
reaches the early endosome compartment.
dIscussIon
In this study, we provided direct evidence that site-specific ubiquitination of a juxtamem-
brane lysine controls lysosomal sorting of the G-CSFR and that disturbances thereof result 
in perturbation of G-CSF signaling. In addition, our data suggest that, instead of preferential 
lysine selection by the ubiquitination machinery, selectivity of the lysine may stem from the 
interaction of the specifically ubiquitinated cargo protein with downstream sorting proteins. 
Finally, the observation that G-CSFR ubiquitination peaks around 30 min after activation 
and that an internalization defective G-CSFR mutants showed delayed and reduced ubiquit-
ination indicates that ubiquitination predominantly takes place in early endosomes.
We observed robust ubiquitination of four of the five lysines within the cytoplasmic domain 
of G-CSFR. The detection of Ub smears ranging from 135 to 170 kDa rather than discrete 
single ubiquitinated forms of the G-CSFR add-back mutants is indicative of polyubiquit-
ination of these lysines. This is in line with the emerging concept that activated membrane 
receptors predominantly undergo poly- rather than mono-ubiquitination, which then 
provokes sorting of receptors from early to late endosomes/lysosomes (Huang et al., 2006; 
Traub and Lukacs, 2007; Umebayashi et al., 2008). The finding that a single lysine (K632) is 
not only sufficient but also exclusive to direct lysosomal sorting and signal downregulation 
of the G-CSFR argues against an earlier assumption, derived from studies on Ub-dependent 
proteasomal degradation, that multiple lysines can act as redundant Ub acceptor sites (King 
et al., 1996). It also challenges the current view that the amount of poly-Ub attached to a 
receptor, rather than the specific site of ubiquitination, is important for lysosomal sorting 
(Huang et al., 2006; Mukhopadhyay and Riezman, 2007; Umebayashi et al., 2008). This lat-
ter notion is supported by the observation that although ubiquitination levels of mutants 
mKA and K632R were comparable, their intracellular behaviour after activation was entirely 
different: mKA is sorted to lysosomes with normal signal downregulation, whereas K632R 
accumulates in early endosomes and displays prolonged signaling (Irandoust et al., 2007). 
However, in recent years it has been increasingly recognized that for functions other than 
protein degradation specific lysine residues are ubiquitinated and that the position of these 
lysines can be functionally important. For instance, mutation of 5 lysines within the kinase 
domain of the EGFR to arginine is already sufficient to inhibit its degradation, although 
there are in total 28 lysines present in the cytoplasmic domain (Huang et al., 2006). Similarly, 
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lysosomal degradation of the IFNAR1 is dependent on three out of seven cytoplasmic lysines 
(Kumar et al., 2003). Together with our data presented here, these findings imply that site-
specific ubiquitination, rather than a certain amount of (poly-)Ub, is essential for directing 
lysosomal sorting of these membrane receptors.
Transposition of the entire juxtamembrane domain surrounding the functional lysine to the 
C-terminus of a lysine-less G-CSFR did not restore lysosomal routing and signal downregu-
lation. On the other hand, the position of the lysine within the membrane-proximal region 
of the G-CSFR was to a limited extent flexible. These findings have several implications: First, 
the flexible position within the membrane-proximal region argues against the idea that K632 
is part of a strictly conserved spatial motif, in which positioning of the lysine relative to other 
structurally important residues is crucial for interaction with proteins involved in lysosomal 
sorting. However, our findings do not definitely rule out that there is a so far unknown linear 
motif within the G-CSFR in proximity to the functional lysine, which may cooperate with 
the ubiquitinated lysine in regulating lysosomal sorting. Cooperation between site-specific 
ubiquitination and a linear endocytic motif nearby has recently been implicated in ligand-in-
duced IFNAR1 internalization by regulating interaction of the receptor with the AP2 adaptin 
complex (Kumar et al., 2007). Second, the prerequisite for a membrane-proximal position-
ing of the lysine suggests an imperative role of the cell membrane in the interaction of the 
ubiquitinated G-CSFR with certain components of the lysosomal sorting machinery. Indeed, 
several sorting proteins, like Hrs, epsins, and some members of ESCRT complexes contain 
binding sites for membrane phosphoinositides in addition to their Ub binding domains 
(Slagsvold et al., 2006). For instance, EAP45/Vps36, a component of the ESCRT-II complex 
that is responsible for sorting cargo proteins to the lumenal vesicles of multi-vesicular bodies/
late endosomes, interacts with Ub and membrane posphoinositides with its GLUE domain 
(Slagsvold et al., 2005; Teo et al., 2006). Crystal structures of the EAP45 GLUE domain/Ub 
complex revealed that their binding sites are linked physically indicating cooperative binding 
of Ub and phosphoinositides (Alam et al., 2006). It is tempting to speculate that interaction of 
the G-CSFR with proteins involved in this sorting step, like EAP45, relies on ubiquitination 
of a properly positioned juxtamembrane lysine of the G-CSFR.
In a recent study employing a temperature sensitive E1 expressing cell line (ts20), it was dem-
onstrated that inhibition of E1 activity interferes with internalization of the G-CSFR (Kindwall-
Keller et al., 2008). These results suggest that internalization of the activated G-CSFR requires 
intact ubiquitination machinery. This might be interpreted as contradictory to our results, 
showing that lysine-less G-CSFR mutant K5R internalizes normally. However, as has been 
demonstrated for the growth hormone receptor, this may involve ubiquitination of intermedi-
ate proteins that link a nonlysine-containing ubiquitin-dependent endocytosis motif within the 
receptor to the clathrin-mediated endocytosis machinery (Govers et al., 1999). 
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Fusion of Ub to the internalization-deficient G-CSFR-d715 restored internalization implicat-
ing that Ub acts as an endocytotic signal independent of its positioning. Accordingly, fusion 
of Ub to the C-terminus of MHC I molecules (Duncan et al.,2006), CD33 (Walter et al., 
2008), and leptin receptor  (Belouzard and Rouille, 2006) resulted in ligand-induced and/
or constitutive internalization of these fusion proteins. These studies commonly establish 
that Ub can act as an endocytotic signal independent of its positioning. This emphasizes the 
marked distinction between Ub-mediated endocytosis, for which positioning of Ub appears 
nonessential, and lysosomal sorting, for which site-specific ubiquitination in the juxtamem-
brane region is crucial. 
Although our observations are limited so far to the G-CSFR, site-specific ubiquitination 
of a juxtamembrane lysine may also be implicated in regulating lysosomal sorting of other 
receptors. Intriguingly, a lysine exactly corresponding to the crucial K632 in the G-CSFR 
(position -5 to box-1) is found to be highly conserved in many cytokine receptors, like gp130, 
LR, IL-4R and IL-7R. In addition, given the flexible position of the lysine within this region, 
other cytokine receptors harbor a conserved lysine within their juxtamembrane domain in 
close proximity to the position of K632 in the G-CSFR, e.g. the EPOR at position -4 to box-1. 
Finally, the finding that the SCN/AML derived mutant G-CSFR-d715 is not only grossly 
delayed in internalization but is also completely blocked in its lysosomal degradation pro-
vides an additional mechanism for its ability to induce prolonged STAT5 activation, a feature 
that was recently linked to clonal dominance of hematopoietic stem cells expressing such 
truncated G-CSFR forms and to its predicted role in the leukemic evolution of the disease 
(Liu et al., 2008).
96
Chapter 3
reFerences
Aarts, L.H., Roovers, O., Ward, A.C. and Touw, I.P. (2004) Receptor activation and 2 distinct COOH-
terminal motifs control G-CSF receptor distribution and internalization kinetics. Blood, 103, 571-
579.
Alam, S.L., Langelier, C., Whitby, F.G., Koirala, S., Robinson, H., Hill, C.P. and Sundquist, W.I. (2006) 
Structural basis for ubiquitin recognition by the human ESCRT-II EAP45 GLUE domain. Nat Struct 
Mol Biol, 13, 1029-1030.
Akbarzadeh, S. and Layton, J.E. (2001) Granulocyte colony-stimulating factor receptor: structure and 
function. Vitam Horm, 63, 159-194.
Avalos, B.R., Gasson, J.C., Hedvat, C., Quan, S.G., Baldwin, G.C., Weisbart, R.H., Williams, R.E., Golde, 
D.W. and DiPersio, J.F. (1990) Human granulocyte colony-stimulating factor: biologic activities 
and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood, 75, 
851-857.
Belouzard, S. and Rouille, Y. (2006) Ubiquitylation of leptin receptor OB-Ra regulates its clathrin-
mediated endocytosis. Embo J, 25, 932-942.
Boyle, K., Egan, P., Rakar, S., Willson, T.A., Wicks, I.P., Metcalf, D., Hilton, D.J., Nicola, N.A., Alexan-
der, W.S., Roberts, A.W. and Robb, L. (2007) The SOCS box of suppressor of cytokine signaling-3 
contributes to the control of G-CSF responsiveness in vivo. Blood, 110, 1466-1474.
de Koning, J.P., Soede-Bobok, A.A., Schelen, A.M., Smith, L., van Leeuwen, D., Santini, V., Burgering, 
B.M., Bos, J.L., Lowenberg, B. and Touw, I.P. (1998) Proliferation signaling and activation of Shc, 
p21Ras, and Myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor. Blood, 
91, 1924-1933.
Dong, F., Brynes, R.K., Tidow, N., Welte, K., Lowenberg, B. and Touw, I.P. (1995) Mutations in the 
gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia 
preceded by severe congenital neutropenia. N Engl J Med, 333, 487-493.
Duncan, L.M., Piper, S., Dodd, R.B., Saville, M.K., Sanderson, C.M., Luzio, J.P. and Lehner, P.J. (2006) 
Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. 
Embo J, 25, 1635-1645.
Ea, C.K., Deng, L., Xia, Z.P., Pineda, G. and Chen, Z.J. (2006) Activation of IKK by TNFalpha requires 
site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell, 22, 245-257.
Erkeland, S.J., Aarts, L.H., Irandoust, M., Roovers, O., Klomp, A., Valkhof, M., Gits, J., Eyckerman, S., 
Tavernier, J. and Touw, I.P. (2007) Novel role of WD40 and SOCS box protein-2 in steady-state 
distribution of granulocyte colony-stimulating factor receptor and G-CSF-controlled proliferation 
and differentiation signaling. Oncogene, 26, 1985-1994.
Fuchs, S.Y., Spiegelman, V.S. and Kumar, K.G. (2004) The many faces of beta-TrCP E3 ubiquitin ligases: 
reflections in the magic mirror of cancer. Oncogene, 23, 2028-2036.
Germeshausen, M., Ballmaier, M. and Welte, K. (2007) Incidence of CSF3R mutations in severe con-
genital neutropenia and relevance for leukemogenesis: Results of a long-term survey. Blood, 109, 
93-99.
97
Chapter 3
Govers, R., ten Broeke, T., van Kerkhof, P., Schwartz, A.L. and Strous, G.J. (1999) Identification of 
a novel ubiquitin conjugation motif, required for ligand-induced internalization of the growth 
hormone receptor. Embo J, 18, 28-36.
Haglund, K., Sigismund, S., Polo, S., Szymkiewicz, I., Di Fiore, P.P. and Dikic, I. (2003) Multiple 
monoubiquitination of RTKs is sufficient for their endocytosis and degradation. Nat Cell Biol, 5, 
461-466.
Hermans, M.H., van de Geijn, G.J., Antonissen, C., Gits, J., van Leeuwen, D., Ward, A.C. and Touw, 
I.P. (2003) Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor 
receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood, 101, 2584-2590.
Hicke, L. and Dunn, R. (2003) Regulation of membrane protein transport by ubiquitin and ubiquitin-
binding proteins. Annu Rev Cell Dev Biol, 19, 141-172.
Hortner, M., Nielsch, U., Mayr, L.M., Johnston, J.A., Heinrich, P.C. and Haan, S. (2002) Suppressor of 
cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and 
modulates its signal transduction. J Immunol, 169, 1219-1227.
Huang, F., Goh, L.K. and Sorkin, A. (2007) EGF receptor ubiquitination is not necessary for its inter-
nalization. Proc Natl Acad Sci U S A, 104, 16904-16909.
Huang, F., Kirkpatrick, D., Jiang, X., Gygi, S. and Sorkin, A. (2006) Differential regulation of EGF 
receptor internalization and degradation by multiubiquitination within the kinase domain. Mol Cell, 
21, 737-748.
Hunter, T. (2007) The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol Cell, 28, 
730-738.
Hunter, M.G. and Avalos, B.R. (1999) Deletion of a critical internalization domain in the G-CSFR in 
acute myelogenous leukemia preceded by severe congenital neutropenia. Blood, 93, 440-446.
Irandoust, M.I., Aarts, L.H., Roovers, O., Gits, J., Erkeland, S.J. and Touw, I.P. (2007) Suppressor of 
cytokine signaling 3 controls lysosomal routing of G-CSF receptor. Embo J, 26, 1782-1793.
Kamura, T., Maenaka, K., Kotoshiba, S., Matsumoto, M., Kohda, D., Conaway, R.C., Conaway, J.W. 
and Nakayama, K.I. (2004) VHL-box and SOCS-box domains determine binding specificity for 
Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev, 18, 3055-3065.
Kindwall-Keller, T.L., Druhan, L.J., Ai, J., Hunter, M.G., Massullo, P., Loveland, M. and Avalos, B.R. 
(2008) Role of the proteasome in modulating native G-CSFR expression. Cytokine, 43, 114-123.
King, R.W., Deshaies, R.J., Peters, J.M. and Kirschner, M.W. (1996) How proteolysis drives the cell 
cycle. Science, 274, 1652-1659.
Kumar, K.G., Barriere, H., Carbone, C.J., Liu, J., Swaminathan, G., Xu, P., Li, Y., Baker, D.P., Peng, J., 
Lukacs, G.L. and Fuchs, S.Y. (2007) Site-specific ubiquitination exposes a linear motif to promote 
interferon-alpha receptor endocytosis. J Cell Biol, 179, 935-950.
Kumar, K.G., Krolewski, J.J. and Fuchs, S.Y. (2004) Phosphorylation and specific ubiquitin acceptor 
sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon 
receptor. J Biol Chem, 279, 46614-46620.
98
Chapter 3
Kumar, K.G., Tang, W., Ravindranath, A.K., Clark, W.A., Croze, E. and Fuchs, S.Y. (2003) SCF(HOS) 
ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor. 
Embo J, 22, 5480-5490.
Laney, J.D. and Hochstrasser, M. (1999) Substrate targeting in the ubiquitin system. Cell, 97, 427-430.
Li, Y., Kumar, K.G., Tang, W., Spiegelman, V.S. and Fuchs, S.Y. (2004) Negative regulation of prolactin 
receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase. Mol Cell Biol, 24, 
4038-4048.
Link, D.C., Kunter, G., Kasai, Y., Zhao, Y., Miner, T., McLellan, M.D., Ries, R.E., Kapur, D., Nagarajan, 
R., Dale, D.C., Bolyard, A.A., Boxer, L.A., Welte, K., Zeidler, C., Donadieu, J., Bellanne-Chantelot, 
C., Vardiman, J.W., Caligiuri, M.A., Bloomfield, C.D., DiPersio, J.F., Tomasson, M.H., Graubert, 
T.A., Westervelt, P., Watson, M., Shannon, W., Baty, J., Mardis, E.R., Wilson, R.K. and Ley, T.J. 
(2007) Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting 
of severe congenital neutropenia. Blood, 110, 1648-1655.
Liu, F., Kunter, G., Krem, M.M., Eades, W.C., Cain, J.A., Tomasson, M.H., Hennighausen, L. and Link, 
D.C. (2008) Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5. J 
Clin Invest, 118, 946-955.
Marmor, M.D. and Yarden, Y. (2004) Role of protein ubiquitylation in regulating endocytosis of recep-
tor tyrosine kinases. Oncogene, 23, 2057-2070.
Meyer, L., Deau, B., Forejtnikova, H., Dumenil, D., Margottin-Goguet, F., Lacombe, C., Mayeux, P. and 
Verdier, F. (2007) beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor 
and controls cell proliferation. Blood, 109, 5215-5222.
Mosesson, Y., Shtiegman, K., Katz, M., Zwang, Y., Vereb, G., Szollosi, J. and Yarden, Y. (2003) Endo-
cytosis of receptor tyrosine kinases is driven by monoubiquitylation, not polyubiquitylation. J Biol 
Chem, 278, 21323-21326.
Mukhopadhyay, D. and Riezman, H. (2007) Proteasome-independent functions of ubiquitin in endo-
cytosis and signaling. Science, 315, 201-205.
Raiborg, C., Bache, K.G., Gillooly, D.J., Madshus, I.H., Stang, E. and Stenmark, H. (2002) Hrs sorts 
ubiquitinated proteins into clathrin-coated microdomains of early endosomes. Nat Cell Biol, 4, 
394-398.
Raiborg, C., Rusten, T.E. and Stenmark, H. (2003) Protein sorting into multivesicular endosomes. Curr 
Opin Cell Biol, 15, 446-455.
Sigismund, S., Polo, S. and Di Fiore, P.P. (2004) Signaling through monoubiquitination. Curr Top 
Microbiol Immunol, 286, 149-185.
Slagsvold, T., Aasland, R., Hirano, S., Bache, K.G., Raiborg, C., Trambaiolo, D., Wakatsuki, S. and Sten-
mark, H. (2005) Eap45 in mammalian ESCRT-II binds ubiquitin via a phosphoinositide-interacting 
GLUE domain. J Biol Chem, 280, 19600-19606.
Slagsvold, T., Pattni, K., Malerod, L. and Stenmark, H. (2006) Endosomal and non-endosomal func-
tions of ESCRT proteins. Trends Cell Biol, 16, 317-326.
Tanaka, Y., Hamano, S., Gotoh, K., Murata, Y., Kunisaki, Y., Nishikimi, A., Takii, R., Kawaguchi, M., 
Inayoshi, A., Masuko, S., Himeno, K., Sasazuki, T. and Fukui, Y. (2007) T helper type 2 differentia-
99
Chapter 3
tion and intracellular trafficking of the interleukin 4 receptor-alpha subunit controlled by the Rac 
activator Dock2. Nat Immunol, 8, 1067-1075.
Teo, H., Gill, D.J., Sun, J., Perisic, O., Veprintsev, D.B., Vallis, Y., Emr, S.D. and Williams, R.L. (2006) 
ESCRT-I core and ESCRT-II GLUE domain structures reveal role for GLUE in linking to ESCRT-I 
and membranes. Cell, 125, 99-111.
Traub, L.M. and Lukacs, G.L. (2007) Decoding ubiquitin sorting signals for clathrin-dependent endo-
cytosis by CLASPs. J Cell Sci, 120, 543-553.
Umebayashi, K., Stenmark, H. and Yoshimori, T. (2008) Ubc4/5 and c-Cbl Continue to Ubiquitinate 
EGF Receptor after Internalization to Facilitate Polyubiquitination and Degradation. Mol Biol Cell.
van de Geijn, G.J., Gits, J., Aarts, L.H., Heijmans-Antonissen, C. and Touw, I.P. (2004) G-CSF receptor 
truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppres-
sion of STAT3 intact. Blood, 104, 667-674.
Walter, R.B., Raden, B.W., Zeng, R., Hausermann, P., Bernstein, I.D. and Cooper, J.A. (2008) ITIM-
dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphoryla-
tion, and the tyrosine phosphatases, Shp1 and Shp2. J Leukoc Biol, 83, 200-211.
Ward, A.C., van Aesch, Y.M., Schelen, A.M. and Touw, I.P. (1999) Defective internalization and 
sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe 
congenital neutropenia/acute myeloid leukemia. Blood, 93, 447-458.
Ward, A.C., Smith, L., de Koning, J.P., van Aesch, Y. and Touw, I.P. (1999) Multiple signals mediate 
proliferation, differentiation, and survival from the granulocyte colony-stimulating factor receptor 
in myeloid 32D cells. J Biol Chem, 274, 14956-14962.
Yoshimura, A., Naka, T. and Kubo, M. (2007) SOCS proteins, cytokine signalling and immune regula-
tion. Nat Rev Immunol, 7, 454-465.
4CHAPTER
4 Janus kinases promote cell surface  expression and provoke autonomous  signaling from routing defective G-CSF receptorsAnnemarie Meenhuis, Mahban Irandoust, Albert Wölfler,  Marijke Valkhof, and Ivo P. Touw(Manuscript accepted; Biochemical Journal)
102
Chapter 4
abstract
The G-CSF receptor (CSF3R) controls survival, proliferation and differentiation of myeloid 
progenitor cells via activation of multiple Janus kinases (JAKs). In addition to their role 
in phosphorylation of receptor tyrosines and downstream signaling substrates, JAKs have 
recently been implicated in controlling expression of cytokine receptors, predominantly 
by masking critical motifs involved in endocytosis and lysosomal targeting. Here we show 
that increasing the levels of JAK1, JAK2 and TYK2 elevated steady state CSF3R cell surface 
expression and enhanced CSF3R protein stability in hematopoietic cells. This effect was not 
due to inhibition of endocytotic routing, since JAKs did not functionally interfere with the 
dileucine-based internalization motif nor lysine-mediated lysosomal degradation of CSF3R. 
Rather, JAKs appeared to act on CSF3R in the biosynthetic pathway at the level of the ER. 
Strikingly, increased JAK levels synergized with internalization or lysosomal routing defec-
tive CSF3R mutants to confer growth factor independent STAT3 activation and cell survival, 
providing a model for how increased JAK expression and disturbed intracellular routing of 
CSF3R synergize in the transformation of hematopoietic cells.
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IntroductIon
The granulocyte colony-stimulating factor receptor (G-CSFR, now referred to as CSF3R) is 
the major hematopoietic growth factor receptor involved in neutrophil development (Avalos 
et al., 1990). The CSF3R contains four conserved tyrosine residues in the cytoplasmic domain, 
which upon phosphorylation by Janus tyrosine kinases (JAKs) become docking sites for Src 
homology 2 (SH2)-containing signaling proteins such as signal transducer and activator of 
transcription (STAT)-3, the adapter proteins SHC and GRB2, and suppressor of cytokine 
signaling (SOCS)-3 (Touw and Bontenbal, 2007). The cytoplasmic domain of CSF3R fur-
ther comprises a dileucine-based motif crucial for internalization (Aarts et al., 2004), and 
five conserved lysine (K) residues. We have recently shown that one of these lysines, the 
juxtamembrane K632, is the major determinant for ligand-induced lysosomal routing of the 
activated CSF3R, a process that involves SOCS3-mediated ubiquitination of K632 (Irandoust 
et al., 2007).
Ligand-induced CSF3R internalization and lysosomal sorting are both crucial for a 
balanced signaling output and disruption of either of these processes results in increased 
proliferation signaling at the expense of G-CSF-induced neutrophilic differentiation (Aarts 
et al., 2004; Irandoust et al., 2007). Perturbed signaling from CSF3R, owing to mutations in 
the CSF3R gene or overexpression of signaling defective splice variants, has been implicated 
in the development of acute myeloid leukemia (AML) (Touw and van de Geijn, 2007). Im-
portantly, C-terminal truncation mutants of CSF3R found in patients with severe congenital 
neutropenia that are at high risk of developing AML lack the dileucine-based internalization 
motif as well as the recruitment site Y729, essential for SOCS3-induced ubiquitination of 
K632 (Irandoust et al., 2007; Ward et al., 1999b). While signal attenuation involving ligand-
induced endocytosis and lysosomal degradation has been studied in considerable detail for 
different receptor systems, less attention has been paid to mechanisms regulating ligand in-
dependent distribution and stability of cytokine receptors and their consequences for signal 
intensity and duration.
Recently, JAKs have been implicated in the regulation of cell surface expression of various 
cytokine receptors. For instance, JAK1 binding to the oncostatin M receptor (OSMR) has 
been suggested to mask a signal within the juxtamembrane part of the receptor that inhibits 
expression of the mature form of the OSMR at the plasma membrane (Radtke et al., 2006). 
Similarly, binding of JAK2 or TYK2 to the thrombopoietin receptor (TpoR) augmented 
membrane expression and stability of its mature (EndoH resistant) form (Royer et al., 2005; 
Tong et al., 2006). Studies on the interferon receptor-α1 (IFNAR1) revealed that binding of 
TYK2 attenuates degradation and increases cell surface expression by masking dileucine- 
and tyrosine-based internalization motifs present in the JAK binding domain of the receptor 
(Kumar et al., 2008; Ragimbeau et al., 2003). Taken together, these findings fit into a model 
in which JAKs interfere with the function of motifs involved in receptor endocytosis and 
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lysosomal degradation, thereby increasing receptor expression on the cell surface. On the 
other hand, an alternative mechanism was demonstrated for erythropoietin receptor (EpoR), 
where JAK2 binding does not affect receptor endocytosis, but enhances the appropriate fold-
ing of the EpoR protein in the ER, leading to more efficient Golgi processing and enhanced 
forward routing of mature protein to the cell surface (Huang et al., 2001).
Increased JAK expression has been implicated in several hematopoietic malignancies, in-
cluding AML, and amplification of the JAK2 gene has been reported in Hodgkin’s lymphoma 
(Joos et al., 2000; Rucker et al., 2006). In the present study, we examined whether JAKs control 
the expression of CSF3R and how this might affect signaling in the absence of ligand-induced 
receptor activation. We show that JAKs elevate the steady state CSF3R cell surface expres-
sion but that this occurs independent of the major determinants of receptor internalization 
(dileucine motif) or lysosomal routing (conserved lysine residues). Strikingly, increased JAK 
levels resulted in growth factor independent cell survival and spontaneous STAT3 activation 
in cells expressing internalization or lysosomal routing defective CSF3R mutants.
MaterIal and MetHods
antibodies
Mouse anti-human CSF3R (un- or PE- conjugated) were purchased from Becton-Dickinson/PharMin-
gen (San Diego, CA). Monoclonal rabbit anti-JAK2, polyclonal rabbit anti-JAK1, rabbit anti-TYK2, 
rabbit anti-pSTAT3 and the secondary goat anti-rabbit coupled to horseradish peroxidase (GAM-HRP) 
were obtained from Cell Signaling Technology (Danvers, MA). Mouse anti-pSTAT5a/b was obtained 
from Upstate Biotechnology (New York, USA). Goat anti-actin and mouse anti-ubiquitin (P4D1) 
were purchased form Santa Cruz Biotechnology inc. (Santa Cruz, CA). Anti-mouse CD2 coupled to 
fluorescein isothiocyanate (FITC) and anti-human CD4-FITC were purchased from Becton Dickinson 
Biosciences (BD Biosciences, Erembodegem, Belgium). Secondary goat anti-mouse, goat anti-rabbit 
and donkey anti-goat either coupled to IRDyeTM680 or IR-DyeTM800CW were obtained from LI-
COR Biosciences (Nebraska, USA). Goat anti-mouse Ig coupled to phycoerythrin (GAM-PE) was 
obtained from Dako (DakoBV, Heverlee, Belgium). Donkey anti-mouse Alexa fluor 488 and 7-AAD 
were purchased from Molecular Probes (Invitrogen, Breda, The Netherlands).
expression constructs
The pLNCX and pBabe retroviral plasmids containing wild type (wt) CSF3R, the single lysine mutants 
K632R, K672R, K681R, K682R, K762R , the lysine null mutant K5R, and the single lysine add-back 
mutants mKA, mKB, mKC, mKD and mKE were described previously (Irandoust et al., 2007), as were 
the W650R and the d715 receptor mutants (Barge et al., 1996; Dong et al., 1993). The pSG513 vector 
with wt JAK2 and the bicistronic vectors pRex TYK2-IRES-CD2, pRex JAK1-IRES-CD2 were previ-
ously reported (Royer et al., 2005; van den Akker et al., 2004).
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cell culture, transfection and retroviral transduction
Murine myeloid 32D.cl8.6, a subline of the interleukin 3 (IL-3) dependent murine myeloid 32Dcl3 
cell line that lacks endogenous CSF3R expression (Greenberger et al., 1983) and Ba/F3 cells, which 
are mouse pro-B cells that lack endogenous CSF3R (Greenberger et al., 1983; Palacios and Steinmetz, 
1985) were maintained in RPMI-1640 medium supplemented with 10% fetal calf serum (FCS), 10 ng/
ml murine IL-3, 100 IU/ml penicillin and 100µg/ml streptomycin at 37°C and 5% CO2. Ba/F3 cells 
expressing murine JAK1, murine JAK2 or human TYK2 have been described previously (Royer et al., 
2005). Phoenix E, HeLa and the parental human fibrosarcoma cells 2C4 (Watling et al., 1993) were 
cultured in Dulbecco’s Modified Eagle’s medium (DMEM) supplemented with 10% FCS, 100 IU/
ml penicillin and 100 µg/ml streptomycin at 37°C and 5% CO2. JAK1-deficient U4C (Muller et al., 
1993) and JAK2-deficient γ2A (Watling et al., 1993) human fibrosarcoma cell lines were cultured in 
DMEM containing 400 µg/ml geneticin (G418). The TYK2-deficient human fibrosarcoma cell line 11.1 
(Velazquez et al., 1992) was cultured in DMEM in the presence of 400 µg/ml hygromycin. Ba/F3 cells 
and 32D cells were retrovirally transduced with virus from the Phoenix E packaging cell line (G. Nolan, 
Stanford, CA) as previously described (Aarts et al., 2004).
constitutive and ligand-induced internalization determined with flow cytometry
For constitutive internalization 32D cells expressing wt or K5R CSF3R were incubated with mouse 
anti-human CSF3R in PSA (PBS supplemented with 1% v/v FCS and 0.05% w/v NaN3) for 1 hr at 4°C. 
After washing, cells were incubated at 37°C for 0, 30, 60, 120 and 240 min. Next, cells were stained 
with secondary antibody goat anti-mouse-PE in PSA for 1 hr at 4°C and, after a final wash, analyzed by 
flow cytometry using a FACS Calibur (Becton-Dickinson Biosciences). Mean fluorescence intensity of 
histograms was taken as a measure of the average CSF3R expression.
To study ligand-induced internalization of the CSF3R along with JAK overexpression, Ba/F3 cells 
were incubated with 10 ng/ml human G-CSF for 30 min. at 4°C. Thereafter the cells were incubated 
at 37°C for 0, 15, 30 and 60 min. Cell surface expression of the G-CSF receptor was determined by 
labeling the cells with PE-conjugated mouse anti-human CSF3R antibody for 1 hr at 4°C followed by 
flow cytometric analysis.
receptor protein stability assay
Phoenix E cells were transiently transfected with CSF3R constructs in pBabe with or without co-trans-
fecting murine JAK2 using calcium phosphate precipitation. Two days after transfection, cells were 
incubated for 3 hrs with 50 μg/ml cycloheximide (CHX) to block protein synthesis or left untreated. 
Ba/F3 cells stably transduced with CSF3R and JAK vectors were treated with 50 μg/ml CHX for 5 hrs. 
Cells were washed with cold PBS and resuspended in lysis buffer containing 20 mM Tris-HCl pH8.0, 
137 mM NaCl, 10 mM EDTA, 100 mM NaF, 1% v/v NP-40, 10% v/v Glycerol, 50 µg/ml aprotinin, 
1 mM pefablock and 2 mM Na3VO4. Lysates were put on ice for 30 min, centrifuged for 15 min. at 
14,000 rpm to remove insoluble proteins. CSF3R was pulled down from lysates by adding magnetic 
protein G-beads (Dynabeads, Invitrogen) pre-incubated with CSF3R o/n at 4°C. Beads were incubated 
in Laemmli buffer for 5 min. at 95°C and then subjected to SDS-polyacrylamide gel electrophoresis and 
Western blotting as described previously (Ward et al., 1999a). Proteins were detected by fluorescently 
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labeled secondary antibodies followed by detection using Odyssey Infrared Imaging System (LI-COR 
Biosciences, Nebraska, USA).
ubiquitination of csF3r
Ba/F3 cells were incubated with 500 nM bafilomycin A1 (Calbiochem, Darmstadt, Germany) for 30 
min. Cells were stimulated with biotinylated G-CSF (Bio-G) prepared using a biotin labeling kit accord-
ing to manufacturers protocol (Roche Molecular Biochemicals, Mannheim, Germany) for 1 hr at 37°C. 
Cells were washed twice with cold PBS and lysed. CSF3R was pulled down using streptavidin coated 
magnetic beads (Dynabeads, Invitrogen). Beads were washed and resuspended in Laemmli buffer, 
incubated for 5 min. at 95°C and subjected to Western blotting as described (Ward et al., 1999a).
confocal microscopy
HeLa cells were seeded on glass cover slips and transfected with wt or K5R CSF3R in pLNCX using 
lipofectamin (Invitrogen). Cells were prepared and analyzed by confocal microscopy using a LSM510 
microscope equipped with argon and He/Ne lasers as described (Irandoust et al., 2007).
statistical analysis
For comparing two groups Student t-tests were performed. When comparing multiple groups One-
Way ANOVA was performed followed by a post-hoc test.
endoglycosidase H (endoH) treatment
Phoenix E cells were transiently transfected with wt CSF3R. For membrane receptor pull-down, cells 
were incubated with 1:100 BioG for 30 min. at 37°C. Cells were then washed twice with cold PBS and 
resuspended in lysis buffer. For total CSF3R levels cells were first lysed and subsequently 1:50 BioG 
was added o/n at 4°C. CSF3R was pulled down using streptavidin-coated magnetic beads. For EndoH 
treatment (New England Biolabs, Ipswich, United States), beads were washed and resuspended in 50μl 
1x GD denaturation buffer and boiled for 10 min. at 100°C. After adding 10x G5 reaction buffer, the 
supernatant was divided into two portions, to one of which EndoH was added and to the other H2O as 
a control. The samples were incubated for 3 hrs at 37°C and thereafter resuspended in Laemmli buffer, 
boiled for 5 min. at 95°C and subjected to Western blotting.
Proliferation and survival assay
JAK2 overexpressing Ba/F3 cells stably expressing wt, K5R or d715 were washed and transferred to 
RPMI medium without growth factors. Cells were counted and cell viability was assessed by flow cy-
tometry using 7-AAD on a daily basis. For the inhibitor study, 10 μM LY 294002, 10 μM JAK inhibitor 
I, 10 μM SB 203580, 10 μM U0126, 0.2 μM Akt inhibitor IV or 10 μM PP2 (Calbiochem, Darmstadt, 
Germany) all dissolved in DMSO, or DMSO as solvent control was added to the medium. Half of the 
medium was replaced daily by fresh medium with fresh inhibitors.
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results
JaKs enhance csF3r cell surface expression
To determine the effects of elevated JAK1, JAK2 or TYK2 expression on CSF3R cell membrane 
levels, we used the previously described Ba/F3 cell system co-expressing CD2 or CD4 from an 
IRES-containing expression (Royer et al., 2005). First, we confirmed that the amount of CD2 
or CD4 on the cell surface, determined by flow cytometry, correlated with the expression of 
the different JAKs, determined by Western blot analysis (Figure 1A and 1B). Parental Ba/F3 
cells and the JAK-overexpressing cells were then retrovirally transduced to express wt CSF3R 
and cell membrane expression was determined by flow cytometry. JAK1, JAK2 or TYK2 
transduced cells showed a 2- to 4-fold higher level of CSF3R expression on the cell surface 
compared to parental control cells (Figure 1C). Complementary to the experiments in the Ba/
F3 transfectants, we studied the consequences of the absence of each of these JAK proteins 
on CSF3R expression using JAK-deficient fibrosarcoma cell lines (Figure 1D). All cell lines 
showed comparable cell surface expression of CSF3R, implicating that JAK1, JAK2 and TYK2 
are redundant in controlling steady-state cell CSF3R expression (Figure 1E). These results 
raised the additional question whether CSF3R cell surface expression would be significantly 
hampered in the absence of any JAK binding. To address this, we introduced the CSF3R 
mutant W650R, which fails to activate JAKs (Barge et al., 1996), into Ba/F3 cells. CSF3R-
W650R was severely hampered in both JAK2 binding and activation (Figure 2A and 2B). In 
agreement with its inability to bind JAKs, no significant increase in cell surface expression of 
CSF3R-W650R was seen in the JAK overexpressing Ba/F3 cells relative to parental controls 
(Figure 2C). Notably, membrane expression of CSF3R-W650R in parental Ba/F3 cells was 
equal to wt CSF3R, suggesting that JAK binding is not required for CSF3R expression as such 
(Figure 2C).
role of receptor lysines in steady state cell surface expression and stability of csF3r
One of the mechanisms implicated in the JAK-mediated effects on cell surface expression of 
cytokine receptors is that motifs involved in receptor endocytosis and lysosomal degradation 
are masked by steric interference (Kumar et al., 2008; Radtke et al., 2006; Ragimbeau et al., 
2003). We previously demonstrated that ubiquitination of lysines in the intracellular domain 
of CSF3R mediated by G-CSF-induced expression of the E3-ligase SOCS3 is important for 
ligand-induced receptor endocytosis (Irandoust et al., 2007). However, we did not analyze 
whether this ubiquitination of lysine residues affects ligand-independent receptor endocy-
tosis. We first studied membrane expression of a receptor mutant in which all 5 cytoplasmic 
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lysines were replaced by arginines (mutant K5R). Myeloid 32D cells stably expressing K5R 
showed higher membrane expression levels compared to wt CSF3R (Figure 3A), a result 
that was confirmed by confocal microscopy in 32D cells (Figure 3B, upper panel) and in 
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Figure 1. JAK1, JAK2 and TYK2 augment cell surface expression of CSF3R 
 
 
Figure 1. JaK1, JaK2 and tyK2 augment cell surface expression of csF3r
(A) JAK overexpression in Ba/F3 cells assessed by flow cytometry using CD2- or CD4-FITC antibodies. Control 
is Ba/F3 cells without antibody staining. (B) Western blot analysis showing JAK levels in parental Ba/F3 cells and 
JAK transfectants. (C) Expression of wt CSF3R in stably transduced Ba/F3 cell lines determined by flow cytom-
etry using CSF3R-PE antibody. Control is Ba/F3 parental cells without antibody staining. (D) Immunoblot of 
total cell lysates from human parental fibrosarcoma cells (2C4) and derivatives deficient for either JAK1, JAK2 or 
TYK2 (U4C, γ2A and 11.1, respectively). Cells were stained for anti-JAK1, anti-JAK2 and anti-TYK2 to confirm 
JAK-deficiencies. (E) Flow cytometric analysis of CSF3R cell surface levels in the human fibrosarcoma cell lines 
stably transduced with wt CSF3R. Control is 2C4 cells without antibody staining.
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HeLa cells (Figure 3B, lower panel). However, kinetics of ligand independent internalization 
of wt and K5R CSF3R were similar, indicating that lysines are not critical in this process 
(Figure 4A). Taken together, these results suggest that lysines within the CSF3R cytoplasmic 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. JAK-induced surface expression of CSF3R depends on a tryptophan residue (W650) that is 
critical for JAK binding 
 
 
 
Figure 2. JaK-induced surface expression of csF3r depends on a tryptophan residue (W650) that is critical for 
JaK binding
(A) JAK2 overexpressing Ba/F3 cells with the indicated CSF3R variants were stimulated with biotinylated G-CSF 
(Bio-G) for 30 min. Receptor complexes were isolated using streptavidin pull down and analyzed by Western blot-
ting for the presence of CSF3R, JAK2 or phospho-JAK2. A representative blot of three independent experiments is 
shown. (B) Quantification of total JAK2 (left panel) and phospho-JAK2 (right panel) binding to wt CSF3R, mutant 
K5R and W650R. Data are expressed as mean ± SD of three experiments. (C) Expression of mutant W650R rela-
tive to wt CSF3R in Ba/F3 parental and JAK overexpressing cells. Cell surface expression was determined by flow 
cytometry. Data are expressed as mean fluorescence intensities (MFI) ± SEM. *P< 0.05 compared to parental Ba/F3 
cells expressing wt CSF3R.
Chapter 4 
 
 
 
 
 
Figure 1. JAK1, JAK2 and TYK2 augment cell surface expression of CSF3R 
 
 
Chapter 4 
 
 
 
 
 
Figure 1. JAK1, JAK2 and TYK2 augment cell surface expression of CSF3R 
 
 
Chapter 4 
 
 
 
 
 
Figure 1. JAK1, JAK2 and TYK2 augment cell surface expression of CSF3R 
 
 
110
Chapter 4
 
 
 
 
Figure 3. Role of receptor lysines in CSF3R cell surface expression 
 
Figure 3. role of receptor lysines in csF3r cell surface expression
(A) Sublines of 32D cells were generated with wt or K5R CSF3R. Membrane expression was determined by flow 
cytometry using CSF3R-PE antibody. Results are shown as MFI ± SEM of 12 clones relative to wt receptor. ***P< 
0.001 compared to wt receptor. (B) Confocal microscopy images of 32D clones stably expressing wt or K5R CSF3R 
(upper panel) and HeLa cells transiently transfected with wt or K5R CSF3R constructs (lower panel). 
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Figure 4: Lysines are important for steady state CSF3R cell surface expression but are not involved in 
constitutive internalization 
Figure 4: lysines are important for steady state csF3r cell surface expression but are not involved in constitu-
tive internalization
(A) 32D cells stably expressing wt or K5R CSF3R were labeled with CSF3R antibody and were allowed to internalize 
during 4 hrs in the absence of ligand. CSF3Rs remaining at the cell surface were labeled with goat anti-mouse-PE and 
analyzed by flow cytometry. Data from three independent experiments are expressed as MFI ± SEM relative to t=0, 
which was set at 100%. (B) Protein synthesis in Ba/F3 cells stably expressing wt or K5R was blocked by CHX added to 
the medium for 0, 3 and 6 hrs. The amount of CSF3R in total cells lysates was visualized on Western blot using CSF3R 
specific antibody (lanes 1-3). Addition of the lysosomal inhibitor bafilomycin shows that CSF3R is constitutively 
degraded via the lysosomal pathway (lanes 4-6). (C) CSF3R cell surface expression on Ba/F3 parental cells trans-
duced with wt CSF3R, lysine substitution (K632R, K672R, K681R, K682R and K762R) or add-back mutants (mKA, 
mKB, mKC, mKD and mKE). Data are expressed as in A. ***P<0.001 K632R compared to wt CSF3R. **P<0.01 K5R 
compared to mKA CSF3R.
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region are involved in control of membrane expression through the biosynthetic pathway. 
To confirm this, we studied the role of the receptor cytoplasmic lysines in CSF3R stability. 
To this end, Ba/F3 cells stably expressing wt or K5R CSF3R were incubated for 3-6 hrs with 
cycloheximide (CHX) to inhibit de novo protein synthesis. While degradation of wt CSF3R 
was observed after inhibition of protein synthesis, K5R CSF3R was found to be stable (Figure 
4B). The lysosome inhibitor bafilomycin prevented degradation of wt CSF3R, suggesting 
that steady state receptor levels are regulated via lysosomal degradation and that lysines are 
important for this mechanism.
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The lysines in the cytoplasmic domain of CSF3R are fully conserved between multiple species. 
Using a panel of lysine substitution (K→R) and single lysine add-back (mKA-mKE) mutants, 
we investigated which of these lysines are involved in the negative control of steady state 
CSF3R membrane expression. Among the 5 conserved lysines, K632 is the major inhibitory 
determinant for constitutive CSF3R cell surface expression (Figure 4C).
JaKs do not mask motifs involved in csF3r endocytosis or lysosomal routing
Next we examined the kinetics of CSF3R internalization in parental and JAK transfected 
Ba/F3 cells. As shown in Figure 5A, none of the JAKs had a significant influence on the 
kinetics and magnitude of CSF3R endocytosis. Studying the effects of JAKs on the expres-
 
 
 
 Figure 5: enhanced csF3r cell surface expression by JaKs is not due to masking of internalization or lysosomal 
sorting motifs
(A) Ba/F3 parental and JAK overexpressing cells stably expressing wt CSF3R were incubated with G-CSF (100 ng/ml) 
and at indicated time points stained with anti-CSF3R-PE followed by flow cytometric analysis. Data are expressed 
as mean fluorescence intensities relative to t=0, which was set at 100%. (B) Cell surface expression of internalization 
defective CSF3R-d715 and lysosomal routing defective K5R is strongly increased by JAK2 or TYK2 and to a lesser 
extent JAK1 overexpression. Receptor membrane expression was determined as in A and data are expressed as MFI 
relative to parental Ba/F3 cells expressing wt CSF3R (set at 100%). (C) CSF3R cell surface expression on JAK2 over-
expressing Ba/F3 cells transduced with wt CSF3R, lysine substitution (K632R, K672R, K681R, K682R and K762R) 
or add-back mutants (mKA, mKB, mKC, mKD and mKE) and parental Ba/F3 cells transduced with wt receptor (set 
at 100%). Data are expressed as in 4C. **P<0.01 K632R compared to wt CSF3R. *P<0.05 K5R compared to mKA 
CSF3R.
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Figure 6. JAKs control CSF3R expression in the biosynthetic pathway irrespective of receptor 
ubiquitination 
 
 
 
    
 
 Figure 6. JaKs control csF3r expression in the biosynthetic pathway irrespective of receptor ubiquitination
(A) Ubiquitination status of the lysine at position 632 of membrane CSF3R determined in Ba/F3 parental and JAK 
overexpressing cells. Cells were stimulated with Bio-G for 30 min. in the presence of bafilomycin, where after CSF3R 
was pulled down with streptavidin-coated magnetic beads, eluted and subjected to Western blot analysis using anti-
ubiquitin antibody P4D1. Vertical line (left) indicates size variation of receptor-ubiquitin complexes. Blots were 
restained with anti-CSF3R to determine CSF3R loading. As an input control, an immunoblot with whole cell lysate 
was stained for actin. (B) Stability of wt and K5R CSF3R transiently expressed with or without JAK2 in Phoenix E 
cells. Cells were left untreated or treated with CHX for 3 hrs to block protein synthesis. CSF3R was immunoprecipi-
tated using CSF3R antibodies and subjected to western blotting using the same antibodies. Quantification of mature 
and immature forms of CSF3R is shown in part C; protein levels are expressed in arbitrary units (A.U.). Total cell 
lysates were also stained for JAK2 content and for actin (loading control). Endogenous JAK2 is below detection level 
on this blot. Results shown are representative of three independent experiments. 
A
C
B
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sion of internalization defective mutant d715 (lacking the dileucine motif) and the lysosomal 
routing defective mutant K5R we observed that JAK2 and TYK2, and to a lesser extent JAK1, 
significantly enhanced surface expression of CSF3R-d715 and K5R (Figure 5B). This indi-
cates that JAKs do not elevate CSF3R expression by blocking internalization or lysine-based 
lysosomal sorting motifs (which are lacking in these mutants). Also in the presence of excess 
JAKs, K632 remains the most prominent lysine inhibiting CSF3R surface expression (Figure 
5C, compare to Figure 4C).
JaKs do not affect ubiquitination of K632 in ligand-activated csF3r
From the above studies, K632 emerges as a major negative determinant in constitutive CSF3R 
expression, not functionally affected by JAKs. Upon ligand activation of the CSF3R-JAK 
complex, K632 is ubiquitinated (a process involving SOCS3), which is essential for G-CSF-
induced lysosomal routing of CSF3R (Irandoust et al., 2007). Because JAKs are activated in 
this setting, we wondered whether increased JAK levels may interfere with ubiquitination 
of K632 to attenuate ligand-induced lysosomal degradation. As shown in Figure 6A, ubiq-
uitination of K632, the only cytoplasmic lysine retained in mKA, increased proportionally 
with elevated CSF3R levels in JAK1, JAK2 or TYK2-overexpressing cells relative to parental 
cell controls. Together, these data indicate that neither in forward nor retrograde routing of 
CSF3R JAKs interfere with the function of K632.
JaKs enhance protein stability of csF3r
To determine if JAKs influence CSF3R protein stability, as e.g., shown for the TpoR (Royer et 
al., 2005), Ba/F3 parental cells and JAK transfectants expressing wt CSF3R were cultured in 
the presence or absence of CHX for 5 hrs to block protein synthesis. Immunoblots revealed 
two CSF3R species, the higher band representing the mature form and the lower band the 
immature protein that was sensitive to Endo H treatment (data not shown). Overexpression 
of JAK1, JAK2 and TYK2 predominantly enhanced the stability of the mature form of the wt 
CSF3R (Figure 6B and data not shown). In contrast, both the mature and immature forms 
of K5R were stabilized (Figure 6B). This was seen in three independent experiments and also 
observed when overexpressing JAK1 and TYK2 (data not shown). These data indicate that 
JAKs protect both the mature and immature form of CSF3R, provided that lysine-mediated 
degradation is prevented.
Increased JaK levels confer ligand independent signaling to routing defective K5r and 
internalization defective d715 mutants
Having established that JAKs increase the stability of CSF3R by a mechanism that is distinct 
from delayed internalization or lysosomal sorting, we wondered whether increased JAK 
levels can cooperate with mutant CSF3R defective in receptor downregulation to enhance 
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Figure 7. JAK2 overexpression provokes ligand-independent pro-survival signaling by internalization 
defective and lysosomal routing deficient CSF3R mutants 
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downstream signaling. As reported previously (Lu et al., 2005), both parental and JAK2-
overexpressing Ba/F3 cells failed to proliferate or survive in the absence of growth factor 
(IL-3) (Figure 7A). Expression of wt CSF3R in these cells did not alter this growth behavior. 
In contrast, JAK2-overexpressing Ba/F3 cells transduced with either the lysosomal routing 
defective mutant K5R or the internalization defective mutant d715 showed a moderately 
enhanced proliferation and a pronounced increase in cell survival (Figure 7B). To determine 
which pathways are responsible for the growth factor independent cell survival of the JAK2 
overexpressing Ba/F3 cells stably expressing K5R CSF3R, cells were cultured in the presence of 
a variety of inhibitors (Figure 7C). JAK inhibitor I, a potent inhibitor of JAK2 (IC50 = 1nM), 
MEK inhibitor U0126 and Akt inhibitor IV completely abolished cell survival. Blocking of 
PI-3 kinase, acting upstream of PKB/Akt, by LY294002 also severely diminished survival 
as did inhibition of Src activity by tyrosine kinase inhibitor PP2. This result indicates that 
multiple pathways contribute to the growth-factor independent cell survival of the routing 
defective K5R CSF3R mutant. In contrast, inhibition of the stress-associated p38 MAPK [25] 
by SB203580, resulted in significantly increased survival. Because both STAT3 and STAT5 
have been implicated as important signalling molecules for G-CSF-induced proliferation 
and survival [26, 27], we investigated whether these STATs are constitutively activated in 
JAK2-overexpressing Ba/F3 cells harbouring CSF3R K5R or d715. A prominent ligand inde-
pendent activation of STAT3, but not STAT5, was observed in JAK2-overexpressing Ba/F3 
cells transduced with mutants K5R or d715, but not with wt CSF3R (Figure 7D).
dIscussIon
We investigated the role of JAK proteins in controlling CSF3R expression and intracellular 
routing. Specifically, we addressed to what extent JAKs interfere with the internalization and 
lysosomal routing machinery, linked to the dileucine-based internalization and conserved 
cytoplasmic lysines, respectively. Major observations were: (1) increased JAKs significantly 
elevated CSF3R membrane expression and protein levels, (2) JAKs did not exert this effect 
by masking motifs essential for internalization, as previously demonstrated for IFNAR1, or 
by reducing the ubiquitination of the lysosomal routing determinant K632 of CSF3R and 
Figure 7. JaK2 overexpression provokes ligand-independent pro-survival signalling by internalization defective 
and lysosomal routing deficient csF3r mutants 
Parental and JAK2 overexpressing Ba/F3 transfectants were cultured in medium with IL3 and transferred to medium 
without growth-factors. (A) total cell numbers and (B) the percentage of living cells based on 7-AAD staining were 
assessed at the indicated time points. Representative graphs of three independent experiments are shown. (C) Effects 
of various kinase inhibitors on cell survival. See main text for details on the specificity of different compounds. 
DMSO: solvent control. Representative graphs of three independent experiments are shown. (D) Cell lysates were 
made after removal of growth factor (GF) at the indicated time points (hrs) and subjected to Western blot analysis 
with antibodies against pSTAT3, pSTAT5 and actin for loading control.
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(3) simultaneous perturbation of internalization or lysosomal routing and JAK-mediated 
increase in forward routing resulted in ligand-independent activation of CSF3R complexes.
Enhanced cell surface expression after JAK overexpression has been reported for a number 
of cytokine receptors (Huang et al., 2001; Radtke et al., 2002; Radtke et al., 2006; Ragimbeau 
et al., 2003; Royer et al., 2005), but whether endogenous JAKs control receptor routing has 
been a matter of controversy. For example, a variety of EpoR mutants that failed to bind 
JAK2 showed only moderately reduced cell surface expression compared to wt EpoR and 
EpoR was still expressed on the cell surface of JAK2-deficient embryonic fibroblasts (Pelletier 
et al., 2006). Because EpoR exclusively binds JAK2, these results implied that cell surface 
expression of EpoR does not require JAKs. On the other hand, a clear relationship between 
loss of TYK2 and reduced membrane expression was reported for IFNAR1, owing to TYK2-
mediated masking of endocytosis motifs (Kumar et al., 2008; Ragimbeau et al., 2003) and 
similarly JAK1 was found to inhibit internalization of OSMR (Radtke et al., 2006). In this 
respect, CSF3R resembles the EpoR, as increased JAK levels did not affect endocytosis and 
because cell surface expression of CSF3R mutant W650R, which fails to activate JAKs and is 
hampered in JAK binding, is approximately similar to that of wt CSF3R. However, it remains 
possible that the residual 10-20% JAK binding observed with CSF3R-W650R might still suf-
fice to promote cell surface routing.
Among the 5 conserved lysines in the cytoplasmic tail of CSF3R, the juxtamembrane resi-
due K632, in addition to being a major determinant for ligand-induced lysosomal routing 
(Irandoust et al., 2007), also appeared to be uniquely involved in the control of CSF3R cell 
surface expression. Although lysines have been reported to regulate constitutive internaliza-
tion of the short isoform of the leptin receptor (Belouzard and Rouille, 2006), we could not 
detect any role of lysines in constitutive internalization of the CSF3R. Hence, loss of K632 
rather leads to enhanced cell surface expression by redirection of receptors from the en-
doplasmic reticulum-lysosomal degradative pathway towards the plasma membrane. Major 
players involved in intracellular trafficking of surface membrane proteins are the endosomal 
sorting required for transport (ESCRT) and Golgi-localized γ-ear containing (GGA) protein 
complexes, respectively (Hurley et al., 2006). Because key proteins within these complexes, 
such as Hrs and GGA, interact with ubiquitinated lysines in cargo proteins but simultane-
ously require interaction with phosphoinositides to increase affinity (Hurley, 2008; Wang et 
al., 2007), this might explain why membrane proximal positioning of lysine K632 is impera-
tive for lysosomal routing of CSF3R. This is supported by recent experiments showing that 
relocation of K632 to a more membrane distant position disrupted its role in routing despite 
the fact that ubiquitination was unaffected (Wölfler et al., submitted for publication).
How JAKs control basal cell surface expression of CSF3R remains to be resolved. Because 
JAKs bind with their N-terminal FERM domain to the juxtamembrane domain of CSF3R 
that encompasses K632, a feasible explanation was that JAK overexpression would mask the 
function of this lysine, e.g., by preventing its ubiquitination or by hindering the binding of 
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effector proteins. This hypothesis can now be discarded because increased JAK levels did not 
prevent ubiquitination of K632 and elevated cell surface levels of mutants K632R and K5R at 
as efficiently as the wt CSF3R. Most likely, JAKs associate with the CSF3R already early in the 
biosynthetic pathway and help to protect CSF3R from misfolding and degradation, similar to 
what has been proposed for the EpoR (Huang et al., 2001).
Abnormal responses to hematopoietic growth factors, including G-CSF, have long been 
suspected to be involved in leukemic cell growth in AML (Lowenberg and Touw, 1993). The 
discovery of acquired mutations in CSF3R in patients with severe congenital neutropenia that 
are strongly associated with progression to AML have strongly supported this idea (Freed-
man et al., 2000). Although CSF3R mutations are rarely detected in de novo AML, a scenario 
can be envisaged in which increased levels of JAK confer spontaneous pro-survival signal-
ing from lysosomal routing defective CSF3R. Such a combinatorial mechanism might, e.g., 
involve deubiquitinating enzymes that attenuated lysosomal routing by deubiquitination of 
critical lysines in CSF3R or proteins of the ESCRT machinery. Notably, this is not without 
precedent, since it was demonstrated earlier that expression of the deubiquitinating enzyme 
DUB-2 increases survival of haematopoietic cells following cytokine withdrawal (Migone et 
al., 2001).
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abstract
Signals induced by granulocyte colony-stimulating factor (G-CSF), the major cytokine 
involved in neutrophil development, are tightly controlled by ligand-induced receptor inter-
nalization. Truncated G-CSF receptors that fail to internalize show sustained proliferation 
and defective differentiation signaling. Steady state forward routing also determines cell 
surface levels of cytokine receptors, but mechanisms controlling this are poorly understood. 
Here, we show that Wsb-2, a SOCS box-containing WD40 protein with currently unknown 
function, binds to the COOH-terminal region of G-CSF receptor. Removal of this region did 
not affect internalization, yet resulted in increased membrane expression of G-CSF receptor 
and enhanced proliferation signaling at the expense of differentiation induction. Conversely, 
Wsb-2 binding to the G-CSF receptor reduced its cell surface expression and inhibited pro-
liferation signaling. These effects depended on the SOCS box involved in ubiquitylation and 
on cytosolic lysines of G-CSF receptor and imply a major role for ubiquitylation through 
the G-CSFR C-terminus in forward routing of the receptor. Importantly, the Wsb-2 gene is 
commonly disrupted by virus integrations in mouse leukemia. We conclude that control of 
forward routing of G-CSF receptor is essential for a balanced response of myeloid progenitors 
to G-CSF and suggest that disturbance of this balance may contribute to myeloid leukemia.
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IntroductIon
The granulocyte colony-stimulating factor receptor (G-CSFR) is the major cytokine receptor 
involved in neutrophil development (Avalos, 1996; Demetri and Griffin, 1991; van de Geijn 
et al., 2003). G-CSFR activates multiple signaling molecules that control the proliferation 
and survival of myeloid precursors. In myeloid cell line models such as 32D, G-CSFR in-
duces proliferation in the first 4-6 days of culture, followed by growth arrest and terminal 
granulocytic differentiation (Dong et al., 1993; Fukunaga et al., 1993). How this balance is 
maintained is largely unknown. Truncated G-CSFR resulting from nonsense mutations in 
CSFR3 are found in ~20% of patients with severe congenital neutropenia (SCN). These muta-
tions are linked with progression of SCN to acute myeloid leukemia (AML) (van de Geijn et 
al., 2003). The truncated G-CSFRs confer a hyperproliferative response to G-CSF in knock-in 
mouse models and are unable to transduce differentiation signals in 32D cells (Aarts et al., 
2004; Dong et al., 1998; Hermans et al., 1999; McLemore et al., 1998; Ward et al., 1999b). Im-
portantly, these mutants are defective in internalization, supporting the importance of a tight 
control of G-CSFR membrane expression for a balanced signaling output (Aarts et al., 2004; 
Hunter and Avalos, 1999; Ward et al., 1999b). While ligand-induced receptor endocytosis is 
a major mechanism for signal attenuation, less is known of mechanisms that control steady 
state expression of cytokine receptors on the plasma membrane and their contribution to 
signaling.
We recently identified the gene encoding WD40-repeat and suppressor of cytokine signaling 
(SOCS) box-containing protein 2 (Wsb-2) in a retroviral screen for leukemia genes (Erkeland 
et al., 2004). Wsb-1 and Wsb-2 proteins share 46% homology and belong to a protein family 
characterized by a SOCS box (Hilton et al., 1998). Together with elongin B/C and cullin 
2 or 5 these proteins form Elongin-Cullin-SOCS protein (ECS) complexes, which function 
as E3 ubiquitin (Ub) ligases and in which the SOCS-box proteins are thought to bind the 
substrates that are targeted for ubiquitylation (Kamura et al., 2004; Kamura et al., 1998). This 
was recently demonstrated for ASB-2, a SOCS box protein involved in myeloid differentia-
tion and for WSB-1, implicated in thyroid hormone activation (Dentice et al., 2005; Heuze 
et al., 2005). Substrate specificities of ECS complexes are still largely unknown. Moreover, it 
is unclear whether SOCS box proteins predominantly participate in polyubiquitylation and 
proteasomal degradation or also in lysosomal routing involving mono-or multi-ubiquitylation 
of substrates (Schnell and Hicke, 2003).
Here, we show that Wsb-2 (and the homologous Wsb-1) binds to the distal 13 amino acids 
of G-CSFR. In myeloid 32D cells, mutants lacking this region confer a hyperproliferative 
response, associated with reduced granulocytic differentiation. Wsb affects cell surface 
expression of G-CSFR via a mechanism depending on the conserved lysine residues in the 
G-CSFR and on the Wsb SOCS box, implicated in ubiquitylation of target substrates. All 
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integrations in Wsb-2 identified in the retroviral screen disrupted the gene structure, suggest-
ing that Wsb-2 may act as a tumor suppressor or as a haplo-insufficient gene. WSB-2 expres-
sion was also reduced in a subclass of AML patients. Based on these findings, we propose a 
model in which Wsb-2 induces ubiquitylation of the G-CSFR, thereby controlling steady 
state surface expression levels. This control appears essential for the appropriate balance of 
G-CSF-induced proliferation and differentiation, and may be lost in cases of murine and 
human acute myeloid leukemia.
MaterIal and MetHods
Pcr primers
Primers are listed in table 1.
table 1. Pcr primers
primers sequence
wsb2a 5’-GGGACCTGAATAAGCACG-3’
wsb2b 5’-CTCCTGTGATTTCTCTCCTG-3’
wsb2c 5’-AGACAACACTGCTTTGGTG-3’
wsb2d 5’-CTGTCATCTGC-CACCGTAG -3’
wsb2e 5’-AGATCCAGGTGTTATCCG-3
wsb2f 5’-ACCAG TGTGATTATGTGGGA-3’
wsb2g 5’-GGATTAGTGTGTAGGACCG-3’
wsb2h 5’-AGATACAAGCC TTCAGGTGAG-3’
L1 5’-TGCAAGATGGCGTTACTGTAGCTAG-3’
L1N 5’-AGCCTTATGGTGGGGTCTTTC-3’
L2 5’-CCAGGTTGCCCCAAAGACCTG-3’
L2N 5’-AAAGACCTGAAACGACCTTGC-3’
WSB F6 5’-CTTCTTACGATACCAATGTGA-3’
WSB R6 5’-TACAAGCCTTCTGGAGAGAA-3’
Y2HGCSFRF1 5’-CCGAATTCTCCTATGAGAACCTCTGGTTCCAG-3’
Y2HGCSFRR1 5’-AACTGCAGTTTTAGTCATGGGCTTATGGACC-3’
Y2HGCSFRR2 5’-AACTGCAGCTACAGGAGGGGGAAGTTGAG-3’
WSB1fw 5’-AAGAATTCAAGCCAGCTTTCCCCCGAG-3’
WSB1r1 5’-AACTCGAGTTAGCCCCTGTAGGAGAGAAACGCCAATA-3’
WSB2fw 5’-AAGAATTCAAGAGGCCGGAGAGGAGCC-3’
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yeast-two-hybrid (y2H) analysis
Y2H was performed using yeast strain PJ69-4A (Dr. Philip James, University of Wisconsin, Madison) 
as described (James et al., 1996; van Zon et al., 2002). As prey library, a mouse 17-day embryo cDNA 
library (Matchmaker, Clontech laboratories, Palo Alto, CA) was used. For a second screen, cDNA 
library plasmids were co-transformed with the pGBT9-GCSFR762-813 or pGBT9-GCSFR762-790 bait. 
Prey inserts from this second selection were nucleotide sequenced (ABI 3100, Applied Biosystems).
constructs generated for yeast two hybrid analysis
Bait constructs. The DNA encoding the 51 C-terminal 51 amino acids of G-CSFR (G-CSFR762-813) 
was obtained with primers Y2HGCSFRF1 and Y2HGCSFRR1. A fragment encoding G-CSFR amino 
acids 762 to 790 (G-CSFR762-790, lacking the 23 most C-terminal amino acids) was amplified with 
primers Y2HGCSFRF1 and Y2HGCSFRR2 using pBabe-G-CSFR (Hermans et al., 2003) as template. 
EcoRI and PstI fragments were cloned in-frame with the DNA binding domain (BD) in pGBT9 vector 
(Clontech), resulting in pACT-BD-GCSFR762-813 and pACT-BD-GCSFR762-790.
Prey constructs. Wsb-1 wild type and Wsb-1 without SOCS box (Wsb-1-ΔSB) sequences were amplified 
with primers WSB1fw and WSB1r1 using pMG2-WSB-1 and pMG2-WSB-1-ΔSB (see MAPPIT) as 
templates. Similarly, Wsb-2 and Wsb-2-ΔSB were amplified with primers WSB2fw and WSB2r1 using 
primers sequence
WSB2r1 5’-AACTCGAGCTAGAAAGTCCTGTATGTGAGGAACTC-3’
GCSFRHA
5’-GGAAGATCTCTACGCGTAATCTGGAACATCGTATGGGTACGCG
TAATCTGGAACATCGTATGG-GTAGAAGCTCCCCAGCGCCTC-3’
pMGEcoMutF 5’-GGCGGTTCGAGAATTCGAAGCA-3’
pMGEcoMutR 5’-TGCTTCGAATTCTCGAACCGCC-3’
WSBMYCf 5’-AAGAATTCAAGCCAGCTTTCCC-3’
Mappit11_749-769F 5’-GGCGAGCTCATCCACCTAGCCCCTCTTG-3’
1250RV 5’ATCTAGATTAGTCATGGGCTTATGGA-3’
Mappit5 5’-GGCGAGCTCAAGGAAGAATCCCCTCTGG-3’
PMG2-SHCf 5’-AAGAATTCAACAAGCTGAGTGGAGGCGGC-3’
PMG2-SHCr 5’-AACTCGAGTCACAG TTTCCGCTCCACAGGTT-3’
WSB1stopf 5’-TGGGCCACTCCAAGGTAAGTCCCTAGCCTT-3’
WSB1stopr 5’AAGGCTAGGGACTTACCTTGGAGTGGCCCA-3’
WSB2stopf 5’-TCCCCGGGTCTAGTCCTCAC-3’
WSB2stopr 5’-GTGAGGACTAGACCCGGGGA-3’
Fw7 5’-GTCCTCACCCTGATGACC-3’
769WSB1fusionR 5’-AAAGCTGGCTGATCCTCCGAACCAGAGGTTCTCATA-3’
769WSB1fusionF 5’-CTCTGGTTCGGAGGATCAGCCAGCTTTCCCCCGAGG-3’
769WSB2fusionR 5’-TCCGGCCTCTGATCCTCCGAACCAGAGGTTCTCATA-3’
769WSB2fusionF 5’-CTCTGGTTCGGAGGATCAGAGGCCGGAGAGGAGCCGCT-3’
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pMG2-WSB-2 and pMG2-WSB-2-ΔSB as templates. The PCR fragments were EcoRI-XhoI digested 
and ligated into the pACT prey vector (Clontech).
Immunoprecipitation and Western blotting
COS cells were transfected with pSG5-HAHA-G-CSFR together with pMG2-WSB-1, pMG2-WSB-2, 
pMG2-FzR-WD40, or pMG2-SVT (Eyckerman et al., 2002; Eyckerman et al., 2001). After 48 h, cell 
lysates were incubated with anti-FLAG (Sigma-Aldrich Chemie, Zwijndrecht, The Netherlands) or anti-
HA (Santa Cruz Biotechnology, CA) antibodies. Immune-complexes were visualized by Western blot-
ting as described (Dong et al., 2001). HEK293 cells were transfected with the different G-CSFR mutants. 
After 48 h, cell lysates were either incubated with anti-Jak-2 antibodies (Bio Connect, Veenendaal, The 
Netherlands) or analyzed by Western blotting using phosphorylation specific antibodies against Stat5 
(Becton Dickinson, Alphen a/d Rijn, The Netherlands), Stat3 (Westburg, Leusden, The Netherlands), 
P38 (Westburg) and Erk (Tebu-Bio, Heerhugowaard, The Netherlands) and against total Erk for load-
ing control (Campro, Veenendaal, The Netherlands). Phosphorylated Jak-2 and total Jak-2 input were 
visualized by Western blotting using anti-phosphotyrosine (PY99) and anti-Jak2 antibodies (Tebu-bio) 
respectively.
constructs generated for co-immunoprecipitation
PSG5-HAHA-G-CSFR. A G-CSFR fragment was amplified using primers GCSFRHA and Fw7 creating 
a double HA-tag at the G-CSFR C-terminus. The HpaI-BglII digested PCR fragment replaces the HpaI-
BglII fragment of pBabe-G-CSFR. The EcoRI-SalI fragment of pBabe-HA-G-CSFR was ligated into 
pSG5 expression vector resulting in pSG5-HAHA-G-CSFR.
Ligation of pACT-prey insert into pMG2. The pMG2 vector was mutated with QuickChange Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, USA), using primers pMGEcoMutF and pMGEcoMutR 
resulting in pMG2-mut vector. The EcoRI-XhoI fragment from pGBT9-Fzr-WD was cloned in the 
EcoRI and XhoI sites of the pMG2-mut vector resulting in pMG2-Fzr-WD.
Immunofluorescence microscopy
HEK293 cells were transfected with EGFP-fusion constructs of WT G-CSFR, G-CSFRΔ715, G-CSFRΔ769 
or G-CSFRΔ749-769 in pBabe (Aarts et al., 2004) together with pMT2-MYC-WSB. Cells were fixed 
and stained using mouse anti-MYC monoclonal antibodies (9E10, Santa Cruz Biotechnology, CA) and 
TRITC-conjugated Goat-anti-mouse secondary antibodies as described (Aarts et al., 2004). To examine 
subcellular localization of the fluorescent proteins, confocal laser scanning microscopy (CLSM) was 
performed on a Zeiss LSM510 (Carl Zeiss BV, Sliedrecht, The Netherlands).
constructs generated for cslM
pMT2-MYC-WSB-1. WSB was amplified with WSBMYCf and WSB1r1 using pMG2-WSB as template 
and cloned in TA cloning vector. The EcoRI fragment was cloned in the EcoRI site of pMT2SM-MYC 
vector (Aarts et al., 2004; van Dijk et al., 2000)
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MaPPIt
MAPPIT was performed as described (Eyckerman et al., 2002). In summary, HEK293-T cells (2x105) 
were transfected with bait and prey constructs in presence of luciferase reporter gene (pXP2d2-rPAP-
Luci). 48h after transfection, cells were treated bait receptors were activated with Epo (0,5 U/ml) for 24 
h. Cultures without Epo stimulation were run in parallel. Luciferase activity from a STAT3 luciferase 
reporter was determined in triplicate using the Steady-Glo luciferase assay system (Promega, Leiden, 
The Netherlands). Activities are expressed as fold induction by dividing luciferase activity of the Epo-
stimulated samples over non-stimulated values. To determine expression levels of the FLAG-tagged 
prey proteins, Western blotting using anti-FLAG M2 monoclonal antibodies (Sigma-Aldrich Chemie, 
Steinheim, Germany) was performed as described (Ward et al., 1999a).
Bait constructs. The C-terminal 65 amino acids fragment of human G-CSFR was generated with prim-
ers Mappit11_749-769F and 1250RV with pLNCX-G-CSFR (Ward et al., 1999a) as template. The entire 
intracellular domains of G-CSFR (G-CSFR630-813) and G-CSFR630-813-Y (intracellular domain 
lacking all tyrosines) were amplified with primers Mappit5 and 1250RV using pLNCX-G-CSFR and 
pLNCX-mutant “null” as templates (Ward et al., 1999a). The fragments were cloned in TA cloning 
vector, sequence checked, SacI and XbaI digested and ligated into pCEL(2L) vector (Eyckerman et 
al., 2002; Tavernier et al., 2002), resulting in pCEL(2L)-G-CSFR748-813, -G-CSFR630-813 and -G-
CSFR630-813-Y. Deletion mutants of the G-CSFR748-813 bait were made by introducing stop codons 
with the QuickChange Site-Directed Mutagenesis Kit (Stratagene).
Prey constructs. Human SHC was amplified using primers PMG2-SHCf and PMG2-SHCr using pHMT-
SHC as template (Gotoh et al., 1996). Murine Wsb-1 and Wsb-2 were amplified from 32D cDNA with 
primers WSB1f and WSB1r1 (Y2H constructs), WSB2f and WSB2r2 (Y2H constructs). PCR products 
were cloned in TA vector, sequence checked and EcoRI-XhoI digested allowing ligation into pMG2 
prey vector (Eyckerman et al., 2002), thus resulting in SHC-, WSB-1- and WSB-2- Flag-tagged-gp130 
fusions. The WSB-1-ΔSB and WSB-2-ΔSB mutants were made by site-directed mutagenesis (Quick-
Change) using primers WSB1stopf, WSB1stopr and primers WSB2stopf, WSB2stopr, respectively.
retroviral gene transfer in 32d cells
IL-3-dependent murine myeloid 32D cells were infected with the different Babe-based retroviral vec-
tors and selected on 1 μg/ml puromycin (Sigma, Zwijndrecht, The Netherlands) as described (Aarts et 
al., 2004).
Production of retroviral vectors
The G-CSFR part of the G-CSFR∆769-Wsb-1 fusion was amplified using primers Fw7 and 769WSB1fu-
sionR, in which italics denote G-CSFR sequence, underlined a flexible linker sequence encoding for two 
glycines and a serine (GGS) (Eyckerman et al., 2002) and regular fond Wsb sequence using pBabe-G-
CSFR (Aarts et al., 2004) as template. The Wsb part was amplified using primers 769WSB1fusionF and 
WSB1r1 (Y2H construct), and pMG2-WSB-1 and pMG2-WSB-1-SBD as template. Both amplification 
products were used as template and the annealed fragments amplified using primers Fw7 and WSB1r1. 
The G-CSFR part of G-CSFR∆769-Wsb2 fusion was amplified using primer 769WSB2fusionR and 
Fw7. The Wsb-2 part was amplified using primers 769WSB2fusionF and WSB2r1 (Y2H construct), 
with pMG2-WSB-2 and pMG2-WSB-2-SBD as input. These fragments were used as PCR template and 
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amplified with primers Fw7 and WSB2r1. Fusion products were cloned in TA vector and sequenced. 
pBabe-G-CSFR was digested with HpaI and BglII, blunted (DNA polymerase I large fragment, Invitro-
gen) and dephosphorylated (shrimp alkaline phosphatase, Roche, Mannheim, Germany). Fusion prod-
ucts were digested with HpaI and XhoI, blunted, ligated in pBabe-G-CSFR and checked by restriction 
analysis and nucleotide sequencing. G-CSFR mutant K5RΔ769-Wsb-2, in which cytoplasmic lysine 
residues K632, K672, K681, K682 and K762 are replaced by arginines was created using QuickChange 
site-directed mutagenesis (Stratagene) using G-CSFRΔ769-Wsb-2 as a template. 32D cells expressing 
G-CSFRΔ800 and G-CSFRΔ715 have been described previously (Aarts et al., 2004).
Flow cytometric analysis of G-csFr expression and internalization in transduced 32d 
cells
To determine G-CSFR expression, transduced 32D cells were labeled with biotinylated antihuman 
antibody recognizing an N-terminal extracellular epitope of the G-CSFR (LMM741; Pharmingen, 
San Diego, CA), subsequently incubated with phycoerythrin-conjugated streptavidin (SA-PE; DAKO 
Diagnostics, Glostrup, Denmark) and analysed by flow cytometry using a FACScan (Becton Dickinson, 
Sunnyvale, CA) as described (Aarts et al., 2004). Ligand induced internalization was assessed at several 
time points after G-CSF treatment as described (Aarts et al., 2004).
stat3 and stat5 electrophoretic mobility assay (eMsa)
EMSA to detect activated STAT3 and STAT5 complexes in nuclear extracts of 32D cell transfectants 
were performed as described (de Koning et al., 2000).
G-csFr ubiquitination
Phoenix E cells (G. Nolan, Stanford, CA) were transfected with HA-tagged wt or mutant-G-CSFR and 
flag-tagged Ub using the calcium-phosphate precipitation method. After 48 h, cells were stimulated 
with G-CSF (100 ng/ml) for 30 minutes or left untreated, washed with cold PBS and resuspended in 
lysis buffer. (Lysis buffer: 20mM Tris HCl pH8.0, 137mM NaCl, 10mM EDTA, 100mM NaF, 1% NP40, 
10% glycerol, 2mM Na3VO4 and 1mM Pefablock SC, 50 µg/ml aprotinin, 50 µg/ml leupeptin, 50 µg/
ml bacitracin, and 50 µg/ml iodoacetamide). Immunoprecipitations using protein G-sepharose beads 
and subsequent Western blotting were performed using anti-Flag and anti-HA and anti polyUb (FK2, 
Affiniti Research Products, Exeter, UK) antibodies. Sepharose beads were washed and resuspended in 
1x laemlli buffer (pH 11) before gel electrophoresis and Western blotting.
detection of virus integrations in Wsb-2
To determine orientation and localization of Gr-1.4 MuLV integrations in Wsb-2, a nested PCR was 
performed on genomic DNA from primary tumors as described (Erkeland et al., 2004) (Figure 1A). For 
the first PCR, Wsb-2 specific primers a, b, c, and d were used in combination with Gr-1.4 LTR specific 
primers L1 and L2. For the nested PCR, Wsb-2 specific primers e, f, g and h were used in combination 
with Gr-1.4 LTR specific primers L1N and L2N. PCR fragments were analyzed as described (Erkeland 
et al., 2004).
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WSB-2 expression in human aMl
Real-time PCR was performed on complementary DNA from 260 AML patients using an Applied 
Biosystems 7900 instrument (Applied Biosystems, Weiterstadt Germany) and SYBR Green PCR Master 
Mix (Applied Biosystems) (Erkeland et al., 2003; Valk et al., 2004). Primers were WSB-2F6 and WSB-
2R6. The porphobilinogen deaminase (PBGD) gene was taken as reference (Erkeland et al., 2003).
results
Wsb binds to the cooH terminus of G-csFr in y2H and co-immunoprecipitation 
assays and colocalizes with G-csFr in intact cells
Previous studies indicated that the C-terminal part of the G-CSFR is crucial for G-CSF-
induced granulocytic differentiation (Dong et al., 1993; Fukunaga et al., 1993). Yeast two 
hybrid analysis was performed to identify proteins that interact with this region. Using G-
CSFR762-813 as bait, candidate interacting proteins were identified, including the WD40 
repeat domain proteins Fizzy-related 1 (FzR1), Wsb-1 and Wsb-2 (Figure 1 upper panel). 
Deletion of the SOCS box domain (ΔSB) did not affect Wsb-1/2 binding to the G-CSFR bait 
(Figure 1, upper panel). Wsb proteins failed to interact with G-CSFR762-790, indicating that 
the distal 23 amino acids of G-CSFR are crucial for binding (Figure 1, lower panel). In COS 
cells, FLAG-tagged Wsb-1 and Wsb-2 co-immunoprecipitated with G-CSFR in HA-IP’s, as 
did the WD40 domain of FzR1 (Figure 2A). No interactions were seen with an irrelevant 
control protein SV40 large T (SVT) or with empty vector controls (Figure 2A). Similar results 
were obtained in the reverse FLAG IP/HA Western experiments (Figure 2B). No interactions 
were observed between G-CSFRΔ715 and Wsb-1, Wsb-2, or FzR-WD40 (Figure 2C,D). Con-
focal laser scanning microscopy (CLSM) showed that Wsb-2 co-localized with WT-G-CSFR 
in transfected HEK293-T cells (Figure 3A), but not with G-CSFRΔ715 or G-CSFRΔ769, 
mutants that lack the WD40-interacting distal 23 amino acids (Figure 3B,C). Conversely, 
G-CSFRΔ749-769, a mutant defective in internalization but retaining its distal region, again 
co-localized with Wsb in intracellular vesicles (Figure 3D).
G-csFr/Wsb interactions in mammalian protein-protein interaction trap (MaPPIt) 
assay
To establish that Wsb and G-CSFR proteins interact in living mammalian cells in the correct 
subcellular context, we performed MAPPIT, a cytokine receptor based two-hybrid assay (Ey-
ckerman et al., 2001). Intracellular fragments of G-CSFR were coupled to the C-terminus of 
the EPO/Leptin receptor hybrid bait (Figure 4A) (Tavernier et al., 2002). First, we validated 
the MAPPIT system for G-CSFR-containing baits using preys containing full length Shc or 
Grb2, proteins that bind directly to phosphorylated Y764 of G-CSFR (Ward et al., 1999a). As 
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predicted, Shc and Grb2 interacted efficiently with bait C65, but not with C65-Y764F (Figure 
4B). Wsb-1 and Wsb-2 strongly interacted with C65, while no binding with the control bait 
(EPO-R) was observed (Eyckerman et al., 2002) (Figure 4C). These results show that Wsb 
specifically binds to the G-CSFR and not to the leptin receptor backbone of the bait. FzR1 
did not bind to the G-CSFR bait (data not shown), indicating that Wsb, but not FzR1 may 
control G-CSFR function. Removal of the SOCS box did not affect Wsb binding to C65. Wsb 
binding to C65Δ803 was strongly reduced and no longer detected with C65Δ792 (Figure 
4D). These results corroborate the Y2H, immunoprecipitation and CLSM experiments and 
establish that Wsb binding specifically occurs to the carboxyl terminal 10 to 20 amino acids 
of the G-CSFR.
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Figure 1. Yeast-two-hybrid analysis  
 
Figure 1. yeast-two-hybrid analysis
Yeast strain PJ69-4A was transformed according to the LiAc/SS-DNA/PEG procedure with either pGBT9-
GCSFR762-813, containing amino acids 762 to 813 of G-CSFR (upper section) or pGBT9-G-CSFR762-790, contain-
ing amino acids 762 to 790 of G-CSFR (lower section) in combination with Wsb-1, Wsb-1 without SOCS Box (SB), 
Wsb-2, Wsb-2 without SB, Fzr-WD40 or empty prey vector expressing the ADdomain only.
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The Wsb-binding region of G-csFr influences steady state expression levels and 
controls the balance between proliferation and differentiation signals
To study the role of Wsb-binding amino acids in G-CSFR distribution and function, we 
generated multiple independent clones of 32Dcl10 cells expressing a C-terminal deletion 
mutant lacking the 13 carboxyl-terminal amino acids (G-CSFRΔ800). Steady state membrane 
expression of G-CSFRΔ800 was consistently increased compared to WT G-CSFR (Figure 
5A). Contrary to G-CSFRΔ715, ligand-induced internalization of G-CSFRΔ800 in 32D cells 
 
 
Figure 2. Co-immunoprecipitation of Wsb-1 and Wsb-2 with G-CSFR 
 
 
Figure 2. co-immunoprecipitation of Wsb-1 and Wsb-2 with G-csFr
COS cells were transfected with pSG5-HA-G-CSFR, pSG5-HA-Δ715 or pSG5-empty vector in combination with 
pMT2-FLAG-Wsb1, pMT2-FLAG-Wsb-2, pMT2-FLAG-FzRWD40 (positive control) or pMT2-FLAG-SVT (nega-
tive control). After 48 hours, cells were lysed and proteins immunoprecipitated with antibodies against HA-tagged 
G-CSFR (A, C) or FLAG-tagged Wsb and control proteins (B, D). Blots were restained with anti-FLAG and anti-HA 
(Santa Cruz Biotechnology, CA) as indicated. Arrows mark positions of co-precipitated products (upper panels) and 
input of precipitates (lower panels). W1,W2: Wsb1,Wsb2; EV: empty vector; SVT: SV40 large T.
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was normal and occurred with similar kinetics as internalization of WT G-CSFR (Figure 5B), 
indicating that increased expression levels were not due to defective endocytosis. The rate 
of proliferation of 32D/G-CSFRΔ800 cells in G-CSF-containing cultures was significantly 
increased compared to 32D/G-CSFR-WT and matched growth rates of 32D/G-CSFRΔ715 in 
the first days of culture (Figure 5C). This was accompanied by a lack of terminal neutrophilic 
differentiation (Figure 5D), indicating a major role of the C-distal 13 amino acids of G-CSFR 
in controlling the proliferation/differentiation balance in response to G-CSF.
Wsb fusion reduces steady-state G-csFr expression on the plasma membrane
Next, we determined the effects of Wsb on G-CSFR distribution. Unfortunately, we could not 
generate 32D clones stably expressing Wsb-1 or Wsb-2, possibly because WD40 repeats bind 
to substrates that are crucial for cell growth (Neer and Smith, 2000; Smith et al., 1999). To over-
come this problem, we generated constructs with Wsb-1 or Wsb-2 fused to G-CSFR mutant 
Δ769 via a flexible linker (GGS) (Figure 6A). While membrane expression of G-CSFRΔ769 was 
 
Figure 3. Co-localization of Wsb and G-CSFR in intracellular vesicles 
 
Figure 3. co-localization of Wsb and G-csFr in intracellular vesicles
CLSM analysis of HEK293-T cells transfected with G-CSFR wt (A), Δ715 (B), Δ749-769 (C) or Δ769 (D) together 
with myc-tagged Wsb-2. Cells growing on glass slides were fixed 2 days after transfection and immunostained for 
G-CSFR (left panels; green) or myc-Wsb (middle panels). After merging left and middle panels, co-localization 
appears as yellow (right panels). Size bar indicates 10μM.
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consistently higher than that of WT G-CSFR, fusion of Wsb-2 to G-CSFRΔ769 significantly 
reduced membrane expression levels, an effect that depended on the SOCS box (Figure 6B). 
Similar results were obtained with G-CSFRΔ769-Wsb1 fusions (data not shown). Replace-
ment of the 5 conserved lysines in the G-CSFR moiety of G-CSFRΔ769-Wsb2 by arginines 
(K5R-G-CSFRΔ769-Wsb2) reverted membrane expression to normal levels, suggesting a 
role of ubiquitylation of receptor lysines in steady state distribution of G-CSFR (Figure 6C). 
Indeed, we could demonstrate ubiquitylation of lysines in WT-G-CSFR (Figure 6D upper 
panel). The size distribution of Ub-G-CSFR species was suggestive of mono- or multi- instead 
of polyubiquitylation, which is in agreement with the lack of reactivity with FK2, a mAb with 
 
 
Figure 4. Interactions of Wsb, Shc and Grb2 to G-CSFR detected by 
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Figure 4. Interactions of Wsb, shc and Grb2 to G-csFr detected by MaPPIt assay
HEK293-T cells were transfected with Epo/LeptinR-G-CSFR bait or Epo/LeptinR-EpoR (control) bait constructs and 
different gp130-based prey constructs as indicated together with a STAT3-driven luciferase reporter (pXP2d2-rPAP-
luci). Transfected cells were cultured with or without Epo and luciferase activity was measured 24 hours after stimu-
lation. Fold induction was calculated by dividing luciferase values of Epo-treated over non Epo-treated cells. Empty 
prey vector was used as negative contol. (A) schematic view of the different MAPPIT bait constructs, with Epo-R 
and G-CSFR bait sequences shown in light grey. EpoBD: extracellular Epo binding domain, TM: transmembrane 
domain, LR-F3: leptin receptor intracellular domain devoid of STAT3 binding receptor tyrosines; (B) specific bind-
ing of Shc and Grb-2 to Y764 of G-CSFR, indicating correct configuration of the G-CSFR C-terminus in MAPPIT 
bait constructs; (C) binding of Wsb-1, Wsb-2 and Wsb1/2-ΔSB to the G-CSFR C-terminus; C65/Shc and EpoR/Shc 
bait/prey combinations were included as positive and negative controls, respectively; (D) progressive truncation of 
G-CSFR C-terminus showing Wsb-2 binding to distal 10-21 amino acids of G-CSFR.
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high affinity for polyUb (Figure 6D, middle panel) (Haglund et al., 2003). Staining for G-
CSFR showed significantly higher protein levels of K5R compared with WT G-CSFR (Figure 
6D, lower panel), suggesting that the receptor lysines are crucial for protein degradation. 
G-CSFRΔ769-Wsb2 predominantly accumulated in the ER and intracellular vesicles, while 
G-CSFRΔ769-Wsb2ΔSB and K5R-G-CSFRΔ769-Wsb2 were both mainly found on the cell 
membrane (Figure 6E). In agreement with this, G-CSF-induced phosphorylation of STAT3, 
STAT5, Erk, p38MAPK (Figure 7A) and JAK2 (Figure 7B) in G-CSFRΔ769-Wsb1/2 expressing 
cells was strongly diminished compared to G-CSFRΔ769. This inhibitory effect of Wsb again 
depended on the presence of the SOCS box. EMSA analysis of activated STAT3 and STAT5 
as well as long-term suspension cultures gave similar results and confirmed that the lysines 
in G-CSFR are crucial for the inhibitory effects of Wsb (Figure 7C,D).
 
 
Figure 5. Role of C-terminal region of G-CSFR in steady-state membrane expression, receptor 
internalization and proliferation/differentiation signaling 
 
 
Figure 5. role of c-terminal region of G-csFr in steady-state membrane expression, receptor internalization 
and proliferation/differentiation signaling
(A) FACS histograms showing steady-state expression of G-CSFR-WT (thin line) and G-CSFRΔ800 (thick line) in 
32D cell clones. Results are representative for 5 independent clones; (B) FACS histograms showing time kinetics of 
G-CSF-induced internalization of G-CSFR-WT (upper panel) and G-CSFRΔ800 (lower panel). Results are repre-
sentative of 5 independent clones; (C) Proliferation of independent 32D cell clones stably expressing G-CSFRΔ800, 
G-CSFRΔ715 or G-CSFR WT in G-CSF-containing suspension culture; (D) Light micrographs of May Grünwald-
Giemsa stained cells on day 10 of culture (x 690).
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Figure 6. steady-state distribution of G-csFr-Wsb fusion proteins.
(A) G-CSFR constructs. Wsb moieties were fused to G-CSFRΔ769 via a flexible linker (GGS), R’s indicate 5 con-
served lysine residues replaced by arginines (K5R); (B) FACS histograms showing steady-state membrane expression 
levels of G-CSFR-WT, G-CSFRΔ769, G-CSFRΔ769-Wsb-2 and G-CSFRΔ769-Wsb-2ΔSB on 32D cells; (C) FACS 
histograms comparing steady state expression levels of K5R-G-CSFRΔ769-Wsb-2 and G-CSFRΔ69-Wsb-2; (D) IP/
Western blot analysis showing ubiquitylation of lysine residues of G-CSFR (upper panel) and lack of reactivity with 
anti poly-Ub mAb FK2 (middle panel); arrows indicate position of nonubiquitylated G-CSFR; lower panel: back-
stain for WT and K5R G-CSFR; (E) CLSM of steady-state distribution of G-CSFRΔ769-Wsb-2 (left), G-CSFRΔ769-
Wsb-2ΔSB (middle) and K5R-G-CSFRΔ769-Wsb-2 (right) on HEK293-T transfectants.
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Involvement of Wsb-2 in acute myeloid leukemia
Previously, we identified Wsb-2 in a common virus integration site in a murine myeloid 
leukemia model (Erkeland et al., 2004). Locus specific PCR (Fig 8A) showed that the 5 inte-
grations in Wsb-2 identified in independent leukemia samples occurred between exon 4 and 
exon 7, leading to disruption of the gene (Figure 8B). Because of the non-clonal nature of 
MuLV-induced tumors (Erkeland et al., 2003; Erkeland et al., 2004), we were unable to verify 
the status of the other allele or to determine Wsb-2 expression levels in single leukemic clones. 
As an alternative, we examined WSB-2 expression in human AML, using gene expression 
profiling data set of 285 AML cases (Valk et al., 2004). Significance analysis of microarrays 
(SAM) (Tusher et al., 2001) revealed that WSB-2 expression is significantly decreased (fold 
change = 0.45152, score = -6.33656, q-value = 0.109866108) in a subclass of patients (cluster 
4), characterized by mutations in CEBPA (Valk et al., 2004). These data were confirmed by 
Figure 6. Steady-state distribution of G-CSFR-Wsb fusion proteins.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Effects of Wsb on G-CSF induced STAT activation and proliferation 
Figure 7. effects of Wsb on G-csF induced stat activation and proliferation
32D clones transduced with indicated G-CSFR constructs were serum deprived for 4 hours and then incubated with 
(+) or without (-) 100 ng/ml G-CSF for 10 min at 37°C. (A) cell lysates analyzed by Western blotting using phos-
phorylation specific antibodies against Stat5, Stat3, p38, and Erk and against total Erk (loading control); (B) Anti 
Jak-2 immunoprecipitation; blots were stained with anti-phospho-tyrosine and anti-Jak2 as indicated; (C) STAT3 
and STAT5 EMSA; nuclear extracts were prepared and assayed by EMSA using STAT5 and STAT3 specific radiola-
beled probes as described in material and methods. Results of one out of three representative clones per construct are 
shown. (D) Proliferation of 32D clones transduced with indicated G-CSFR constructs in G-CSF-containing suspen-
sion culture.
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quantitative RT-PCR (not shown) and suggest that reduced WSB-2 levels may play a role in 
perturbed G-CSF responses in this group of AML patients.
dIscussIon
The key observations reported here are that (i) Wsb proteins bind to the G-CSFR C-terminus 
and thereby modulate plasma membrane levels of G-CSFR, (ii) removal of the Wsb-binding 
domain increases the proliferation signaling abilities of G-CSFR at the expense of its ability 
to induce differentiation and (iii) lysines in the G-CSFR and the E3 ligase-recruiting SOCS 
box of Wsb are both necessary for G-CSFR distribution and signaling function, suggest-
ing that Wsb acts via ubiquitylation of the G-CSFR. Given that one Ub moiety increases  
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Figure 8. Gr-1.4 MuLV integrations in Wsb-2 
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Figure 8. Gr-1.4 Mulv integrations in Wsb-2
(A) PCR strategy to detect position and orientation of Gr-1.4 integrations in Wsb-2. Translated exons of Wsb-2 are 
shown as black boxes; white boxes represent untranslated regions of exons 1 and 9. LTR forward and LTR reverse 
indicate orientations of the integrated virus. Depending on position and orientation of the virus integration, PCR 
products will be formed. For example, when the virus is integrated in the forward orientation in intron 5, use of 
primer combination (a, L1) and nested primers (e, L1N), and/or primer combination (c, L2) and nested primers (g, 
L2N) will result in PCR products. Primer combinations are described in material and methods; (B) Examples of virus 
integration sites in Wsb-2. Arrows indicate positions and orientation of the integrations.
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the molecular size of a protein with ~ 8 kD, it appears that G-CSFR is mainly mono- or 
multi-ubiquitylated. Whereas poly-ubiquitylation serves as a signal for proteasome-mediated 
protein degradation, mono-Ubs act as a sorting signals for delivery of proteins in the bio-
synthetic or endocytic pathway to multi vesicular bodies (MVB) and lysosomes (Aguilar 
and Wendland, 2003; Hicke and Dunn, 2003). Direct or indirect association with E3 ligases 
regulates cell surface expression of a number of receptors. For instance, for the degradation 
of the interferon α receptor 1 (IFNAR1) a mechanism was proposed involving the Homolog 
of Slimb (HOS) F-Box protein, which interacts with Skp1 and Cullin-1 to form the SCFHOS 
E3 complex (Kumar et al., 2004; Kumar et al., 2003). Similar to Wsb, HOS (alternatively 
termed β-TrCP2 or Fbw1b) binds to substrates via its WD40 domain. Lysine residues in 
the cytoplasmic tail that are ubiquitylated by SCFHOS are essential for IFNAR1 degradation 
(Kumar et al., 2003). However, a major difference is that binding of Wsb to G-CSFR does 
not require receptor activation. This supports the notion that Wsb proteins are dispensable 
for ligand-induced internalization but mainly affect the steady state membrane expression 
of G-CSFR by targeting excess protein for lysosomal degradation. A similar role has recently 
been proposed for SOCS5 in the control of the steady state distribution of the epidermal 
growth factor receptor (Kario et al., 2005).
To study the consequences of reduced Wsb levels on G-CSFR distribution, we have at-
tempted to knockdown of Wsb-1 and Wsb-2 expression using small interfering (si) RNA. 
However, although significant reduction of Wsb transcript levels in HEK293 and 32D cells 
was achieved, siRNA’s were found to nonspecifically reduce G-CSFR expression on the cell 
membrane. Recent studies have revealed that siRNA’s cause the activation of Toll-like recep-
tors and induce strong interferon responses in cells, which might explain these nonspecific 
effects (Reynolds et al., 2006). Because Wsb-1 and Wsb-2 (double) knockout mice are not 
yet available, the question whether Wsb-1 and Wsb-2 have unique or (partly) redundant 
functions in G-CSFR routing and signaling cannot be addressed at present.
Wsb fusion to the G-CSFR resulted in more prominent effects than the presence of the G-
CSFR region involved in Wsb binding, both on receptor routing (compare Figures 6D and 
3A, left panel) and on signaling (Figure 7). The reason for this is unclear but likely relates to 
temporal and stoichiometric aspects of the protein-protein interaction that that are over-
ridden by the fusion. Nonetheless, the results are compatible with a role of the receptor 
C-terminus in recruiting E3 ligase activity that ubiquitylates one or more of the conserved 
lysine residues in the G-CSFR, thereby controlling its steady-state membrane expression 
as well as overall protein stability. Previous studies showed that SOCS3 acts in a negative 
feedback loop, involving G-CSF-induced activation of STAT3, STAT3-induced transcription 
of SOCS3 and binding of SOCS3 protein to phosphorylated Y729 of G-CSFR [Hermans, 
2003 #17;Hortner, 2002 #25;van de Geijn, 2004 #26]. In contrast, Wsb-1 and Wsb2 transcript 
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levels were high in nonstimulated 32D cells and primary bone marrow progenitors and not 
altered by G-CSF (data not shown). While SOCS3 attenuates G-CSF signaling from activated 
receptors, Wsb appears to control steady-state lysosomal degradation as well as the levels 
of G-CSFR expressed on the cell membrane, thereby contributing up front to a balanced 
response of myeloid precursors to G-CSF. The observation that disruption of the Wsb-2 gene 
(mouse leukemia) and truncation of the G-CSFR C-terminus (SCN/AML patients) are both 
associated with acute myeloid leukemia supports the notion that disruption of the control of 
steady state expression of G-CSFR leads to perturbed myeloid differentiation in vivo and may 
contribute to leukemic outgrowth.
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6.1. suMMary
In the past decade, considerable attention has been paid to the intracellular trafficking of 
growth factor receptors and the mechanisms controlling this process. These studies have 
revealed that ubiquitination of lysine residues within the cytoplasmic domain of receptor 
play a crucial role in endocytosis and sorting of the receptor complex to degradation com-
partments. Much of this work has been performed on model systems of intrinsic tyrosine 
kinase receptors, the EGF receptor in particular (Haglund et al., 2003a; Huang et al., 2007; 
Huang et al., 2006; McCullough et al., 2006; Pennock and Wang, 2008; Row et al., 2006; Stang 
et al., 2004). While these studies have provided general paradigms of how these processes are 
controlled, investigations of other receptor systems, for instance the cytokine receptors, have 
revealed a significant level of variation on the theme. For instance, this applies to the role of 
receptor lysines in ligand-induced internalization, the ubiquitin ligation complexes involved, 
specific domains that interact with these complexes and the type of ubiquitin modification 
(mono-, multi- and poly-ubiquitination). Experiments reported in this thesis have illustrated 
the mechanisms that regulate intracellular trafficking of the G-CSFR.
Chapter 1 offers an overview of current knowledge in ligand-dependent and –independent 
routing of cytokine receptors. Endocytosis of receptor complex is one of the mechanisms that 
negatively control cytokine signalling. Trafficking of G-CSFR through endocytotic pathway, 
including internalization, routing to early endosomes, late endosomes, multivesicular bod-
ies and lysosomes and its effect on signal downregulation have been introduced in more 
detail in this chapter. Furthermore, the role of receptor ubiquitination by the function of E3 
ubiquitin-ligases and involvement of effector proteins directing lysosomal sorting in both 
retrograde and forward routing are described.
While Chapter 2 and 3 focus on endocytosis and retrograde routing of the G-CSFR fol-
lowing its activation, forward routing and constitutive distribution of receptor have been 
discussed in Chapters 4 and 5. In Chapter 2, the role of G-CSFR ubiquitination and the E3 
ubiquitin ligase involved in ligand-induced endocytosis and lysosomal routing was studied. 
Specifically, the differential involvement of cytoplasmic lysines of the G-CSFR in intracel-
lular routing and downregulation of signalling was investigated. These studies established 
that the juxtamembrane lysine located at position 632 is target for ubiquitination by SOCS3 
following G-CSFR activation. Interestingly, lysosomal sorting and signal downregulation 
of the G-CSFR exclusively relied on this lysine residue, even though there are five lysines 
present in the C-terminal region of the receptor that are highly conserved among different 
species. Mutation of K632 G-CSFR in myeloid progenitors expressing this receptor mutant 
leads to sustained signalling and hyperproliferation phenotype in response to G-CSF due to 
perturbed signalling and accumulation in early endosomes.
Findings presented in Chapter 3 show that endocytosis is a prerequisite for receptor site-
specific ubiquitination. In addition, the molecular determinants which identify the proper 
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functionality of the G-CSFR lysine 632 were investigated in further detail. An imperative 
membrane-proximal position of this lysine residue was indispensable to direct lysosomal 
sorting and signal downregulation of the G-CSFR, therefore specificity of K632 stems from 
its interaction with downstream effector proteins.
In Chapter 4, it is shown that two mechanisms lead to increased cell surface expression and 
stability of the G-CSFR in forward routing: 1) the juxtamembrane lysine residue of G-CSFR 
at position 632, which controls the distribution of receptor by regulation of its degradation, 
and 2) elevated levels of JAK proteins. The effect of JAKs is not exerted by masking motifs 
essential for receptor internalization or by reducing the level of ubiquitination. Furthermore, 
it is observed that increased JAK levels confer ligand independent signalling and cell survival 
to routing defective G-CSFR mutants.
In Chapter 5, regulation of G-CSFR expression on the cell surface by its cytoplasmic lysine 
residues has been addressed in further detail. It has been demonstrated that Wsb proteins bind 
to the G-CSFR C-terminus and function as an E3 ubiquitin ligase in steady state situations. 
Fusion of Wsb2 protein to the C-terminal region of G-CSFR indicates that ubiquitination 
of G-CSFR lysine residues by the SOCS box of Wsb modulate receptor distribution on the 
plasma membrane and play an important role in appropriate balance between proliferation 
and differentiation of myeloid cells.
6.2. dIscussIon and Future PersPectIves
6.2.1. Involvement of ubiquitination in endocytotic pathway of G-csGr
Proper downregulation of activated G-CSFR and therefore attenuation of signalling are criti-
cal mechanisms in maintaining granulopoiesis. Retrograde endocytosis followed by sorting 
to intracellular compartments and post translational modifications such as phosphorylation 
and ubiquitination of receptor and its complex are involved in regulation of this process. 
In chapter 2 and 3 of this thesis, endocytosis and ubiquitination of the G-CSFR following 
its activation were studied. Ligand stimulation results in rapid endocytosis of G-CSFR in 
clathrin coated vesicles. Ubiquitin modification of cytoplasmic lysines of the G-CSFR is not 
required for internalization; however fusion of a single ubiquitin molecule to the C-terminal 
region of an internalization-deficient mutant can induce its internalization. This observa-
tion is in agreement with the findings presented for EGFR (Haglund et al., 2003a; Mosesson 
et al., 2003) and IL-2 receptor α chain (Nakatsu et al., 2000). However, in a recent report 
dealing with endocytotic routing of the fibroblast growth factor receptor (FGFR) (Haugsten 
et al., 2008), it was shown that fusion of an ubiquitin moiety does not always give rise to 
an endocytosis signal This discrepancy could relate to the type of internalization-defective 
receptors used for mentioned studies or to the dominant pathway governing endocytosis at 
the cell membrane.
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Whereas ubiquitination appears dispensable for G-CSFR internalization, it plays a cru-
cial role in intracellular trafficking of receptor from early to late endosomes/lysosomes. A 
schematic representation of intracellular trafficking of G-CSFR is shown in Figure 1. After 
ligand stimulation, SOCS3 recruits to the phosphorylated tyrosine of G-CSFR on position 
729 (Y729). In addition, we observed that ligand stimulation results in ubiquitination of four 
out of five conserved lysines located at the cytoplasmic tail of the G-CSFR. Although we 
cannot exclude that SOCS3 is involved in the ubiquitination of these four lysine, , we showed 
that SOCS3 is responsible for ligation of ubiquitin molecules to the juxtamembrane lysine 
of G-CSFR at position 632 and that this results in signal attenuation, lysosomal trafficking 
and subsequent degradation of receptor. Other E3 ubiquitin ligases appear to be involved 
in ubiquitin modification of lysine residues 672, 681 and 682, since the G-CSFR lacking the 
SOCS3 binding site (Y729F G-CSFR) is still ubiquitinated, although to a significantly lower 
extent compared to wt receptor.
One candidate E3 ubiquitin-ligase is c-Cbl, which has been reported to play a negative role 
in G-CSF signalling (Grishin et al., 2000; Wang et al., 2002). C-Cbl is a member of RING-type 
ubiquitin ligase family and has been shown to be involved in downregulation of receptors 
including hepatocyte growth factor receptor (HGFR/ Met), EGFR and stem cell factor recep-
tor (SCFR/ c-Kit). Direct binding of c-Cbl to phosphorylated tyrosine of activated receptor 
is sufficient for its function (Carter et al., 2004; Masson et al., 2006; Thien and Langdon, 
2005). However, we were not able to demonstrate the association of c-Cbl with G-CSFR by 
employing different techniques such as co-immunoprecipitation and the MAPPIT assays as 
described in Chapter 5 (Eyckerman et al., 2002).
6.2.2. ubiquitin-dependent sorting of G-csFr in the biosynthetic pathway
Newly synthesized proteins that arrive at the trans-Golgi network (TGN) are sorted either to 
the plasma membrane or to an endosomal compartment and route to the lysosome degrada-
tion pathway (Figure 1). Although there is controversy over the type of ubiquitin modifica-
tions in this pathway, studies on yeast amino acid permeases made it evident that ubiquitin 
signals play an important role in regulation of forward trafficking (Beck et al., 1999; Helliwell 
et al., 2001; Soetens et al., 2001).
Low levels of G-CSFR expression at the cell surface compared to a large intracellular pool, 
implicates in a balance between routing of the receptors to the plasma membrane and their 
turn over. In Chapter 5, it is proposed that SOCS box-containing Wsb proteins serve as the 
E3 ubiquitin-ligases involved in regulation of receptor in forward routing (Figure 1). Like 
SOCS3, Wsb proteins are able to form an ECS complex through their SOCS box. Impor-
tantly, binding of WD40 domain of Wsb to the COOH terminus of the G-CSFR is not ligand 
dependent, supporting the notion that it affects constitutive routing. Controlling membrane 
expression of G-CSFR by Wsb2 at steady state situation depends on its E3 ligase activity and 
cytoplasmic lysines of the receptor, particularly the juxtamembrane lysine residue. Accord-
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ingly, lysine-less G-CSFR has a high cell surface expression, which is a due to increased for-
ward routing rather than inefficient constitutive internalization. Involvement of lysines and 
their ubiquitination in controlling the receptor distribution has also been recently reported 
for CD33, an ITIM-containing immunoreceptor (Walter et al., 2007)and gp130 (Tanaka et 
al., 2008).
Whether Wsb proteins are exclusively involved in the control of forward routing of G-CSFR 
or whether alternative E3 complexes may play a role remains to be elucidated. Interestingly, 
another WD40-containing protein, β-Trcp, which comprises an F box, has been identified 
as the E3 ligase responsible for ubiquitinatiion of several cytokine receptors, including EpoR 
(Meyer et al., 2007) and IFNAR1 (Kumar et al., 2004). Although for these latter receptors, 
it was shown that β-Trcp binds to the activated, i.e., serine phosphorylated receptor chains 
(Fuchs et al., 2004; Li et al., 2004), it is possible that β-Trcp binds directly to the G-CSFR 
C-terminus via its WD40 domain.
6.2.3. The role of e2 ubiquitin-conjugating and e3 ubiquitin-ligating enzymes in 
intracellular trafficking of membrane receptors
As described earlier, ubiquitin modification is a concerted action of three enzymes. E1 acti-
vates and generates a thiol ester bond with Gly76 of ubiquitin in an ATP-dependent manner 
and the ubiquitin molecule is then transferred to an E2 ubiquitin-conjugating enzyme (Ubc). 
Finally the ubiquitin ligates to a lysine residue of the substrate by the action of E3 ubiquitin-
ligating enzyme. There are only one or two E1 enzymes, approximately 60 E2 enzymes and 
more than 400 E3 ligases in the human genome (Li et al., 2005). Interaction of E2 with E3 and 
recognition of limited substrates by certain E3s regulate specificity of the ubiquitin modifica-
tion (Jackson et al., 2000).
All E2 ubiquitin-conjugating enzymes share a conserved catalytic domain consisting of 
approximately 150 amino acids. Some family members have N- or C-terminal extensions 
that may facilitate specific interactions (Pickart, 2001; Pickart and Eddins, 2004). Certain 
E2s interact with E3s from both HECT- and RING-domain families. For example, UbcH7 is 
able to bind to HECT domain of E6-AP (Huang et al., 1999; Kumar et al., 1997; Nuber et al., 
1996) and also to several known RING E3 ubiquitin ligases like Cbl (Moynihan et al., 1999; 
Yokouchi et al., 1999; Zheng et al., 2000).
It has been proposed that specificity of target lysine in formation of polyubiquitin chains 
may be determined by the E2 (Pickart and Eddins, 2004). For example Lysine48-linked 
ubiquitin chains are formed by members of Ubc4, Ubc5 and Ubc7, whereas generation of 
polyubiquitin chains via Lysine63 is mediated by Ubc13 and some other Ubc variants (Hof-
mann and Pickart, 1999). In agreement with this, it was recently reported that CHIP, a U-box 
E3 ubiquitin ligase, is able to form lysine63-linked polyubiquitin chains with its functional 
partner, Ubc13 (Zhang et al., 2005). However a more recent study demonstrated that Ubc4/5 
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family is the primary E2 for Cbl mediated EGFR polyubiquitination (Umebayashi et al., 
2008), which is made by lysine63-linked ubiquitin chains (Huang et al., 2006).
The E2 ubiquitin-conjugating enzymes involved in ubiquitination of G-CSFR have not yet 
been identified. Screening different members of E2 family in E2-E3 interaction assays can 
assist in uncovering the E2 partner of SOCS3-mediated G-CSFR ubiquitination. Impor-
tantly, functional studies such as colocalization, knockdown and in vitro analyses should be 
conducted to confirm the protein-protein interactions, since binding assays do not always 
identify functional E2-E3 pairs (Christensen et al., 2007; Deffenbaugh et al., 2003). Interest-
ingly, localization studies of E2-E3 pair can reveal where receptor ubiquitination occurs and 
if this proceeds after internalization in intracellular compartments such as early endosomes. 
Indeed, localization of Ubc4/5 as an E2 for Cbl-mediated EGFR ubiquitination in endosomal 
vesicles demonstrated that ubiquitinated status of EGFR is in fact maintained owing to the 
continuous ubiquitination (Umebayashi et al., 2008).
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Figure1. schematic representation of endocytosis and forward trafficking of G-csFr
PM: plasma membrane, CCV: clathrin-coated vesicles, RE: recycling endosome, EE: early endosome, MVB: multive-
sicular bodies, ER: endoplasmic reticulum. See main text for detailed explanation.
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Despite intensive studies on ubiquitin-mediated events, very little is known concerning the 
specificity of an E3 ligase for a certain substrate and subsequent ubiquitin modifications. 
One mechanism is presence of linear motifs within the cytoplasmic tail of plasma membrane 
receptors which has been shown to be involved in site-specific ubiquitination and recognition 
of substrate by E3 ubiquitin ligases as it was shown for β-Trcp (Kumar et al., 2007; Meyer et 
al., 2007). More recently, a consensus pattern was identified as a recognition determinant for 
substrates of a RING domain E3 ubiquitin ligase, TRAF6 (Jadhav et al., 2008). In the case of 
G-CSFR, however, we can not definitely rule out that there is a so far unknown linear motif 
within the proximity of functional lysine of G-CSFR, which may cooperate with recruitment 
of SOCS3 and activate lysosomal sorting pathway.
On the other hand, the type of ubiquitination (mono versus polyubiquitination) and 
topology of ubiquitin chains generated by E3 ligases can be specific for a certain target and 
therefore play an important role in the fate of ubiquitinated target. Whereas monoubiquit-
ination and lysine-63 linked polyubiquitination are involved in endocytosis and lysosomal 
sorting of membrane receptors, elongation of ubiquitin chains via lysine48 of ubiquitin 
molecule is a signal for proteasomal degradation. Some E3 ligases can catalyze both mono 
and polyubiquitination such as c-Cbl and β-Trcp E3 ubiquitin ligases in the case EGFR and 
EpoR, respectively (Haglund et al., 2003b; Huang et al., 2006; Kumar et al., 2007; Rubin et 
al., 2003; Soubeyran et al., 2003; Yokouchi et al., 2001). Although it is mostly reported that 
SOCS proteins through their SOCS box are involved in proteasomal degradation of their 
targets, we have shown that ligand-induced downregulation of G-CSFR can also be regulated 
by lysosomal sorting of receptor by SOCS3. The nature of ubiquitin chains made by SOCS3-
mediated G-CSFR ubiquitination needs further investigation. However the smear of ubiquit-
ination ranging from 135 to 170kDa rather than single ubiquitin implies oligoubiquitination 
or lysine-63 linked polyubiquitination. Further studies like mass spectrometry (Huang et 
al., 2006; Kirkpatrick et al., 2006; Kumar et al., 2007)or utilizing ubiquitin mutants lacking 
functional lysines (for example lysine-63) are required to determine the precise role of these 
modifications.
6.2.4. Possible endocytotic adaptors linked to lysine-632 responsible for G-csFr lysosomal sorting
G-CSFR lysine-632 is located at position –5 relative to the box1 region (PGIPSP). Intrigu-
ingly, this residue is a highly conserved lysine upstream of box1 region among several other 
cytokine receptors such as leptin receptor, gp130 and human EpoR (table I). Furthermore, 
most of these receptors have a SOCS3 binding site. This might be suggestive of a general 
mechanism of the juxtamembrane lysine and merits investigations to demonstrate its poten-
tial role in regulation of lysosomal routing. Interestingly, TpoR possessing an arginine at this 
position recycles to the plasma membrane in myeloid cells (Dahlen et al., 2003). However 
mutation of K632 to arginine in G-CSFR (K632R G-CSFR) does not generate a recycling 
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receptor and results in retention of the mutant receptor in early endosomal compartment 
and preclude its trafficking to lysosomes.
In the experiments described in Chapter 3, it was shown that the position of the ubiquitinated 
lysine of the G-CSFR in an imperative proximity of the plasma membrane is crucial for its 
appropriate function. Therefore, selection of this lysine by ubiquitin machinery may stem 
from the interaction of the specifically ubiquitinated cargo protein with downstream sorting 
proteins linked to the plasma membrane. Indeed, it has been postulated that several sorting 
proteins containing ubiquitin-binding domains (UBDs) posses binding sites for membrane 
phosphoinositides (Slagsvold et al., 2005; Slagsvold et al., 2006; Stahelin et al., 2002). These 
proteins such as epsin, Hrs (a member of ESCRT-0 complex) and Eap45 (a member of ES-
CRT-II complex) play a critical role in sorting of the cargo to late endosomes/ multivesicular 
bodies. Furthermore, electron microscopic studies show localization of these proteins with 
clathrin coated vesicles (Stang et al., 2004; Wendland, 2002).
An interesting question is which UBD-containing protein(s) linked to K632 is involved in 
sorting of the G-CSFR. Several strategies, such as pull-down assays, mass spectrometry and 
employing siRNAs against candidate sorting proteins could assist to address this question. 
Thus far, we were unable to show interactions of UBD-containing proteins such as Hrs, 
STAM and Eap45 with G-CSFR. However, it must be noted that showing these interactions is 
not effortless for several reasons. First, binding of a UBD to a free ubiquitin has a low affinity 
(Kd=0.1-1 mM) (Fisher et al., 2003). Additionally, these proteins are target of ubiquitination 
themselves, which hasten their degradation (Di Fiore et al., 2003; Katz et al., 2002; Polo et al., 
2002). And finally, given the fact that ubiquitination is a dynamic and reversible process, dis-
sociation of ubiquitin molecules from the ubiquitinated cargo reduces the chance of detection 
of ubiquitin-UBD association. Recent developments by using siRNAs against proteins such 
as Hrs and STAM give the opportunity to demonstrate the role of these proteins in lysosomal 
trafficking. However, siRNAs against such essential components of MVB sorting may have 
a secondary effect which is aggregation of endosomes. Generation of enlarged/abnormal 
endosomes can in turn inhibit further routing of the ubiquitinated cargo to lysosomes.
6.2.5. Potential role of deubiquitinating enzymes in trafficking of G-csFr
It has been shown that the attachment of ubiquitin molecules to the cytoplasmic lysine 
residues of several cytokine receptors results in sorting to lysosomal compartments, whereas 
the receptors such as tranferrin and low-density lipoprotein receptors that do not undergo 
ubiquitination, recycle back to the plasma membrane. Therefore, the process of routing to 
multivesicular bodies and lysosomes is regulated by ubiquitin modifications at the level of 
endosomes. Ubiquitination is a reversible post translational modification and ubiquitin 
molecules can be removed from ubiquitinated cargo by deubiquitinating enzymes (DUBs). 
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There are approximately 95 putative DUBs encoded by human genome (Nijman et al., 2005). 
Functions of DUB and their substrate specificity are poorly studied as compared to that of 
the ligase enzymes.
The Src homology 3 (SH3) domain of STAM, a member of ESCRT-0 complex is a com-
mon binding site for two DUBs called UBPY (Ub-specific protease 1) and AMSH (associated 
molecule with the SH3 domain of STAM) (Kato et al., 2000; McCullough et al., 2006; Tanaka 
et al., 1999). Both UBPY and AMSH have been shown to be required for efficient degradation 
of EGFR (McCullough et al., 2006; Mizuno et al., 2005; Row et al., 2006). However deubiq-
uitination of EGFR by UBPY depletion and its involvement in enhancement or inhibition of 
degradation is a matter of debate (Alwan and van Leeuwen, 2007; Mizuno et al., 2005; Row 
et al., 2006). Whereas UBPY does not discriminate between polyubiquitin chains elongated 
via lysine 63 or lysine 48, AMSH can only process lysine 63-linked polyubiquitin chains. 
Therefore, AMSH does not play a direct role in proteasomal degradation. Primary studies 
in overexpression of both AMSH and UBPY showed decreased ubiquitination of G-CSFR 
table I. alignment of receptors harbouring the conserved juxtamembrane lysine residue and involvement of 
socs3 in receptor signalling
receptor species sequence
socs3 binding
(reference)
G-csFr
mouse
human
KRRGKTSFW SDVPDP
SPNPKNPLW PSVPDP
Hortner et al. 2002
van de Geijn et al. 2004
epor
mouse
human
 RRTLQQKIW PGIPSP
 RRALKQKIW PGIPSP
Sasaki et al. 2000
Hortner et al. 2005
GHr
mouse
human
 QQRIKMLIL PPVPVP
 QQRIKMLIL PPVPVP
Ram et al.1999
Riddersrale et al. 2003
gp130
mouse
human
 RDLIKKHIW PNVPDP
 RDLIKKHIW PNVPDP
Nicholson et al. 2000
Bergamin et al. 2006
Il4r
mouse
human
 ITKIKKIWW DQIPTP
 ITKIKKEWWDQIPNP
Hague et al. 2000
Ratthe et al. 2007
Il7r
mouse
human
 KKRIKPVVW PSLPDH
 KKRIKPIVW PSLPDH
Il9r
mouse
human
 SPRLKRIFY QNIPSP
 SPRVKRIFY QNVPSP
Lejeune et al. 2001
lepr
mouse
human
HQRMKKLFW DDVPNP
HQRMKKLFW EDVPNP
Eykerman et al. 2000 Bjorbak 
et al. 2000
tpor
mouse
human
YRRLRHALW PSLPDL
YRRLRHALW PSLPDL
-
Il2 rβ
mouse
human
GPWLKTVLK CHIPDP
GPWLKKVLK CNTPDP
Cohney et al.1999
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(ongoing experiments). Controlling the level of protein ubiquitination by DUBs takes place 
at early stages of the endosomal sorting, indicating that DUBs act before full commitment of 
ubiquitinated cargo to MVBs (Clague and Urbe, 2003). Removing ubiquitin at this step may 
enhance receptor recycling; however wt G-CSFR does not recycle to the plasma membrane. 
In addition lack of ubiquitination in K5R G-CSFR mutant does not influence recycling path-
way. One explanation is immediate attachment of ubiquitin molecules to the deubiquitinated 
G-CSFR and subsequent routing to the lysosomal pathway. Another explanation is involve-
ment of DUBs in later stages of sorting when ubiquitinated G-CSFR is already committed to 
MVBs. The latter model has been proposed for AMSH in receptor tyrosine kinase sorting by 
competing with Vps4 for CHMP (ESCRT-III) binding after commitment of RTK to the MVB 
(Agromayor and Martin-Serrano, 2006; Clague and Urbe, 2006; Tsang et al., 2006). However 
a recent report suggests that ubiquitinating and deubiquitinating activities compete along the 
endocytotic pathway (Umebayashi et al., 2008). Involvement of DUBs in G-CSFR deubiquit-
ination and their potential role in regulation of lysosomal sorting by opposing SOCS3 need 
to be investigated in more detail.
6.2.6. socs3 as a negative regulator of G-csF signaling in vivo
The studies presented in this thesis and in earlier work from our laboratory (van de Geijn et 
al., 2004b) have elucidated the various functions of SOCS3 protein in the negative regulation 
of G-CSF signaling in vitro. However, the biological role of SOCS3 is best exemplified in 
mouse models.
As described earlier, SOCS3 knockout mice were shown to be embryonic lethal (Marine 
et al., 1999; Roberts et al., 2001). To investigate the role of SOCS3 in adult tissues several 
conditional mouse models were generated to examine the role of SOCS3 in various systems 
including hematopoietic system. Two models were used for deletion of SOCS3 in all he-
matopoietic and endothelial tissues (Croker et al., 2004; Kimura et al., 2004). In both models, 
SOCS3 was found to be a negative regulator of G-CSF signaling. These mice are viable and 
healthy; however from 17 weeks of age they demonstrate neutrophil leukocytosis and infiltra-
tion of hematopoietic cells into the liver and lungs (Croker et al., 2004). Administration of 
G-CSF to these mice resulted in neutrophilia, with neutrophil levels exceeding those of wild 
type littermates, indicating that loss of Socs3 results in hypersensitive to G-CSF stimulation 
in vivo (Croker et al., 2004). Recently, a mouse model lacking the SOCS box motif of SOCS3 
was generated by Boyle and colleagues. These mice are viable and do not reveal any abnor-
malities (Boyle et al., 2007). Interestingly, they exhibited exaggerated responses to G-CSF 
administration. Furthermore, JAK/STAT signaling downstream of G-CSFR was enhanced in 
the bone marrow cells. This was in agreement of in vitro studies suggesting that SOCS box 
was required for negative regulation of STAT5 and, to a lesser extent, STAT3 activation fol-
lowing G-CSF stimulation (van de Geijn et al., 2004a). The delta SOCS box mouse model was 
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the first in vivo demonstration that the SOCS box of SOCS3 plays a crucial role in inhibition 
of G-CSF signaling.
6.2.7. altered ubiquitin signalling and its implications for myeloid disorders
 As discussed above maintenance of balance between proliferation and differentiation of 
myeloid progenitors to mature neutrophils is controlled by appropriate signal transduction 
via G-CSFR. Aberrant signalling function of G-CSFR caused by a number of mutations or 
rare polymorphisms in the G-CSFR gene (Touw and van de Geijn, 2007), results in enhanced 
number of blood cells and upregulated levels of signalling in myeloid disorders. Lack of 
lysosomal sorting of a G-CSFR mutant, due to lack of ubiquitination leads to prolonged G-
CSF signalling. This receptor mutant contributes to hyperproliferation phenotype without 
induction of differentiation in myeloid 32D cells. Therefore, G-CSFR turnover and signal 
downregulation plays a pivotal role in G-CSF-controlled neutrophil development.
Analysis of AML patients did not show any mutations in the cytoplasmic lysines of the G-
CSFR or SOCS3. However further investigation is required to determine abnormal activation 
of endocytotic adaptor proteins directing lysosomal trafficking, other E3 ligases and DUBs 
involved in ubiquitination or deubiquitination of G-CSFR, respectively.
Involvement of endocytotic adaptors and their alteration such as loss or overexpression 
have been implicated in oncogenesis (for review see Crosetta et al. 2005). An extensively-
studied example is Tsg101 which has also been identified in truncated transcripts in human 
leukaemia and lymphoma cell lines (Hosokawa et al., 2000; Li et al., 1998)Ferrer et al. 1999). 
Regarding E3 ubiquitin ligases, different types of molecular alterations such as mutation or 
misexpression have been demonstrated that occur in haematopoietic malignancies. For in-
stance, inactivating mutations in the Von Hippl-Lindau (VHL) E3 ligase is detected in patients 
with congenital polycythemia (Pastore et al., 2003a; Pastore et al., 2003b). An example of E3 
ligase misexpression was presented in chapter 3.  Using gene expression profiling, we showed 
that Wsb2 is downregulated in a subclass of patients with CEBPα mutations (Erkeland et 
al., 2007; Gaullier et al., 1999). Furthermore, Wsb2 has been identified in a common virus 
integration site in a murine myeloid leukemia, leading to disruption of the gene (Erkeland et 
al., 2004). Therefore misexpression of Wsb2 may contribute to myeloid leukemia through G-
CSFR accumulation. And finally, deregulation of specific DUBs has also been implicated in 
leukemogenesis. For instance, the DUB USP42 was identified in a translocation with RUNX1 
in acute myeloid leukaemia (Paulsson et al., 2006). These observations suggest that altered 
ubiquitin signalling pathways are important in normal haematopoiesis and characterization 
of such molecular alterations is critical to develop new treatments for blood cancer. 
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In het afgelopen decennium is veel onderzoek verricht aan intracellulaire “trafficking” van 
groeifactorreceptoren en de mechanismen die dit proces besturen. Deze studies hebben laten 
zien dat ubiquitinering van lysine residuen in het cytoplasmatisch domein van receptoren 
een cruciale rol speelt bij de endocytose en sortering van membraanreceptoren naar com-
partimenten waarin eiwitten worden afgebroken. Veel werk is uitgevoerd in modelsystemen 
van de zogenaamde intrinsieke tyrosine kinase receptoren, in het bijzonder de EGF recep-
tor {Pennock et al MBC 2008, Huang et al. PNAS 2007, Huang et al. Mol cell 2006, Stang 
et al MBC 2004, Haglund et al MCB 2003, Row et al. JBC 2006, McCullough et al. Curr 
Biol 2006}. Hoewel deze studies de algemene principes van internalisering en endosomale 
sortering hebben blootgelegd, is uit onderzoek aan andere receptorsystemen, met name de 
cytokinereceptoren, een aanzienlijke mate van diversiteit naar voren gekomen. Dit geldt 
bijvoorbeeld voor de rol van receptor lysines in de ligand-geïnduceerde internalisering, de 
ubiquitine ligase (E3) complexen betrokken bij deze processen, specifieke domeinen die een 
interactie met deze complexen aangaan en de aard van de ubiquitine modificaties (mono-, 
multi- en poly-ubiquitinering). De experimenten beschreven in dit proefschrift hadden tot 
doel de mechanismen betrokken bij de intracellulaire “trafficking” van de G-CSF receptor op 
te helderen.
Hoofdstuk 1 geeft een overzicht van de huidige kennis van zaken over ligand-afhankelijke en 
–onafhankelijke intracellulaire routing van cytokine receptoren. Endocytose van het receptor 
complex is een van de mechanismen verantwoordelijk voor het uitschakelen van cytokine-
geïnduceerde signaaltransductie. Trafficking van de G-CSFR via de endocytotische route, 
middels internalisering, routing via vroege endosomen naar late endosomen, multivesicular 
bodies (MVB) en lysosomen, en de effecten daarvan op de remming van de signaalfunctie 
worden in dit hoofdstuk geïntroduceerd. Tevens wordt de rol van receptor ubiquitinering 
door E3 ubiquitine-ligasen en de rol van effector-eiwitten betrokken bij lysosomale sortering 
in zowel de retrograde als de voorwaartse richting beschreven.
Hoofdstukken 2 en 3 behandelen endocytose en retrograde routing van de G-CSFR na 
activering door het ligand G-CSF. In Hoofdstuk 2 wordt de rol van G-CSFR ubiquitinering en 
de daarbij betrokken E3 ubiquitine-ligase beschreven in relatie tot endocytose en lysosomale 
routing. In het bijzonder is de differentiële betrokkenheid van de cytoplasmatische lysines van 
de G-CSFR onderzocht. Deze studies hebben laten zien dat K632, een lysine residu gelegen in 
het juxtamembraan domein van de G-CSFR, afhankelijk van SOCS3 wordt geubiquitineerd 
na receptor activering. De lysosomale sortering en SOCS3-geinduceerde signaalremming van 
de G-CSFR blijken exclusief afhankelijk van dit lysine residu, ondanks het feit dat er in totaal 
5 geconserveerde lysines in het cytoplasmatisch domain van de G-CSFR aanwezig zijn.
De bevindingen beschreven in Hoofdstuk 3 laten zien dat endocytose een voorwaarde is 
voor de ubiquitinering van de G-CSFR. Tevens werden de moleculaire determinanten ve-
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rantwoordelijk voor de functie van K632 van de G-CSFR lysine 632 verder onderzocht. De 
membrane-proximale positionering van het lysine residue blijkt essentieel voor de rol die 
deze lysine speelt bij lysosomale sortering en signaalremming, hoewel een beperkte mate van 
flexibiliteit in de positionering getolereerd wordt. De in dit hoofdstuk beschreven resultaten 
suggereren verder dat de specifieke betrokkenheid van K632 bij lysosomale routing voort-
komt uit interacties met effector-eiwitten die voor hun functie afhankelijk zijn van een positie 
dicht bij de plasmamembraan. Bovendien blijkt uit de resultaten beschreven in dit hoofdstuk 
dat er geen rigide positionering van K632 ten opzichte van de SOCS3 bindingsplaats Y729 
noodzakelijk is voor het ubiquitineren van K632 door SOCS3.
Voorwaartse routing en constitutieve distributie van de G-CSFR zijn beschreven in 
hoofdstukken 4 en 5. In Hoofdstuk 4 worden twee determinanten verantwoordelijk voor de 
regulatie van membraanexpressie en stabiliteit van de G-CSFR in de context van voorwaartse 
routing nader bestudeerd: 1) de juxtamembraan gelokaliseerde lysine K632 van G-CSFR, 
betrokken bij de regulatie van degradatie, en 2) verhoogde expressie van JAK eiwitten. De 
effecten van JAKs blijken niet te worden veroorzaakt door maskering van motieven in de 
G-CSFR die essentieel zijn voor receptor internalisering en lysosomale routing of door het 
reduceren van de ubiquitinering van G-CSFR. Wel blijkt uit dit hoofdstuk dat verhoogde 
expressie van JAK eiwitten aanleiding geeft tot spontane (G-CSF onafhankelijke) signaalac-
tiviteit van routing-defectieve G-CSFR mutanten, hetgeen leidt tot verhoogde celoverleving 
van groeifactor afhankelijke cellen in afwezigheid van groeifactoren.
In Hoofdstuk 5 wordt de regulatie van G-CSFR expressie op het celoppervlak door de cyto-
plasmatische lysine residuen verder onderzocht. Getoond wordt dat Wsb eiwitten binden 
aan de C-terminus van de G-CSFR, waar zij vervolgens als E3 ubiquitine ligasen functioneren 
onder ligand onafhankelijke condities. Fusie van Wsb2 aan de C-terminus van G-CSFR laat 
zien dat ubiquitinering van de G-CSFR lysine residues via de SOCS box van Wsb G-CSFR ex-
pressie op de plasmamembraan negatief beinvloedt en op die wijze een belangrijke rol speelt 
bij de het in stand houden van de balans tussen proliferatie en differentiatie van myeloide 
voorlopercellen onder invloed van G-CSF.
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lIst oF abbrevIatIons
aMl: acute myeloid leukaemia
aMsH: associated molecule with the SH3 domain of STAM
bio-G: biotinylated G-CSF
β-trcp: β-transduction repeat-containing protein
ccv: clathrin-coated vesicle
cHX: cycloheximide
clsM: confocal laser scanning microscopy
clP: common lymphoid progenitor
cMP: common myeloid progenitor 
crH: cytokine receptor homology
csF: colony-stimulating factors
dMeM: dulbecco modified Eagle’s medium
dub: deubiquitinating enzyme
ecs: Elongin-Cullin-SOCS box
ee: early endosome
eea-1: early endosomal antigen-1
eMsa: electrophoretic mobility shift assay
ePo: erythropoietin
ePor: erythropoietin receptor
eGFr: epidermal growth factor receptor
erad: endoplasmic reticulum-associated degradation
escrt: endosomal sorting complexes required for transport
Fbs: fetal bovine serum
Fcs: fetal calf serum
FGFr: fibroblast growth factor receptor
FItc: fluorescein isothiocyanate
Fn III: fibronectin type III
Fzr1: Fizzy-related 1
GaM: goat anti-mouse Ig 
Gat: GGA and TOM1
G-csF: granulocyte colony stimulating factor
G-csFr: granulocyte colony-stimulating factor receptor
GF: growth factor
GGa: golgi-localized gamma-ear-containing Arf-binding
GHr: growth hormone receptor 
GM-csF: granulocyte-macrophage colony-stimulating factor
GMP: granulocyte macrophage progenitor
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Ha: haemagglutinin 
Hect: homologous to E6-AP carboxyl terminus
HGFr: hepatocyte growth factor receptor
HrP: horseradish peroxidise
Hsc: hematopoietic stem cell
HGF: hematopoietic growth factor
Hos: homolog of Slimb
Hrs: hepatocyte growth factor regulated tyrosine kinase substrate
IFnar1: interferon alpha receptor1
Ig: immunoglobulin
Il: interleukin
Il-2r: interleukin-2 receptor
JaK: Janus tyrosine kinase
KIr: kinase inhibitory region
lamp-1: lysosome-associated membrane protein-1
lIF: leukemia inhibitory factor
lr: leptin receptor
mab: monoclonal antibody
MaPPIt: mammalian protein-protein interaction trap
MeP: megakaryocyte erythroid progenitor
MFI: mean fluorescence intensity
Mvb: multivesicular body
osMr: oncostatin M receptor
Pe: phycoerythrin 
PH: pleckstrin homology
PI3-kinase: phosphatidylinositol 3-kinase
PIP3: phosphatidylinositol 3-phosphate
PKb: protein kinase B
PM: plasma membrane
Prlr: prolactin receptor
PtdIns: phosphatidylinositol
Py: phosphotyrosine
re: recycling endosome
scF: Skp1/ Cullin/ F box
scFr: stem cell factor receptor
scn: severe congenital neutropenia
sH2: Src homology 2
socs: suppressor of cytokine signalling
staM: signal transducing adaptor molecule
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stat: signal transducer and activator of transcription
tFr: transferrin receptor
tGF: transforming growth factor
tGn: trans-golgi network
toM1: target of Myb1
tPo: thrombopoietin
tPor: thrombopoietin receptor
tsg101: tumor suppressor gene 101
ub: ubiquitin
ubd: ubiquitin binding domain
ubPy: Ub-specific protease
uIM: Ub-interacting motif
vHl: von Hippel-Lindau
vHs: Vps27, Hrs, STAM
Wsb: WD40 repeat and SOCS-box containing protein 
Wt: wild type
y: tyrosine
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Figure 2. Role of G-CSFR lysines in lysosomal routing 
Figure 2. role of G-csFr lysines in lysosomal routing
 HeLa cells ectopically expressing wt or K5R G-CSFR were incubated with G-CSFR antibodies and G-CSF for 20 min 
at 16°C, washed and transferred to 37°C for 15 or 120 min as indicated. Subsequently, cells were fixed and stained for 
internalized G-CSFR (green, left panels) and organelle markers EEA1, Rab7 or Hrs (red, middle panels) and analyzed 
by CLSM. Merged pictures are shown in the right panels, indicating co-localization in yellow. Insets show enlarge-
ments of the boxed areas. (A) Presence of wt G-CSFR in EEA1-positive early endosomes at 15 min and in Rab7- posi-
tive late endosomes/lysosomes at 120 min after internalization. (B) K5R is present in EEA1-positive endosomes at 
15 min, but is not detectable at Rab7-positive endosomes/lysosomes at 120 min after internalization. (C) Presence of 
K5R (arrows) but not wt G-CSFR in EEA1-positive endosomes at 120 min after internalization. (D) Presence of K5R 
but not wt G-CSFR in Hrs-positive endosomes 120 min after internalization. Scale bar, 10μm
 
Figure 3. Co-localization of Wsb and G-CSFR in intracellular vesicles 
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supplementary Figure 1. retention of K5r G-csFr in early endosomes 4hrs after internalization
Hela cells were transfected with wt or K5R G-CSFR and stained for localization in EEA1 positive endosomes as 
detailed under Figure 2 (chapter 2).
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Figure 3. Intracellular localization of K5R G-CSFR in myeloid 32D cells 
 
 
 
 
Supplementary Figure 2. Co-localization of wt G-CSFR with Hrs, 30min after internalization 
 
 
 
 
Figure 3. Intracellular localization of K5r G-csFr in myeloid 32d cells
32D clones expressing wt or K5R G-CSFR were allowed to bind biotinylated G-CSF (bio-G) for 60 min at 4°C, 
washed and transferred to 37°C for an additional 60 min. Subsequently, cells were spun on glass slides, fixed, immu-
nostained for bio-G and Lamp-1 and analyzed by CLSM. Scale bar: 10 μm
 
 
Figure 3. Intracellular localization of K5R G-CSFR in myeloid 32D cells 
 
 
 
 
Supplementary Figure 2. Co-localization of wt G-CSFR with Hrs, 30min after internalization 
 
 
 
 
supplementary Figure 2. co-localization of wt G-csFr with Hrs, 30min after internalization
Hela cells were transfected with wt G-CSFR and stained for localization in HRS positive endosomes as detailed under 
Figure 2 (chapter 2).
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Figure 5. Intracellular localization of G-CSFR mutants   
 
Figure 5. Intracellular localization of G-csFr mutants
(A) HeLa cells were transfected with G-CSFR mutants K632R, K672R and Y729F and examined for localization in 
Rab7-positive endosomes or lysosomes after 120 min as detailed under Figure 2. (B) HeLa cells were co-transfected 
with wt G-CSFR and 30 nM SOCS3 siRNA (upper panel) or 30 nM control siRNA (lower panel) and analyzed as 
outlined above.
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Supplementary Figure 3. Intracellular localization of G-CSFR mutants 
 
 
supplementary Figure 3. Intracellular localization of G-csFr mutants
HeLa cells were transfected with G-CSFR mutants K6812R, K682R and K762R and examined for localization in Rab7 
positive endosomes or lysosomes as detailed under Figure 2 (chapter 3).
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Figure 3. Fusion of ubiquitin to the c-terminus does not restore lysosomal sorting and downregulation stat5 
activation
(A) HeLa cells ectopically expressing WT, K5R or K5R-monUb G-CSFR were incubated with anti-G-CSFR antibod-
ies and G-CSF for 20 min at 16°C, washed and transferred to 37°C for 60 min. Subsequently, cells were fixed and 
stained for internalized G-CSFR (green, left panels) and the late endosomal/lysosomal marker rab7 (red, middle 
panels) and analyzed by CLSM. Merged pictures are shown in the right panels indicating colocalization in yellow. 
Insets show enlargements of boxed areas.
 
Figure 3. Co-localization of Wsb and G-CSFR in intracellular vesicles 
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Supplementary figure 2. Lysosomal routing of selected ‘walking’ lysine G-CSFR mutants  
 
sup le e tary figure 2. lysosomal routing of selected ‘walking’ lysine G-csFr mutants 
HeLa cells ectopically expressing indicated G-CSFR mutants were processed as described (Figure 3A) and analyzed 
by CLSM after staining for internalized G-CSFR (green, left panels) and the late endosomal/lysosomal marker rab7 
(red, middle panels). Merged pictures are shown in the right panels indicating colocalization in yellow. Insets show 
enlargements of boxed areas
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Figure 6. A G-CSFR mutant lacking the di-leucine-based internalization motif (d749-69) is hampered and 
delayed in ubiquitination, while a disease-associated truncated G-CSFR mutant lacks ubiquitination 
completely 
 
Figure 6. a G-csFr mutant lacking the di-leucine-based internalization motif (d749-69) is hampered and de-
layed in ubiquitination, while a disease-associated truncated G-csFr mutant lacks ubiquitination completely
(E) HeLa cells ectopically expressing G-CSFR_d715 mutants were processed as described (Figure 3A) and analyzed 
by CLSM after staining for internalized G-CSFR (green, left panels) and the late endosomal/lysosomal marker rab7 
(red, middle panels). Merged pictures are shown in the right panels indicating colocalization in yellow.
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Figure 7. Fusion of ubiquitin to the C-terminus of G-CSFR_d715 restores internalization but not lysosomal 
sorting 
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Figure 7. Fusion of ubiquitin to the C-terminus of G-CSFR_d715 restores internalization but not lysosomal 
sorting 
 
Figure 7. Fusion of ubiquitin to the c-terminus of G-csFr_d715 restores internalization but not lysosomal 
sorting
(A) HeLa cells ectopically expressing wt, d715 or d715-Ub G-CSFR were labeled with anti-GCSFR antibody prior to 
incubation with G-CSF for 30min. After washing cells were permeabilized, stained with a secondary goat anti-mouse 
Alexa Fluor 488 and analyzed by CLSM. (B) HeLa cells ectopically expressing G-CSFR_d715-Ub were processed as 
described (Figure 3a) and analyzed by CLSM after staining for internalized G-CSFR (green, left panels) and the late 
endosomal/lysosomal marker rab7 (red, middle panels). Merged pictures are shown in the right panels indicating 
colocalization in yellow.
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Figure 3. Role of receptor lysines in CSF3R cell surface expression 
Figure 3. role of receptor lysines in csF3r cell surface expression
(B) Confocal microscopy images of HeLa cells transiently transfected with wt or K5R CSF3R constructs.
 
Figure 3. Co-localization of Wsb and G-CSFR in intracellular vesicles 
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Figure 3. Co-localization of Wsb and G-CSFR in intracellular vesicles 
 
Figure 3. co-localization of Wsb and G-csFr in intracellular vesicles
CLSM analys s of HEK293-T cells transfected with G-CSFR wt (A), Δ715 (B), Δ749-769 (C) or Δ769 (D) together 
with myc-tagged Wsb-2. Cells growing on glass slides were fixed 2 days after transfection and immunostained for 
G-CSFR (left panels; green) or myc-Wsb (middle panels). After merging left and middle panels, co-localization 
appears as yellow (right panels). Size bar indicates 10μM.
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Figure 6. steady-state distribution of G-csFr-Wsb fusion proteins.
(E) CLSM of steady-state distribution of G-CSFRΔ769-Wsb-2 (left), G-CSFRΔ769-Wsb-2ΔSB (middle) and K5R-G-
CSFRΔ769-Wsb-2 (right) on HEK293-T transfectants.
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Figure 3. Co-localization of Wsb and G-CSFR in intracellular vesicles 
 
 
Figure 5. role of c-terminal region of G-csFr in steady-state membrane expression, receptor internalization 
and proliferation/differentiation signaling
(D) Light micrographs of May Grünwald-Giemsa stained cells on day 10 of culture (x 690).
